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Eine Vielzahl der Proteine des menschlichen Körpers werden mit verschiedensten Krank- hei-
ten in Verbindung gebracht. Dies führt dazu, dass viele dieser Proteine als Biomarker für die
Diagnose eines bestimmten Krankheitsbildes genutzt werden können. So z.B. Autoantikörper,
welche im Falle einer Autoimmunerkrankung auftauchen und somit Biomarker für die jeweili-
ge Autoimmunerkrankung sind. Durch die Detektion dieser, mittels der Verwendung des ent-
sprechenden Autoantigens in diagnostischen Assays kann die jeweilige Autoimmunerkrankung
diagnostiziert, sowie deren Verlauf überwacht werden. Proteinautoantigene werden biotechnolo-
gisch, mittels rekombinanter Expression, Zellkultur- und Extraktionstechniken hergestellt. Die
Reinigung dieser Proteine gestaltet sich oft besonders schwierig, da die Proteine meist sehr nied-
rig konzentriert in äußerst komplexen Gemischen (z.B. Zelllysaten) vorliegen. In der vorliegenden
Doktorarbeit wurden Lösungsansätze für die Schwierigkeiten, welche mit der Prozessentwicklung
für die Reinigung dieser Proteine assoziiert sind, erarbeitet. Das Ziel der Arbeit war es durch
die Entwicklung systematischer Screeningmethoden die Prozessentwicklung zur Reinigung von
Autoantigenen deutlich zu vereinfachen und zu beschleunigen. Die Arbeit ist in drei Hauptteile
und einen zusätzlichen Teil gegliedert:
I. Entwicklung einer systematischen Vorgehensweise zur Generierung von Puffersystemen für
die pH Gradienten Ionenaustauschchromatographie (IAC).
II. Multi-dimensionale, chromatographische Analytikmethoden basierend auf pH- und Salz-
gradienten IAC zur Ermittlung physikochemischer Parameter für die Auslegung von Rei-
nigungsprozessen für komplexe, biotechnologische Gemische mit niedrigen Produkttitern.
III. Entwicklung eines neuartigen Ansatzes zur Ermittlung mechanistischer Parameter in einem
weiten pH Bereich, für die in silico Optimierung (SMA Modell [1]) chromatographischer
Prozesse (IAC).
IV. Zusätzlich: Entwicklung und Anwendung einer hochauflösenden Methode basierend auf
pH Gradienten IAC, zur Charakterisierung von PEGylierungs - Positions - Varianten von
mono-PEGyliertem Lysozym.
Im ersten Teil der Arbeit ist die systematische Generierung von Puffersystemen, bestehend aus
mehreren Puffersubstanzen, für die pH Gradienten IAC dargestellt. Hierbei wurde ein Ansatz
entworfen die Zusammensetzung der verwendeten Puffersysteme in silico für deren Anwendung
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zu optimieren. Um lineare, kontrollierbare pH Gradienten in der IAC zu erhalten, muss die Puf-
ferkapazität eines Puffersystems so konstant wie möglich gehalten werden. Durch die Variation
der Puffersubstanzen, sowie deren Konzentrationen kann die Abweichung der Pufferkapazität ei-
nes Puffersystems, von einem konstanten Wert, minimiert werden. Hierzu wurde eine MATLAB-
Prozedur (Mathworks, Natick, MA, USA) zur Berechnung aller notwendigen Gleichungen, der
Pufferkapazität, der Titrationskurve und der Ionenstärke eines Puffersystems bestehend aus
mono-, di- und tri- basischen/protischen Substanzen, aufgesetzt. Um Puffersysteme mit mög-
lichst konstanter Pufferkapazität zu erhalten wurde die Prozedur durch einen Non-linear Least
Squares Algorithmus zur Minimierung der Abweichung der Pufferkapazität von einem konstan-
ten Wert, erweitert. Im Anschluss wurden Puffersysteme mit konstanter Pufferkapazität (10
mmol*l−1) über einen Bereich von 7.5 pH Einheiten für die pH Gradienten An- und Kathio-
nenaustauschchromatographie (AAC / KAC) erstellt. Bei der Verwendung der generierten Puf-
fersysteme (Mono Q / S 4.6/100 Säule, GE Healthcare, Uppsala, Sweden) wurden hochlineare
pH Gradienten mit einer Linearität R2 > 0.99 erzielt. Die Anwendbarkeit der Puffersysteme
für die Bestimmung der Elutions-pH Werte von Proteinen mittels pH Gradienten IAC wurde
im Anschluss gemäß den ICH Richtlinien [2], durch den Einsatz vier verschiedener Modellpro-
teine, validiert. Die ermittelten Abweichungen der Wiederholbarkeits- und Präzisionsmessung
für die Bestimmung der Elutions-pH Werte von Proteinen betrugen ∆pH < 0.1 pH Einheiten.
Die validierte Methodik wurde im Anschluss genutzt um das Elutionsverhalten von 22 verschie-
denen Modellproteinen in der pH Gradienten IAC zu untersuchen. Die Resultate zeigen klare
Unterschiede zwischen den verschiedenen Methoden, der pH Gradienten AAC / KAC und der
isoelektrischen Fokussierung (IEF). Diese resultieren aus der Wechselwirkung der Proteine in
der IAC mit einer geladenen Oberfläche. Darüber hinaus wurde eine unterschiedliche Selekti-
vität der beiden Ionenaustauschermodi beobachtet, welche durch die unterschiedliche Ladung
und somit abgeänderte Wechselwirkung der Proteine mit dem Adsorber erklärt werden kann.
Die gewonnenen Erkenntnisse bezüglich der Selektivität der unterschiedlichen Methoden für ver-
schiedene Trennprobleme erleichtern deren Auswahl für spezifische, analytische Fragestellungen.
Darüber hinaus wurde eine Möglichkeit geschaffen, durch ein einfaches und schnelles Verfahren
Puffersysteme für die pH Gradienten IAC als Hilfsmittel zur Entwicklung chromatographischer
Reinigungsprozesse [3], zu generieren.
Im zweiten Teil der Arbeit ist die Entwicklung und Validierung zweier multidimensionaler Tren-
nansätze zur Charakterisierung biotechnologischer Rohextrakte mit niedrigen Produkttitern,
mit dem Hintergrund der Prozessentwicklung für die Reinigung enthaltener Zielproteine, darge-
stellt. Dieser Teil kann in zwei Ansätze unterteilt werden: 1. Die multidimensionale Charakte-
risierung eines Zelllysates unter Einsatz von pH Gradienten IAC zur Auslegung eines einfachen
Reinigungsprozesses; 2. Die multidimensionale Charakterisierung eines Zelllysates mithilfe von
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Salzgradienten IAC zur Ermittlung mechanistischer Parameter für die in silico Simulation /
Optimierung chromatographischer Prozesse.
Zunächst wird eine generelle Methodik vorgestellt, mittels pH Gradienten IAC, SDS PAGE und
LC-MS basierter Proteinidentifikation ein Zelllysat zu charakterisieren, um im Anschluss die
gewonnenen Informationen zur systematischen Auslegung eines Reinigungsprozesses zu nutzen.
Das biotechnologische Rohextrakt wird hierzu zunächst durch pH Gradienten IAC (AAC pH
10.5 - 3 / KAC pH 4 - 11.5) aufgetrennt um spezifisch den Elutions-pH Wert des Zielproteins zu
bestimmen. Danach wird der verwendete pH Bereich auf den Elutionsbereich des Zielproteins
verringert (Elutions-pH +/- 1). Die resultierenden Fraktionen der Trennung des Rohextraktes
durch die fokussierte pH Gradienten IAC werden zunächst aufkonzentriert (Lyophilisation / Re-
solubilisation) und dann mittels Gelelektrophorese weiter aufgetrennt. Die enthaltenen Proteine
werden im Anschluss extrahiert und durch LC-MS basierte Proteinidentifikation identifiziert. Die
identifizierten Proteine stellen die kritischen Verunreinigungen für die Reinigung des Zielproteins
mittels IAC dar, da sie aufgrund ihrer elektrostatischen Eigenschaften dem Zielprotein ähnlich
sind. Die erhaltenen Daten (Protein-ID, Molekulargewicht, Elutions-pH AAC / KAC) bezüglich
des Zielproteins, sowie der kritischen Kontaminanten können anschließend zur systematischen
Auslegung der Reinigung des Zielproteins mittels IAC verwendet werden. Die Anwendbarkeit
des beschriebenen Ansatz wurde durch dessen Verwendung zur Charakterisierung eines Insekten-
zell / Baculovirus Lysat, mit einem enthaltenen Zielprotein (Nucleolin, GI 55956788, Fragment
RRM1-4) demonstriert. Bei dem Protein Nucleolin handelt es sich um ein RNA-bindendes Prote-
in, welches als Antigen für die Diagnose von systemischem Lupus Erythematosus eingesetzt wird.
Die Elutions-pHWert Bestimmung mittels zielproteinspezifischer Dot-Blot Analytik der Fraktio-
nen ergab Elutions-pH Werte von 4.85 (AAC) und 10.44 (KAC, bei 200 mM NaCl). Der enorme
Unterschied der beiden Elutions-pH Werte kann durch die positiv geladenen RNA-bindenden
Domänen des Proteins erklärt werden, da diese eine stark anisotropische Ladungsverteilung auf
der Proteinoberfläche und somit ein stark unterschiedliches Elutionsverhalten auf den beiden
unterschiedlichen Adsorbertypen verursachen. Um die kritischen Verunreinigungen zu identifi-
zieren wurde das Zelllysat mittels pH Gradienten IAC im Elutions-pH Bereich des Zielproteins
(AAC pH 5.5 - 3.5 / KAC pH 9.5 - 11.5, 200 mM NaCl) fraktioniert, durch SDS PAGE weiter
aufgetrennt und die enthaltenen Proteine abschließend mithilfe LC-MS basierter Proteiniden-
tifikation identifiziert. Die hierbei gewonnenen Informationen (Protein-ID, Molekulargewicht,
Elutions-pH Werte AEC/CEC) konnten erfolgreich zur Auslegung einer Zweischrittreinigung
des Zielproteins mittels IAC genutzt werden. Das Zelllysat wurde dazu zunächst auf einen Ka-
thionenaustauscher gebunden (SP Sepharose FF, pH 8.75, 200 mM NaCl) und im Anschluss mit
einem Elutionsschritt eluiert (pH 8.75, 500 mM). Die Ionenstärke der Elutionsfraktion wurde
nachfolgend mittels Ultrafiltration halbiert. Die Reinigung wurde dann durch Salzgradienten
x
AAC (Q Sepharose FF, pH 5.2, 0-500 mM NaCl) fortgesetzt. Durch die Zweischrittreinigung
konnte bereits eine Reinheit des Zielproteins von 80% erreicht werden. Die erreichte Reinheit
verdeutlicht klar den Nutzen des beschriebenen, analytischen Ansatzes um möglichst effizient
Reinigungsprozesse für Proteine aus komplexen, biotechnologischen Extrakten zu entwerfen.
Im zweiten Ansatz ist eine multidimensionale Analytikmethode zur Bestimmung chromatogra-
phischer Retentionsvolumina von Einzelproteinen im komplexen Gemisch dargestellt. Die ermit-
telten Retentionsvolumina werden im Anschluss dazu benutzt mechanistische Parameter (SMA
Modell [1]) für die Simulation / Optimierung chromatographischer Trennverfahren zu errechnen.
Die Analytikmethode besteht aus einer Salzgradienten IAC, einem Entsalzungsschritt mittels
Umkehrphasenchromatographie, einem Aufkonzentrierungsschritt und abschließender Analytik
durch Hochdurchsatz-Kapillar-Gelelektrophorese (HT-CGE). Die geschilderte Methodik wurde
dazu benutzt ein Insektenzell / Baculovirus Lysat mit einem enthaltenen Zielprotein zu analysie-
ren. Hierbei wurden die Konzentrationen, die Molekulargewichte und die Retentionsvolumina der
enthaltenen Einzelproteine ermittelt. Die Retentionsvolumina konnten durch die Rekonstrukti-
on der Peaks (Gauss-Peak-Fitting) aus den erhaltenen Daten der multidimensionalen Trennung
für vier unterschiedliche IAC Salzgradientenlängen bestimmt werden (5, 10, 20, 80 Säulenvo-
lumina, MonoQ 4.6/100, pH 5.2, 0-500 mM). Anhand der vier ermittelten Retentionsvolumina
jedes Einzelproteins, wurden die linearen SMA Parameter, die charakteristische Ladung ν und
die Gleichgewichtskonstante KSMA mittels des Formalismus von Shukla et al. [4] berechnet. Die
erhaltenen Parameter wurden im Anschluss erfolgreich, durch den Vergleich errechneter mit ex-
perimentel ermittelten Retentionsvolumina, validiert. Der Vergleich resultierte in einer mittleren
Abweichung von 5 % und einer maximalen Abweichung von 13.6 %. Darüber hinaus wurden die
Chromatogramme dreier Proteine exemplarisch über das Transport-Dispersive-Modell berech-
net. Der hierfür notwendige, nicht-lineare, sterische Faktor σ wurde für jedes Protein festgelegt
(σ = 30), da dieser sich experimentell nicht aus einem Gemisch ermitteln lässt. Der Einfluss dieses
Faktors ist in beschriebenem Fall jedoch vernachlässigbar, da die Konzentrationen der enthalte-
nen Proteine im linearen Bereich der Adsorptionsisothermen liegen und σ somit keinen Einfluss
auf die resultierenden Chromatogramme hat. Die vorhergesagten Chromatogramme stimmen
gut mit den experimentell ermittelten überein, dies bestätigt klar die Qualität der bestimmten
Parameter. Die Resultate verdeutlichen, dass mittels einer multidimensionalen Analytikmethode
schnell und im analytischen Maßstab die notwendigen Parameter für die in silico Optimierung
einer chromatographischen Trennung aus einem komplexen Gemisch ermittelt werden können.
Darüber hinaus kann eine solche Methodik auch zur kontinuierlichen Überwachung der Zusam-
mensetzung biotechnologischer Rohextrakte verwendet werden.
Im dritten Teil der Arbeit wird ein neuartiger Ansatz zur Ermittlung von SMA Parametern
für weite pH Bereiche vorgestellt. Die experimentelle Bestimmung solcher Parameter, für deren
xi
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ist meist sehr zeit- und arbeitsaufwändig. Aus diesem Grund werden diese meist nur für ein-
zelne, oder einige wenige verschiedene pH Werte bestimmt. Trotz alledem spielt der pH Wert
eine essentielle, nicht zu vernachlässigende Rolle für die Entwicklung von Reinigungsprozessen
über IAC. Daher wurde ein Ansatz entwickelt der es ermöglicht durch pH Gradienten IAC und
einigen wenige isokratische Elutionsexperimenten die SMA Parameter mehrerer Proteine im Ge-
misch über einen gesamten pH Bereich (hier: pH 4 - 11.5) zu bestimmen. Die SMA Parameter
werden dabei durch die Anpassung des existierenden SMA Modells [5] an die pH Gradienten
Elution in der IAC, ermittelt. Da sich ν und KSMA während des pH Gradienten kontinuierlich
ändern, wird der Verlauf dieser durch die Verwendung geeigneter Funktionen limitiert. Der Ver-
lauf von KSMA wurde über eine inverse, sigmoidale Boltzmann Funktion beschrieben, während
der Verlauf von ν am besten über eine inverse bi-sigmoidale Boltzmann Funktion beschrie-
ben werden konnte. Die Grenzen der einzelnen Kurvenparameter wurden durch die Anpassung
von 100.000 beispielhaften Proteintitrationskurven festgelegt. Für die drei Modelproteine, Cyto-
chrom C, Lysozym und Ribonuklease A wurden die SMA Parameter durch acht pH Gradienten
Elutionen bei Salzkonzentrationen von 10 - 350 mM NaCl und je vier isokratischen Elutionen
(pH 5, 7, 9) auf einer Mono S 4.6/100 Säule ermittelt. Die erhaltenen Parameter konnten durch
den Vergleich vorhergesagter, mit experimentel bestimmten Retentionsvolumina der Proteine
in verschiedenen Elutionsmodi validiert werden. Die mittlere Abweichung betrug hierbei 8%.
Anschließend wurde eine Monte-Carlo Simulation mit der Annahme einer 5%-igen Abweichung
des pH Wertes und der Salzkonzentration durchgeführt, um zu überprüfen ob die Ursache der
Abweichung der Retentionsvolumina durch einen falschen Ansatz zur Parameterbestimmung,
oder durch kleine experimentelle Variationen hervorgerufen wurde. Nahezu alle Abweichungen
der Retentionsvolumina befanden sich im Bereich der Monte-Carlo Simulation und können da-
her durch experimentelle Variationen erklärt werden. Die Parameter wurden im Anschluß dafür
genutzt die chromatographische Auflösung, sowie die Robustheit aller Elutionsmodi der IAC
zu untersuchen. Die Resultate bestätigten die Erwartungen, dass über pH Gradienten und iso-
kratische Elution höhere chromatographische Auflösungen als bei der Salzgradienten Elution
erreichbar sind, während die Robustheit deutlich geringer ausfällt. Die Auflösung der Salzgra-
dienten Elution kann durch einen zusätzlichen pH Gradienten, ohne einen negativen Effekt auf
die Prozessrobustheit, erhöht werden. Abschließend kann gesagt werden, dass mittels geringem,
experimentellem und zeitlichen Aufwand die SMA Parameter mehrerer im Gemisch enthaltener
Proteine für einen ganzen pH Bereich bestimmt werden konnten. Die gewonnenen Daten ermögli-
chen groß angelegte Optimierungs- / Robustheitsstudien, welche das Erlangen eines detaillierten
Prozessverständnis durch in silico Studien ermöglichen.
xii
Im letzten und zusätzlichen Teil der Doktorabeit ist eine Methodik zur analytischen Charakte-
risierung eines mono-PEGylierten Proteins durch pH Gradienten IAC dar-gestellt. Die PEGy-
lierung von Proteinen ist eine häufig eingesetzte Technik zur Ver-besserung der pharmakoki-
netischen Eigenschaften von Proteintherapeutika. Die Charakterisierung PEGylierter Proteine
gestaltet sich jedoch oft sehr schwierig, da hierfür analytische Methoden mit sehr hoher Auflö-
sung notwendig sind. Aufgrund der hohen chromatographischen Auflösung für die Trennung von
Ladungsvarianten eignet sich die pH Gradienten IAC. Um dies zu demonstrieren wurde 5- und
10 kDa mono-PEGyliertes Lysozym mit einem hochauflösenden pH Gradienten (pH 10.5 - 11.5
Mono S 4.6/100) aufgetrennt. Lysozym kann an sechs verschiedenen Lysinen PEGyliert werden,
was zu ebenso vielen positionellen Isomeren bei mono-PEGyliertem Lysozym führt. Mithilfe der
pH Gradienten IAC konnten fünf der Isoformen getrennt werden. Um die PEGylierungsstelle zu
bestimmen wurden die pI Werte der einzelnen Isoformen anhand 3d-Struktur-basierter (PDB-
ID: 132L) Berechnung [6] errechnet und im Anschluss mit den Elutions-pH Werten korreliert.
Die Werte korrelierten mit einem Koeffizienten von R2 > 0.99. Die hierdurch vorhergesagte
Elutionsreihenfolge wurde durch die Identifikation der PEGylierungsstelle mittels tryptischem
Verdau und MALDI-MS bestätigt. Die Resultate bestätigten eindrücklich die erhöhte chromato-
graphische Auflösung der pH Gradienten IAC für die Separation von Proteinladungsvarianten.
Die erhöhte Auflösung der pH Gradienten IAC könnte in Zukunft auch für die Analytik anderer
Protein-Ladungsvarianten therapeutischer Proteine (Glykosylierung, Phosphorylierung ...) von
Nutzen sein.
Es kann zusammengefasst werden, dass die Hauptproblematiken bezüglich der Prozessentwick-
lung für die Reinigung von Autoantigenen, die niedrigen Produkttiter, die Komlexität der Ro-
hextrakte, sowie das Fehlen von Affinitätstechniken, durch den Entwurf verschiedener, syste-
matischer Screeningexperimente zur Prozessentwicklung, erfolgreich verringert werden konnten.
Durch die Anwendung dargestellter Screeningexperimente kann die Prozessentwicklung für die
Reinigung dieser Proteine deutlich beschleunigt und vereinfacht werden. Darüber hinaus wurde
eine Methodik zur systematischen Erstellung von Puffersystemen für die pH Gradienten IAC
entwickelt. Die pH Gradienten IAC bewährte sich dabei nicht nur als Screeningmethodik für die
Prozessentwicklung, sondern auch als Werkzeug zur Bestimmung von SMA Parametern und als
Methode der Wahl für die Charakterisierung PEGylierter Proteine.
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Abstract
Many proteins in the human body are associated with diseases, thus a large number of proteins
has a potential of being used as a disease biomarker. Autoantibodies, which appear in case of
an autoimmune disease are such disease biomarkers. By applying the corresponding antigens
in diagnostic assays, these diseases can be diagnosed and monitored. Protein autoantigens, are
usually produced biotechnologically, using recombinant expression, cell culturing and purification
techniques. Purification of these proteins is often very challenging, as they are mostly contained
at low concentrations in very complex matrices (e.g. cell lysates). The challenges associated with
the process development for the purification of these proteins are treated in this PhD thesis. By
introducing systematic screening approaches to rationally design chromatographic purification
processes, downstream process development is simplified and accelerated. The thesis can be
divided in three main parts and one additional:
I. Development of a systematic methodology, to generate buffer systems for pH gradient ion
exchange chromatography (IEC).
II. Multi-dimensional, analytical, chromatographic screenings using pH and salt gradient IEC
to obtain physicochemical parameters of single proteins contained in complex mixtures for
purification process development.
III. A novel approach to obtain mechanistic parameters covering a wide pH range for in silico
optimization (SMA model [1]) of protein purification, using IEC.
IV. Additional: High resolution pH gradient IEC for the characterization of positional PEGyla-
tion variants of mono-PEGylated lysozyme.
In the first part an in silico approach for the systematic generation of buffer systems consisting
of multiple buffer substances for pH gradient IEC was successfully developed and experimentally
validated. To generate buffer compositions for the formation of linear, controllable pH gradients
in IEC, their buffer capacity has to be kept constant in the chosen pH range. By varying buf-
fer substances used in the buffer composition as well as the single substance concentrations,
the deviation of a composition’s buffer capacity from a constant value can be minimized. A
MATLAB (Mathworks, Natick, MA, USA) procedure was set up using all necessary equations
for the calculation of the buffer capacity, the titration curve and the ionic strength of a buffer
composition consisting of mono-, di- and tri- basic/protic substances. A non-linear least square
algorithm was implemented to minimize the deviation of the composition’s buffer capacity from
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a constant value. Hereby, buffer compositions with constant buffer capacity (10 mmol*l−1) for
pH gradient anion or cation exchange (AEC / CEC) chromatography spanning 7.5 pH units,
were generated. Applying these buffer systems to form pH gradients in IEC (Mono Q / S 4.6/100
column, GE Healthcare, Uppsala, Sweden) resulted in highly linear pH gradients with R2 > 0.99.
The applicability of the buffer systems for the analysis of proteins using pH gradient IEC was
validated according to the ICH Guidelines [2] by analysing four model proteins. The determined
intermediate precision and the repeatability for the proteins’ elution-pH values both showed
a ∆pH < 0.1 pH units. Validated methods were subsequently used to investigate the elution
behaviour of 22 model proteins in pH gradient AEC / CEC. The results clearly showed that
there are fundamental differences between IEC and isoelectric focusing (IEF) resulting from the
proteins’ interaction with a charged surface in IEC. Also differences in selectivity between the
two ion exchange modes (AEC / CEC) orginating from the changed interaction of the proteins
with the oppositely charged surface, were observed. These gained insights in the mechanistic
fundamentals of the three separations, pH gradient AEC / CEC and IEF clearly motivate for a
selective use of the methods for specific separation problems. Furthermore, a methodology was
created to easily develop buffer systems for pH gradient IEC, which can be used as a very useful
tool in chromatographic process development for the purification of proteins [3].
The second part of this thesis describes the development and validation of multidimensional,
analytical methods to characterize crude biotechnological feedstocks with low product titers
for accelerated purification process development. It can be further subdivided into two different
approaches, one applying pH gradient IEC based fractionation for the rational layout of an early
purification process and one applying salt gradient IEC to acquire mechanistic parameters for
in silico prediction / optimization of chromatographic separations.
First, a general approach applying pH gradient IEC for the characterization of complex biotech-
nological feedstocks to rationally design IEC purification steps is demonstrated. The feedstock is
analysed using long-range pH gradient IEC (AEC pH 10.5 - 3 / CEC pH 4 - 11.5) to specifically
determine the elution-pH of the target protein. Afterwards, the range of pH gradient IEC is
narrowed around the elution-pH (+/- 1 pH) of the target protein. The fractions resulting from
the separation of the cell lysate using focused pH gradient IEC are further separated after a
preconcentration step (Lyophilization / Resolubilization) using SDS-PAGE. Contained prote-
ins are identified by tryptic digestion and LC-MS. Due to eluting close to the target protein,
the identified proteins represent the major contaminants, difficult to remove by IEC because of
having comparable electrostatic properties. Evaluation of the suggested approach was carried
out by characterizing an insect cell / Baculovirus lysate, containing a target protein (Nucleolin,
GI 55956788, protein fragment containing RRM1-4). Nucleolin is a RNA binding protein, used
as a protein diagnostic for the autoimmune disease systemic lupus erythematosus (SLE). The
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elution-pH values of the target protein, determined by identifying the pH gradient IEC fractions
containing Nucleolin (Dot-Blot analytics), were 4.85 in AEC and 10.44 in CEC (at 200 mM
NaCl). This surprisingly large difference is most likely reasoned by the fact, that the four po-
sitively charged RRM1-4 RNA-binding domains of Nucleolin cause a strong anisotropic charge
distribution on the protein surface and therefore a strongly differing elution behaviour between
both chromatographic modes. The cell lysate was then analysed by focused pH gradient IEC
(AEC pH 5.5 - 3.5 / CEC pH 9.5 - 11.5, 200 mM NaCl), SDS PAGE and LC-MS. Hereby, all
critical impurities were identified. The obtained information was used to rationally lay out a
simple two-step purification applying IEC. The cell lysate was captured on a CEC adsorber (SP
Sepharose FF, pH 8.75, 200 mM NaCl) and eluted by an elution step (500 mM NaCl, pH 8.75).
Ionic strength of the eluted sample was afterwards reduced by one half, using ultrafiltration. The
sample was further purified using salt gradient AEC (Q Sepharose FF, pH 5.2, 0-500 mM NaCl)
with salt gradient elution. A purity of 80% was achieved for Nucleolin, a very good value for
such an early developmental stage. The achieved purity clearly showed how well the described
analytical approach to characterize a complex biotechnological feedstock could be applied for
purification process development.
The second multidimensional fractionation technique was established to track retention beha-
viours of single proteins in complex mixtures with low product titers for the estimation of
mechanistic parameters (SMA model [1]) to simulate / optimize chromatographic separation in
silico. A fast, multi-dimensional fractionation approach using salt gradient IEC, reversed pha-
se desalting, sample concentrating and high-throughput capillary gel electrophoresis (HT-CGE)
was established to analyse cell lysates containing target proteins. Using the multidimensional se-
paration method an insect cell/Baculovirus lysate containing a target protein was analyzed. The
retention volumes of contained, single proteins were determined by reconstructing single protein
chromatograms (Gaussian peak fitting) from the data obtained by the multidimensional analysis.
The analysis was performed for salt gradient separations with four different gradient lengths (5,
10, 20, 80 CV, Mono Q 4.6/100, pH 5.2, 0-500 mM). Also single protein concentrations and sizes
were acquired from the analysis. The obtained retention volumes were further used to estimate
the proteins’ linear SMA parameters, the characteristic charge ν and the equilibrium constant
KSMA using the formalism developed by Shukla et al. [4]. The obtained values were successfully
validated by comparing predicted retention volumes with experimentally derived ones. Compari-
son resulted in a mean deviation of 5 % and a maximal deviation of 13.6 %. Also chromatograms
for three contained proteins were exemplarily predicted using the transport-dispersive model.
The necessary non-linear SMA parameter σ, the steric factor, was defined (σ = 30), because its
determination is not possible from mixtures. However, its influence is neglectable as the con-
centrations of all contained proteins were in the linear range. Predicted chromatograms were
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highly comparable to experimentally determined chromatograms, underlining the quality of the
obtained parameters. The results clearly demonstrate that the described multi-dimensional frac-
tionation approach can be used to rapidly obtain parameters usable for in silico optimization
of chromatographic procedures, which can dramatically decrease the amount of time needed
for purification process development. Furthermore, it can also be used as an analytical tool to
monitor the composition of biotechnological feedstocks also enabling the prediction of possible
consequences on the purification process in case of a changed composition.
In the third part of this work an experimental approach to obtain SMA parameters covering
a broad pH range, is demonstrated. Parameter estimation is generally a very time consuming
procedure and mostly parameters are only determined for several pH values and not for a com-
plete pH range. Nevertheless, pH is a crucial parameter in protein separations by ion exchange
chromatography. Therefore, an approach applying a set of pH gradient and isocratic elution
operations was developed to estimate SMA parameters in a wide pH range (4 - 11.5). SMA pa-
rameters are obtained from the acquired data by extending the applicability of the existing SMA
model [5] to protein elution in pH gradients and by adding certain constraints to the parameter
estimation. In pH gradient elution the two linear SMA parameters KSMA and ν are constantly
changing in a rational way. KSMA was best described using an inverse sigmoidal Boltzmann
function, while ν is following an inverse bi-sigmoidal trend. Boundaries for the function parame-
ters were defined by fitting 100.000 randomly generated protein titration curves. The estimation
of the SMA parameters was performed for three model proteins, cytochrome C, lysozyme and
ribonuclease A. Eight pH gradient elutions (pH 4 - 11.5) at salt concentrations from 10 - 350 mM
and four isocratic elution experiments at three different pH values (5, 7, 9) were performed using
a Mono S 4.6/100 column. From the resulting data a set of SMA parameters was determined.
Validation of these parameters was carried out by comparing predicted retention volumes with
experimentally determined ones, of the single proteins in different elution modes, isocratic, salt
gradient, pH + salt gradient. The mean deviation of the predicted retention volumes from the
experimentally determined retention volumes is 8 %. A Monte-Carlo simulation, assuming a 5
% normally distributed error on pH and salt concentration for the parameter estimation was
performed to access if this error was caused by a general problem with the parameter estimation
or by simple experimental variations. Nearly all variations of the retention volumes were in the
range of the Monte-Carlo simulation, thus it can be concluded that the estimated parameters
are accurate within the margin of expectable deviations. The parameter set was subsequently
used to calculate chromatographic resolutions and robustness for all IEC elution modes. The
results confirmed that isocratic and pH gradient elution reach higher resolution values than salt
gradient IEC, while robustness was much lower. The combination of salt and pH gradient elution
increased chromatographic resolution without a negative effect on process robustness. In con-
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clusion the results showed impressively, that applying a set of pH gradient and isocratic elution
experiments as well as related computations for the determination of SMA parameters resulted
in an impressive and very useful amount of data applicable for in silico process optimization
and robustness studies.
PEGylation is a frequently used technique to improve the pharmacokinetics of protein therapeu-
ticals. However, characterization of PEGylated proteins is often very challenging as separation
of variants needs highly resolving analytical methods. The additional part of the thesis demons-
trates an application of pH gradient IEC for the analysis of positional isoforms of PEGylated
proteins. mono-PEGylated lysozyme with 5 and 10 kDa PEG was analysed by pH gradient IEC
(pH 10.5 - 11.5) using a Mono S 4.6/100 cation exchange column. Lysozyme has six possible
PEGylation sites (lysine residues) resulting in six positional isoforms, of which five isoforms
were successfully separated. To identify lysozyme isoforms the pI of each positional isoform was
calculated using 3d-structure (PDB-ID: 132L) dependent pI calculation [6]. For each positional
isoform the corresponding, PEGylated lysine residue was neutralized for pI calculation. Resul-
ting pI values were correlated with the experimentally determined elution-pH values, showing
a correlation coefficient of R2 > 0.99. Predicted elution order of the positional isoforms was
successfully validated by tryptical digestion of collected fractions and subsequent determination
of the PEGylated peptide by MALDI-MS. With the demonstrated chromatographic method the
evaluation of PEGylation reaction kinetics for lysozyme is possible. Furthermore, pH gradient
IEC showed its superior resolution for the separation of protein charge variants. Therefore, pH
gradient IEC might also be interesting for the chromatographic analysis of other charge variants
e.g. differently glycosylated, phosphorylated ..., therapeutic proteins.
It can be concluded that the main challenges in purifying autoantigens from biotechnologi-
cal feedstocks, the low expression levels, the complexity of the biotechnological feedstock and
the lack of effective affinity techniques for purification are successfully addressed by designing
suitable screening experiments to obtain the necessary information to rationally lay out the pu-
rification steps. Applying these screening procedures will lead to a considerable acceleration in
downstream process development for proteins contained in very complex mixtures at a low titre.
Furthermore, pH gradient IEC proved to be useful not only as a screening tool for purification
process development but also for the determination of SMA parameters covering a wide pH
range as well as the analysis of protein charge variants.
xviii
Introduction
Proteins are the functionary components of organisms carrying out the various functions encoded
in their related genes. Therefore proteins bear a multitude of different functions e.g. enzymatic-
, regulatory-, structural-, transport functions and many more. The number of protein coding
genes in humans ranges from 20.000 to 40.000 [7–9]. As this is only the number of protein
coding genes, the number is supposed to be much higher, due to alternative splicing, post-
translational modification and complex formation. Many of those proteins are associated with
specific diseases due to e.g. mutations, false expression levels, defective regulation and many
more. Therefore, a large number of proteins has a potential of being used as a protein therapeutic
or as a potential disease biomarker. Reasoned by the large amounts of possible applications the
market for biopharmaceuticals was constantly growing in the last few years and is expected to
grow to 167 billion US Dollars by 2015 [10].
Biopharmaceuticals can be classified in four different classes [11]: Group I: protein therapeutics
with enzymatic and regulatory activity; Group II: protein therapeutics with special targeting
activity, e.g. monoclonal antibodies (mAbs); Group III: protein vaccines; Group IV: protein
diagnostics. Group I-III, especially group II play the most important role in the market for
biopharmaceuticals, but also the market for protein diagnostics (Group IV) is expected to reach
a financial volume of 19.8 billion US Dollars by 2015 [12]. Biopharmaceutical proteins are most-
ly, recombinantly produced using various expression systems, e.g. bacteria, yeast, insect cells,
mammalian cells or even transgenic plants (Upstream processing). After recombinant producti-
on of the target protein, purification is carried out using several protein separation technologies
(Downstream processing). The requirements for purity and quality of the final product, which
have to be met, are mostly very strictly defined. In the last few years, due to advances in re-
combinant technologies and fermentation techniques the major costs of the whole production
process for biopharmaceuticals shifted to the downstream processing [13–15]. Also the increasing
interest in more complex proteins, as well as the market entry of biosimilars are posing further
challenges in protein downstream process development. This results in a growing demand for
faster, more cost efficient methodologies to develop highly understood downstream processes.
A specifically challenging case is the process development for the purification of protein dia-
gnostics. Mostly only low amounts of a target protein are required but the variety of diseases,
which can be diagnosed using protein diagnostics, demands for a very diverse product portfolio.
Therefore, the scientific focus in the production of protein diagnostics is on accelerating the
development of time- and cost-efficient downstream processes for such molecules. The facts that
many of those molecules are hardly produced recombinantly and only with low titres, as well as
1
Purification of proteins
the lack of affinity purification steps, are further complicating downstream process development.
This results in an especially strong demand for new, systematic approaches to rapidly develop
purification processes for protein diagnostics.
1 Purification of proteins
1.1 Overview
Each protein has individual physicochemical properties like e.g. surface charges, hydrophobicity,
molecular size. To purify proteins from mixtures the differences between the single molecules’
properties are utilzed to achieve separation. Several separation technologies, making use of dif-
ferent physicochemical properties, are applicable to purify proteins from mixtures. An overview
of the separation technologies and the related properties is shown in Tab. 1
Table 1: Purification of proteins: Technologies, methods and properties












IEC Ion Exchange Chromatography; HIC Hydrophobic Interaction Chromatography; SEC Size Exclusion Chro-
matography; AC Affinity Chromatography; RPC Reversed Phase Chromatography; ATPS Aqueous Two-Phase
Systems;
Purification processes can mostly be divided in four stages [16]: A: Preparation, Extraction,
Clarification; B: Capture; C: Intermediate purification; D: Polishing. Depending on the cha-
racteristics of the target protein, the contaminants and the properties of the biotechnological




To develop each applied single unit operation many process parameters have to be chosen well,
thus a large design space has to be screened. Purification process development for proteins is
often very challenging as biotechnological feedstocks are mostly very complex mixtures con-
taining many different impurities, some of which have very similar physicochemical properties
to the target protein. Nevertheless, the regulatories for purity and quality of pharmaceutical
proteins are very strictly defined. A further complicating fact is the sensitivity of proteins to
denaturation, aggregation, proteolytic degradation, etc.. Because of the risk of denaturation as
well as the complexity of the feedstock, chromatographic methods are still the most applied
separation technique for the purification of proteins, due to their high selectivity and the mild
separation conditions [17], even though they are mostly very cost-intensive. Reasoned by all the
difficulties associated with the purification of proteins downstream process development is very
often economically and technically challenging.
1.2 Purification process development
The main challenge in purification process development for proteins is, that mostly little or
nothing is known about the composition of the biotechnological feedstock as well as the physico-
chemical properties of the target and the impurities. The approaches facing that challenge can be
classified in five classes [17]: Heuristic (knowledge-based) approaches, experimental approaches,
platform approaches, model-based methods and hybrid methods.
Heuristic approaches: Purification process development is carried out by making use of expert
knowledge, experience derived from past processes and several trial-and-error experiments. Even
though such an approach mostly ends up in non-optimal purification processes, it is still a
common way to develop purification processes for proteins.
Experimental approaches: Systematic, experimental approaches to obtain relevant parame-
ters for purification process development. The experiments are mostly HTS (High-Throughput-
Screening) or HTE (High-Throughput-Experimentation) based. Often robotic platforms are
used to perform a large amount of miniaturized experiments in a short time-scale. To reduce
the amount of experiments needed, these approaches are mostly done applying DoE (Design of
Experiments) strategies. Time and costs are strongly reduced by applying these approaches for
protein purification process development [18].
Platform approaches: A special case of process development for the purification of highly
uniform proteins, e.g. mAbs. An established process for the purification of a protein is used as a
template for the generation of purification processes for different proteins from the same mole-
cular class. A typical purification platform for the purification of mAbs consists of two to three
sequential chromatographic steps, Protein A affinity chromatography, followed by polishing ba-
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sed on AEC/CEC and sometimes HIC [17, 19]. Platform process based purification development
does have the significant advantages of being straightforward, simple, cost efficient and less time
consuming.
Model-based methods: Physicochemical models are applied to predict / optimize separation
behaviours of the different components in silico. The major challenge in model-based process
development is the acquisition of the necessary physicochemical parameters of the proteins. Pro-
cess development using mechanistic models is further complicated by the fact that the accuracy
of the prediction directly depends on the quality of these parameters. The parameters are mostly
estimated experimentally using defined screening experiments, but there are also approaches to
predict them using protein structures in QSAR (Quantitative Structure Activity Relationship)
or MD (Molecular Dynamics) simulations [20, 21]. However, process development based on the
usage of mechanistic models for process simulation has significant advantages, like low develop-
mental time, costs and increased process understanding due to the possibility to carry out a
large amount of experiments in silico. Nevertheless, model-based process development is often
not possible as the determination of the parameters is neglected by the unavailability of rational
methodologies to obtain these from complex mixtures.
Hybrid methods: A combination of experimental and model-based methods, e.g. the determi-
nation of mechanistic parameters for in silico process development using HTS or HTE. Protein
mixtures are systematically characterized using experimental screenings to obtain the relevant
physicochemical parameters for process simulation and optimization as demonstrated by Nfor et
al. [22]. Hybrid methods combine the advantages of the large amounts of obtained information
from the biotechnological feedstock using HTS or HTE but also the advantages of model-based
process development, low developmental time and costs as well as increased process understan-
ding. Anyhow, clearly defined experimental procedures to systematically acquire high quality
parameters for process simulation of the single components in complex mixtures are very rare.
Industrial process development for the purification of proteins needs to lead rapidly to optimal,
but also safe and robust processes, fulfilling the requirements on protein purity and quality.
Especially for very complex biotechnological feedstocks, e.g. cell lysates, containing low titer
expressed target proteins, process development can be very time consuming and economically
challenging.
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2 The production of protein diagnostics
2.1 Protein diagnostics
Besides genetic biomarkers, antigens play an essential role in clinical diagnostics of diseases. One
big group of applied protein diagnostics are antigens, being used as binding partners for the de-
tection of present serum antibodies, associated with the respective disease. Mostly, the proteins
are applied in ELISA (Enzyme-Linked-Immunosorbent-Assay) or microarrays for disease diagno-
sis. Examples are the diagnosis of Lyme borreliosis, HIV, Malaria and many more, by ELISA. A
major field of application is the diagnosis of autoimmune diseases, which emerge in case of a mal-
functioning immune system attacking endogenous structures due to the false recognition of own
proteins as pathogens. Autoimmune diseases are related with genetic, environmental and epige-
netic factors [23–25]. By determining the concentration of related autoimmune antibodies, e.g.
using ELISA, autoimmune diseases can be prognosed, diagnosed and in some cases monitored.
The availability of well established diagnostic assays makes it possible to identify the form and
the progression of the disease, based on the results decisions on possible therapeutic intervention
can be made. To establish such diagnostic assays the proteins containing the relevant epitopes
have to be identified and produced in a pure form. Recombinant expression of those proteins
is very often challenging, as the right conformational structure, post-translational modification
[26] and complex formation with DNA, RNA or other proteins (e.g. small ribonuclear particles,
snRNP, [27]) are necessary to properly bind the related autoimmune antibodies. Some proteins /
protein complexes like the U1-snRNP complex for the diagnosis of Systemic lupus erythematosus
(SLE) have not been recombinantly expressed so far. Also the purification of these proteins is
consequently very challenging as the feedstocks are very complex mixtures containing only low
amounts of the target protein.
2.2 Recombinant expression of diagnostic autoantigens
After isolating the gene-of-interest it is cloned into the appropriate vector for the applied expres-
sion organism. Most autoantigens are produced using, Escherichia coli, insect–cell / Baculovirus
or mammalian expression systems, e.g. CHO-cells (Chinese Hamster Ovary cells). The expres-
sion system is chosen due to the fact if a functional protein at preferably high expression level
can be obtained. The molecules activity in immune diagnostics is directly influenced by its
structural authenticity, which depends on the correct folding as well as post-translational modi-
fications. Reasoned by these structural requirements an expression system able to correctly fold
and modify the target protein has to be chosen. Therefore, the expression of protein diagno-
stics in E.coli is often not possible and an eukaryotic system, with the disadvantage of a lower
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expression rate, has to be chosen. Currently, the most frequently used expression system is the
insect–cell / Baculovirus expression system [28], due to the facts that it allows production of
post-translationally modified proteins at a relatively high protein expression rate. Mammalian
cell expression systems are only used, if proteins are to be produced, which can not be expres-
sed stable in insect cell expression systems e.g. due to the need of specific cofactors for correct
folding. The major drawback of mammalian cell expression systems is that they require huge
efforts until being fully established, yielding high protein production rates.
Further challenges in the recombinant production of autoantigens are insolubility of the overex-
pressed proteins, aggregation, instability as well as host cell toxicity. The latter is mostly caused
by the function of the expressed protein. Also most proteins are expressed intracellularly resul-
ting in the need of cell lysis for protein isolation. The low expression rates of the proteins, the
need of cell lysis result in very complex mixtures and thus in challenging purification process
development.
2.3 Purification of diagnostic autoantigens
To use diagnostic autoantigens for disease diagnosis in immunoassays, all contaminants, which
might result in false positive results have to be removed. Recombinantly expressed autoantigens
are mostly purified using attached hexa-histidine tags by applying IMAC (Immobilized-Metal-
Affinity-Chromatography). IMAC is making use of the high affinity and binding strength of
hexa-histidine tags to divalent cations immobilized on the chromatographic resin. Using IMAC
has the advantages of very mild chromatographic conditions, while offering the chromatographic
selectivity of an affinity purification step. After using IMAC for capturing and purifying the
protein, mostly one additional polishing step, involving IEC or HIC, is sufficient to remove the
leftover contaminants. Purity rates of a percentage larger than 90% are mostly sufficient for the
protein’s intended use.
However, sometimes no hexa-histidine tag can be effectively attached to the expressed protein,
due to the loss of the proteins diagnostic activity because of inauthentic protein folding or due
to inaccessible, e.g. intramolecular localisation of the tag. In the case that a protein can not
be produced recombinantly or only without having a hexa-histidine tag attached, purification
is getting very challenging as the biotechnological feedstocks are highly complex and the target
proteins are mostly only expressed with low titres. Also purification process development is
getting very time-consuming in such cases and sometimes no purification process leading to
acceptable results can be reached. The following table (Tab. 2) is showing data on developmental
time scales for purification process development of several antigens from the industrial partner
(Diarect AG, Freiburg, Germany).
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Table 2: Data on purification process development for autoimmune antigens
Autoimmune disease Autoantigen Time and yield
Celiac disease tissue Transglutaminase(tTG)
24 months,
15 mg/l cell culture
SLE Ro/SS-A 60 kDa 33 months,5 mg/l cell culture
Autoimmune thyroiditis Thyroid peroxidase(TPO)
15 months,
2 mg/l cell culture
SLE U1-snRNP 68 kDa 35 months,4 mg/l cell culture
Autoimmune thyroiditis Thyreoglobuline not possible
Tab. 2 shows the enormous increase in developmental time for purification process development
for specific proteins, which are expressed at low titres and without an attached hexa-histidine
tag. For such proteins, purification process development is accompanied by a very long time-to-
market and enormous costs, especially in case of proteins, which have to be derived from native
sources.
2.4 Research objectives
The previously described difficulties concerning downstream process development for the pu-
rification of autoantigens, the low product titers, the high feedstock complexity, high product
diversity and the lack of affinity techniques, clearly demand for a faster, more rational methodolo-
gy to accelerate purification process development for these proteins. One approach to address the
described challenges is the concept of a developmental platform, a series of screening experiments
to characterize the biotechnological feedstock with the aim to obtain the relevant physicoche-
mical parameters of the contained components to rationally lay out a purification process based
on that information. Such approaches demand for clearly defined, systematical, analytical scree-
ning experiments enabling the described characterization of biotechnological feedstocks at a very
early stage in purification process development. Approaches adressing comparable challenges by
employing chromatographic screening experiments were previously described in publications by
Ahamed and Nfor [3, 22]: A multidimensional fractionation approach applying salt, pH gradient
IEC and SDS PAGE as a 2nd analytical dimension to systematically obtain physicochemical
properties of the contained proteins, by tracking their elution behaviour in the mixture.
In these previous publications pH gradient IEC was successfully applied to determine the op-
timal pH value under given salt concentration for the layout of a purification process for a
monoclonal antibody from a cell culture supernatant using IEC. However, the formation of con-
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trollable, linear pH gradients in IEC with preferably low ionic strength is very challenging and
so far there was no approach delivering a fast, simple and systematic way to generate buffer
compositions for controllable pH gradients in a chosen pH range with minimized ionic strength.
Therefore, an in silico approach was developed for the optimization of multi-component buffer
systems to achieve buffer compositions with linear titration curves applicable for the formation
of controllable pH gradients in IEC. After validating the buffers applicability to form linear pH
gradients in IEC for the separation of proteins, the elution behaviour or 22 model proteins was
investigated. Thereby, differences between chromatographic separations and isoelectric focusing
were examined to acquire deeper understanding of the underlying mechanisms of the separation
behaviour. The work and the results are described in detail in chapter I: “Systematic generation
of buffer systems for pH gradient ion exchange chromatography and their application”.
In the second chapter of this work, the previously developed method to generate buffer systems
for pH gradient IEC was applied to analytically characterize a very complex biotechnological
feedstock containing a low titer target protein to obtain parameters useful for purification pro-
cess development. The approach implementing four pH gradient IEC operations was applied to
determine the elution behaviour of the target protein and the major impurities, which were fur-
ther identified using LC-MS based techniques. The gained information on the elution behaviour
of relevant contaminants and the target protein was subsequently used to lay out purification
of the target protein using IEC. The results of the developed screening approach and the resul-
ting purification procedure are discussed in detail in chapter II: “Analytical characterization of
complex, biotechnological feedstocks by pH gradient ion exchange chromatography for purification
process development”.
Parameters obtained by applying the described screening experiments (chapter II) are so called
“heuristic” parameters, which are not applicable for process simulation using mechanistic mo-
dels. Process development based on applying mechanistic models for the in silico optimization
of chromatographic procedures has several advantages as low developmental time, costs and
increased gain of process understanding due to the possibility to carry out a large amount of
experiments in silico. However the determination of mechanistic parameters of single proteins
contained in complex mixtures, allowing for simulation of chromatographic separations, is very
challenging. A rapid, multidimensional fractionation approach, employing salt gradient IEC, re-
versed phase desalting, sample concentrating and high throughput capillary gel electrophoresis
was developed to obtain the parameters allowing for simulation of chromatographic processes
applying the steric-mass action model [1]. The approach was subsequently applied to characteri-
ze a cell lysate containing a low titer expressed target protein. Validation of the parameters was
carried out by comparing predicted retention volumes and chromatograms to experimentally
determined ones. All results as well as the experimental procedure are described in chapter III:
8
The production of protein diagnostics
“A high-throughput 2D-analytical technique to obtain single protein parameters from cell lysates
for in silico process development of ion exchange chromatography”.
Mostly SMA parameters of proteins are only determined for single pH values, completely ne-
glecting optimization of IEC separations at different pH values. Furthermore slight changes in
pH and salt concentration values influence chromatographic separations and it is of great inte-
rest for process development to investigate these effects. In the forth chapter a newly developed
methodology to obtain a full set of SMA parameters of single proteins in a pH range of 4 to
11.5 is described. The method is based on a fully experimental approach, applying pH gradient
IEC at different salt concentrations and a set of isocratic elution experiments. SMA parameters
were obtained by extending the applicability of the existing SMA model [5] to protein elution in
pH gradients and by adding certain constraints to the parameter estimation. Determined model
parameters were used to predict retention times for isocratic, mono- and bi-linear salt gradient
elution as well as for combined pH and salt gradient elution. A Monte Carlo study was made to
investigate the effects of experimental errors on all critical parameters. Furthermore, robustness,
resolution and efficiency of all elution modes in IEC were investigated and compared. The results
and the procedure to determine the parameters are shown in chapter IV: “Parameter estimation
for a wide pH range to model chromatographic separations on ion exchange materials for both
salt and pH gradient elution”.
Analytical technologies, providing sufficient resolution to characterize protein isoforms are very
rare and therefore of great interest for the quality control of therapeutic proteins. PEGylation of
proteins is a common methodology to enhance the therapeutic properties of biopharmaceuticals
as it improves their pharmacokinetic behaviour. The analytical characterization of PEGylated
proteins is a challenging task but necessary for the therapeutics approval. In chapter V a method,
applying pH gradient IEC for the analytical separation of mono-PEGylated lysozyme isomers
is demonstrated, proving its exceptionally high chromatographic resolution for the separation
of protein variants. PEGylation sites of the separated variants were identified, using tryptic
digestion and MALDI-MS. Obtained results, as well as the experimental procedure are shown
in chapter V: “Isoform separation and binding site determination of mono-PEGylated lysozyme
with pH gradient chromatography”.
Chapter I-IV are focusing on the analytical acquisition of parameters for purification process
development of proteins contained in complex mixtures with a low titer. All methods are de-
signed as experimental tools in purification process development especially for the described,
challenging biotechnological feedstocks containing diagnostic antigens. In chapter V an alterna-
tive application for pH gradient IEC as an analytical tool for the characterization of protein
variants is demonstrated, as it provides high chromatographic resolution.
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Abstract
pH gradient protein separations are widely used techniques in the field of protein analytics, of
which isoelectric focusing is the most well known application. The chromatografic variant, based
on the formation of pH gradients in ion exchange columns is only rarely applied due to the
difficulties to form controllable, linear pH gradients over a broad pH range. This work describes
a method for the systematic generation of buffer compositions with linear titration curves,
resulting in well controllable pH gradients. To generate buffer compositions with linear titration
curves an in silico method was successfully developed. With this tool, buffer compositions for
pH gradient ion exchange chromatography with pH ranges spanning up to 7.5 pH units were
established and successfully validated. Subsequently, the buffer systems were used to characterize
the elution behavior of 22 different model proteins in cation and anion exchange pH gradient
chromatography. The results of both chromatographic modes as well as isoelectric focusing were
compared to describe differences in between the methods.




pH gradient based separations of proteins for analytical purposes are among the most used tech-
niques in protein analytics, e.g. isoelectric focusing or 2D-gelelectrophoresis. The chromatogra-
phic variant, pH gradient ion exchange chromatography (IEC), has been valued as an analytical
separation technique in the field of proteomics [29] and as a screening tool for the selection
of pH-related parameters in industrial bioseparation process development [30]. In addition, pH
gradient ion exchange chromatography showed its potential as an excellent analytical tool in
the routine analysis of monoclonal antibody charge variants [31] as well as PEGylation variants
[32]. Another study on the differences between pH gradient and salt gradient IEC showed that
pH gradient IEC might provide a higher chromatographic resolution [33].
Analogous to conventional IEC, protein binding is charge mediated in pH gradient IEC. In pH
gradient IEC proteins are eluted by changing the pH of the mobile phase gradually and thus
titrating the interaction of the protein with the resin. The fact that an interaction with a charged
surface is involved suggests a fundamental difference between classical isoelectric focusing and
pH gradient IEC, which could cause a deviation between the pI and the elution-pH of proteins.
There are two main ways of generating pH gradients in IEC: an internal and an external method.
For the internal method, a weak ion exchange resin with an intrinsic buffer capacity is used.
The column is first equilibrated with the application buffer. The elution is done by titrating
the intrinsic buffer capacity with the running buffer to generate the outlet pH gradient. The
internal method is mostly referred to as chromatofocusing [34]. For the external method, the pH
gradient is formed before entering the column by gradually mixing the running buffer with its
titrant. The focus of this work is on the externally generated pH gradients, which are regularly
run on strong ion exchange resins.
The major challenge in running pH gradients in IEC is the controllability of the pH gradient.
Additionally, it is preferable to keep the ionic strength of the buffer system low, in order to
reduce its influence on the proteins retention behavior. One approach is to use ampholytes,
providing a high buffer capacity covering a broad pH range. However the usage of ampholytes
has major disadvantages, being their lot-to-lot variability, their interaction with the proteins and
chromatographic adsorbers, as well as the fact that they are difficult to remove from solution.
Another approach is to use multiple, equally concentrated buffer substances with equally spaced
pKa values in the chosen pH range [3]. The latter leads to reproducible, linear pH gradients
covering a broad pH range on the corresponding chromatographic resin, but still with relatively
high ionic strength and an inconstant buffer capacity. To lower the ionic strength of the buffer
composition, a further approach uses a very similar buffer chemistry with lower concentrated
buffer substances, compensating gradient non-linearities with a software-enabled, algorithmic
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control of the gradient-mixing [35], resulting in linear pH gradients with uneven buffer capacity,
but reduced ionic strength.
This means that so far there is no approach delivering a simple, fast, systematic way to generate
buffer compositions for controllable pH gradients in every chosen pH range with minimized and
known ionic strength. To generate controllable pH gradients, the buffer capacity of the buffer
has to be kept constant, resulting in a buffer composition with a linear titration curve, which
can then be controlled by the liquid chromatography system to generate the pH gradient. Other
publications focusing on a similar problematic, the in silico optimization of buffer compositions
for isoelectric focusing, as well as the simulation of the resulting pH gradient, have proven to be
successful for the specific case presented [36–39].
In this work, the idea of optimizing a given buffer composition’s capacity, predicting its titration
curve and the course of the ionic strength throughout the gradient was adapted for the purpose
to generate buffer systems for pH gradient IEC. The established in silico buffer optimization
tool was used to generate buffer compositions for long range pH gradient IEC. To demonstrate
their applicability, the optimized buffer compositions were applied for the formation of linear
pH gradients and validated for the characterization of protein elution behavior in pH gradient
IEC. Subsequently, the methods were used for an extensive study of the elution behavior of
22 model proteins on differently charged chromatographic resins. A comparison of the proteins
elution-pH values of the two different chromatographic modes with literature values on the pIs
of the proteins was made to gain better understanding of the differences between the methods,
as well as the electrostatics of the single proteins.
2 Theory
For the generation of controllable pH gradients, the titration curve of the applied buffer system
has to be linear, which results from an even buffer capacity throughout the pH range. The
buffer capacity, the titration curve and the ionic strength from single buffer substances as well
as mixtures can be calculated. By varying the buffer substances and their single concentrations,
buffer mixtures can be optimized to achieve linear titration curves. The theoretical background,
the derivation of the needed equations and the optimization procedure are described in the
following section.
2.1 Calculations
For chromatographic operations, most used buffer substances are mono-, di- or tribasic/-protic,
while higher degrees are only rarely used. Therefore, this work is only focusing on these sub-




The dissociation of a weak monoprotic acid
HA ka−−⇀↽− H + + A−
concludes to the following mass balance, whereby CA is the total acid concentration.
CA = [HA] + [A−], while [HA] = [A
−][H+]
ka
Combining both results in the following term for [A−]:
[A−] = CA ka[H+]+ka
The electroneutrality condition defines the following charge balance for the dissolved acid
[H +] = [A−] + [OH −]
Adding a strong, monobasic substance changes the charge balance to
[B+] + [H +] = [A−] + [OH −]
Including the ionic product of water [H +][OH −] = kw the charge balance can be written as
[B+] + [H +] = [A−] + [kw ][H+]
combining the mass balance and the charge balance leads to




from which the titration curve of the monoprotic acid can be calculated iteratively. To calcu-
late the buffer capacity B, the equation has to be differentiated with respect to [H +], while
remembering that
pH = −log10 [H +] = − 1ln(10 ) ln([H
+])









which includes the intrinsic buffer capacity of water (B(w)). To calculate the ionic strength
of a buffering solution at different pH values, the single ionic species have to be summed up,
independent of their charge. The general formula for the ionic strength of a solution including






C− mol. conc. of ions; z− charge number
and in case of a monoprotic acid the equation is
I−12(
CAka
[H+]+ka︸ ︷︷ ︸ [A−] + kw[H+]︸ ︷︷ ︸ [OH−] + [H +] + [B+]) (3)
The derived equations (1-3) can be used to compute the course of the titration curve, the buffer
capacity and the resulting ionic strength of a single substance. To calculate the values for di-
and tribasic/-protic buffer substances the corresponding equations can be derived in the same
way, the results are:
Diprotic substances
The titration of a diprotic substance











+ kw[H+] + [H
+])
(5)






+ [H+] + [B+])
(6)
Triprotic substances
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+ kw[H+] + [H
+] + [B+])
(9)
With the derived equations 1-9, the titration curve, the buffer capacity and the ionic strength
of mono-, di-, and triprotic substances can be calculated. To calculate the values for basic sub-
stances ka has to be substituted by kb = kw/ka and [H+] by [OH−], with [OH−] = 10−14/[H+].
For the computation of the buffer capacity, the titration curve, or the ionic strength of buffer
compositions consisting of multiple single substances, the values for the single substances are
calculated and summed up. For example, the buffer capacity of m monoprotic, d diprotic and t












+ ln(10)( kw[H+] + [H
+])
The corresponding equations can also be formulated for the computation of the titration curve
and the ionic strength. Combining all the equations in the computing environment MATLAB
(MathWorks, Natick, MA, USA), made it possible to calculate the values for any mixture of
mono-, di- and triprotic/-basic substances.
2.2 Optimization
The key parameter for buffer compositions with a linear titration curve is an even buffer capacity
throughout the chosen pH range. To cover broad pH ranges, multiple buffer substances have to
be chosen with pKa values covering the chosen pH range. The buffer capacity can be kept
constant throughout the pH range by choosing buffer substances with equally distributed pKa
values [3, 36]. Another approach is to vary the concentrations of the single buffer substances
in the mixture. Due to the lack of compatible buffer substances with a broad variety of pKa
values, a buffer composition with evenly distributed pKa values for a linear pH gradient with













Figure 1: The optimization method
Schematic overview of the in silico optimization process for buffersystems applicable for the formation of
controllable, linear pH gradients in IEC.
available buffer substances with optimized concentrations leads to buffer compositions with
constant buffer capacities resulting in linear titration curves.
The deviation of a buffer composition’s buffer capacity from its mean buffer capacity B, throug-
hout a chosen pH range is formulated in the following equation:
∆BpHmin−max = |BpHmin−max −B|
BpHmin−max is the buffer compositions summed buffer capacity Bsum in the chosen pH range.
To keep the buffer capacity as constant as possible, the deviation ∆BpHmin−max has to be as
small as possible, therefore the target function for the optimization of buffer compositions is:
∆BpHmin−max → min. To optimize buffer compositions the MATLAB-based calculation of a
mixture’s buffer capacity was enabled to calculate the target function ∆BpHmin−max . Further on,
the concentrations of the single buffer substances were defined as variables. By varying the single
buffer concentrations the minimum of the target function ∆BpHmin−max can be determined. The
non-linear least square algorithm was used to minimize the target function. Fig. 1 describes the
MATLAB-based optimization procedure graphically. For the optimization of a buffer compo-
sition, the single pKa values of the chosen buffer substances, the chosen mean buffer capacity
B, as well as the chosen pH range have to be entered. After minimizing the target function by
varying the single buffer concentrations, the titration curve, the buffer capacity and the course
of the ionic strength are calculated. This tool enables the generation of buffer compositions with
a linear titration curve in every pH range with a chosen mean buffer capacity B. The only major





The buffer substances for the pH gradient IEC need to fulfill different criteria. The substances
should not interact with the ion exchange resin and thus they have to be oppositely charged.
Therefore, acidic substances are used for cation exchange chromatography (CEC), while basic
substances are used for anion exchange chromatography (AEC). Another important criterion is
that the substances do not interact with proteins, which is the case for ampholytes. We also de-
cided to limit the substances to mono-, di-, and triprotic/-basic acids, because substances with a
higher possible dissociation degree are rarely used in chromatography. Additionally, the substan-
ces have to be commercially available at an acceptable price and with analytical grade purity.
A collection of useful buffer substances with their corresponding pKa values is shown in Tab. 1.
Table 1: Buffer substances
Basic buffer substances Acidic buffer substances
Substance pKa1 pKa2 pKa3 Substance pKa1 pKa2 pKa3
Piperidine 11.12a − − CABS 10.70c − −
Methylamine 10.75b − − CAPS 10.50a − −
1-Ethylpiperidine 10.45a − − CAPSO 9.83a − −
1,2-Ethanediamine 9.93b 6.99b − CHES 9.39a − −
1,2-Propanediamine 9.82a 6.61a − AMPSO 9.14a − −
Piperazine 9.78b 5.52b − TABS 8.90c − −
2-Methylpiperazine 9.54b 5.24b − TAPS 8.44a − −
1-Methylpiperazine 9.16b 4.78b − EPPS 8.00a − −
Bis-tris propane 8.93b 6.59b − POPSO 7.80a − −
Morpholine 8.34b − − TAPSO 7.64a − −
Tris 8.16b − − HEPES 7.56a − −
1,4-Dimethylpiperazine 8.15b 4.04b − MOPS 7.18a − −
Triethanolamine 7.52b − − MOPSO 6.90a − −
4-Methylmorpholine 7.34b − − MES 6.10a − −
Bis-tris 6.22b − − Acetate 4.76a − −
Hydroxylamine 5.67b − − Succinate 4.21a 5.64a −
Pyridine 5.23a − − Formate 3.75a − −
− − − − Malate 3.40a 5.11a −
− − − − Citrate 3.13a 4.76a 6.40a
− − − − Phosphate 2.15a 7.20a 12.35a
a Handbook of Chemistry and Physics 89th Edition, 2008, CRC Press
b Measured pKa value, at 25◦C
c Thiel et al. [40]
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3 Materials and methods
3.1 Chemicals & Buffers
For the pH gradient CEC the chosen substances were MES, formic and acetic acid (Merck,
Darmstadt, Germany), HEPPSO (Molekula, Dorset, UK), and MOPSO, TAPS, CHES, CAPS
(Applichem, Darmstadt, Germany). The buffer for pH gradient AEC consisted of hydroxylami-
ne, methylamine, 1,2-ethanediamine, 1,4-dimethylpiperazine from Merck (Darmstadt, Germa-
ny), 1-methylpiperazine from Sigma-Aldrich (St. Louis, MO, USA) and Bis-Tris from Molekula
(Dorset, UK). Sodium chloride, hydrochloric acid and sodium hydroxide were obtained from
Merck (Darmstadt, Germany). All substances were purchased in analytical grade. The used
model proteins were purchased from Sigma-Aldrich (St. Louis, MO, USA), except glucose iso-
merase, which was purchased from Hampton Research (Hampton Research, Aliso Viejo, CA,
USA). To set up the buffers for the pH gradient IEC, all substances were weighed in, dissolved
in ultrapure water and split in two equal volumes. One part was titrated to the low pH extreme,
the other to the high pH extreme, with the appropriate strong titrant. The pH adjustment was
carefully performed with a freshly, five-point calibrated pH meter (HI-3220, Hanna Instruments,
Woonsocket, RI, USA). The pH calibration buffers, pH 3, 5, 7, 9, 11, were high precision stan-
dards from Hanna Instruments. After adjusting the pH, the buffers were brought to their final
volume. All buffers have been filtered through 0.2 µm cellulose acetate filters (Sartorius, Goet-
tingen, Germany). All buffer solutions were prepared with ultrapure water from a Arium water
purification system (Sartorius, Goettingen, Germany). After preparation, the buffers were used
for a maximum time period of two weeks.
3.2 Buffer optimization for pH gradient IEC
For the optimization of the buffer composition a mean buffer capacity of 10 mM was chosen. The
pH range for the optimization was pH 10.5-3.5 for pH gradient AEC and 4.0-11.0 for pH gradient
CEC. After optimizing the compositions, the buffers were prepared as described previously.
The applicability of the buffer systems was validated by examining the linearity of the resulting
pH gradients. For the pH gradient CEC, a Mono S 4.6/100 column (GE Healthcare, Uppsala,
Sweden) was used. The pH gradient AEC was run on a Mono Q 4.6/100 column (GE Healthcare,
Uppsala, Sweden).
The experiments were done on an Aekta Purifier (GE Healthcare, Uppsala, Sweden) equipped
with a pH electrode for online pH measurement. The pH electrode was calibrated with pH 3 and
pH 12 high precision calibration standards. The column was equilibrated offline with ten column
volumes (CV = 1.662 ml) of the application buffer. The gradient from 0-100% was performed in
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15 column volumes. After running the gradient, a post-gradient, at 100% of the elution buffer
was maintained for another five column volumes. The chromatographic run was executed with
a flow rate of 1.5 ml/min.
To validate the reproducibility, three different experimental setups were run by three different
persons. This means, for all three chromatographic runs the buffers were prepared fresh and
the online-pH measurement was calibrated again. Each experiment was performed by a different
person.
3.3 Elution-pH measurement of model proteins
The model proteins were prepared by dissolving 2 mg protein in 2 ml of the application buffer.
Particulates in the protein solution were removed by centrifugation. The protein elution-pH
values were determined by using the same chromatographic procedure as described in 3.2, but
with an injection of 250 µl of the protein solution. The pH was monitored online, as well as
the UV-absorption at 280 nm. To analyse the chromatograms of the pH gradient AEC the
UV280 absorption of a blank run had to be subtracted first as the buffer showed a reproducible
ghost peak at the beginning of each run probably resulting from minor impurities of the buffer
substances. Afterwards, the proteins’ elution-pH values could be determined from the peak
maxima in the chromatograms. The Unicorn 5.2 software (GE Healthcare, Uppsala, Sweden)
was used to analyse the chromatograms.
To validate the applicability of the method for the characterization of proteins in terms of
repeatability as well as intermediate precision [2], the elution-pH values of four different model
proteins were determined in three different experimental setups by a six time repeat measurement
run by three different people.
After validation of the method’s applicability, 22 model proteins were characterized by pH
gradient IEC. Every model protein was analyzed by a repeat measurement on the cation and
the anion exchange resin. The average protein’s elution-pH value was then calculated for each
chromatographic mode.
4 Results and discussions
4.1 Buffer optimization for pH gradient IEC
The aim was to generate buffer compositions for pH gradient AEC and CEC providing a broad
pH range with low ionic strength. At first the buffer substances were chosen. With the known
pKa values and a mean buffer capacity of 10 mM, the MATLAB optimization procedure was
applied for the minimization of the previously mentioned target function ∆B, varying the single
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Table 2: Buffer systems for pH gradient IEC
AEC buffer pH 10.5 - 3.5
Substance pKa1 pKa2 Conc.[mM]
Methylamine 10.75 − 9.8
1,2-Ethanediamine 9.93 6.99 9.1
1-Methylpiperazine 9.16 4.78 6.4
1,4-Dimethylpiperazine 8.15 4.04 13.7
Bis-tris 6.22 − 5.8
Hydroxylamine 5.67 − 7.7
min. ionic str. = 8.5 mM / max. ionic str. = 104.3 mM
CEC buffer pH 4.0 - 11.0
Substance pKa1 pKa2 Conc.[mM]
CAPS 10.50 − 15.6
CHES 9.39 − 9.4
TAPS 8.44 − 4.6
HEPPSO 8.04 − 9.9
MOPSO 6.90 − 8.7
MES 6.10 − 11.0
Acetate 4.76 − 13.0
Formate 3.75 − 9.9
min. ionic str. = 8.3 mM / max. ionic str. = 89 mM
buffer concentrations. The optimization resulted in the buffer compositions listed in Tab. 2. The
course of the buffer capacity and the calculated titration curve of each buffer composition are
visualized in Fig. 2. The high linearity of the calculated titration curve clearly proves that this
approach was successful. The ionic strength of the buffer systems at the extreme pH values (Tab.
2) is acceptably low, leading to a minimal effect of the ionic strength on the chromatographic
elution behavior of proteins.
4.2 Validation
To validate the applicability of the buffer systems, they have been applied on their correlating
chromatographic resin. The resulting pH gradients were determined by measuring the pH online
at the column outlet. The resulting pH gradients are shown in Fig. 3. Both gradients reached a
linearity with R2 > 0.99.
To reach high linearity at the extreme pH values 10 mMNaCl was added to suppress the exchange
of the resins counterion: This means the exchange of Cl− by OH− at very basic pH values on
the anion exchange resin or of Na+ by H+ at very acidic pH values on the cation exchange resin.
Suppressing this ion exchange procedure by adding a small amount of salt, improved linearity
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Figure 2: Buffer calculations
Illustration of the course of the buffer capacity and the titration curve of the optimized buffer compositions
described in Tab. 2. Optimization of the buffer systems and the calculation of the related plots were done in
MATLAB. A & B: AEC buffer pH 10.5 - pH 3.5: A: calculated course of the buffer capacity, B: calculated
titration curve; C & D: CEC buffer pH 4.0 - pH 11.0: C: calculated course of the buffer capacity, D: calculated
titration curve;
greatly. The concentration of NaCl depends on the ion exchange rate of the resins counterion
with H+ /OH
− and would therefore probably need adaption for other resins. Obviously, the ionic
strength of 10 mM NaCl has to be added to the calculated buffers ionic strength.
However, there was still a small effect of the columns on the resulting pH gradients. It can be
seen from the chromatograms in Fig. 3, that both gradients slightly deviate from linearity in the
beginning and their starting points are delayed by 4–5 ml. This is little more than the gradient
delay volume, which was 3.5 ml from the pump to the pH probe for the chosen setup. It is likely
to be that this is still an effect caused by the described not completely suppressed ion exchange
process. It seems that a small amount of H+/OH− ions still bound to the column and were then
titrated off the adsorbent by the gradual increase of the elution buffer. This consequently would
have leaded to delayed gradient starting points and an increased steepness in the beginning of
the gradient, which correlates well with the presented results in Fig. 3. Therefore, a further
increase of the amount of NaCl in the buffer would eliminate this effect. However, increasing the
salt concentration further would effect the proteins’ elution behaviour, which was not wanted.































Figure 3: pH gradients - linearity
Experimental determination of pH gradient lineari-
ty. pH gradients were formed by the application of
each optimized buffer (Tab. 2) on the corresponding
MonoQ / MonoS column. pH was monitored online
at the column outlet with a delay volume from pump
to pH probe of 3.5 ml. The gradient length was 24,9
ml with the starting point at 0 ml. The columns we-
re equilibrated offline before the run. The linearity
of the gradient was determined by linear regression.
A: AEC buffer applied on MonoQ column, linea-
rity R2 > 0.99; B: CEC buffer applied on MonoS
column, linearity R2 > 0.99;






























Figure 4: pH gradients - reproducibility
Illustration of the overlay of three pH gradients
(length = 24.9 ml, start at 0 ml) on a MonoS / Mo-
noQ column formed by using the optimized buffer
systems (Tab. 2). pH was monitored at the column
outlet with a delay volume of 3.5 ml. Experiments
were run as three independent setups by three dif-
ferent users. A: AEC buffer pH 10.5 - 3.0, 3x ex-
perimental setups; B: CEC buffer pH 4.0 - 11.5, 3x
experimental setups;
of the NaCl concentration would not be of any advantage.
The results of the validation, done by running the experiments in three different experimental
setups by three persons, are shown in Fig. 4. The nearly identical course of the three pH gradients
indicates the reproducibility of the method under common lab circumstances. Additionally we
recognized that the gradients linearity could be maintained even when the range was extended
by 0.5 pH units (AEC 10.5 - 3.0; CEC 4.0 - 11.5). This implies the minor disadvantage that the
buffer capacity is lower, out of the optimized buffer systems pH range. To validate the method for
its actual purpose, being the separation and characterization of proteins with pH gradient IEC,
the elution-pH values of four model proteins were determined in a six time repeat measurement
in three different experimental setups by three different people. The experiments were done for
both chromatographic modes. The model proteins for pH gradient AEC were cytochrome C,
myoglobin, glucose oxidase and amyloglucosidase. For the pH gradient CEC, glucose oxidase,
bovine serum albumine, alpha-chymotrypsinogen A and cytochrome C were chosen. The decision
for the model proteins was made due to their clearly defined chromatografic peak in the applied
chromatografic mode. The results are shown in Tab. 3.
The results clearly indicate a high repeatability and intermediate precision with a standard de-
viation for both 0.1 pH units, in both chromatografic modes. Thus the experimental setup using
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Table 3: Experimental validation of pH gradient IEC
1. pH gradient AEC
Protein pH Repeatability Int. prec.
RNAse A 9.38 +/− 0.03 +/− 0.04
Myoglobin 8.65 +/− 0.01 +/− 0.02
Glucose Oxidase 4.68 +/− 0.01 +/− 0.06
Amyloglucosidase 3.93 +/− 0.01 +/− 0.04
2. pH gradient CEC
Protein pH Repeatability Int. prec.
Cytochrome C 10.25 +/− 0.01 +/− 0.09
α-Chymo-trypsinogen A 10.07 +/− 0.01 +/− 0.05
BSA 5.84 +/− 0.00 +/− 0.06
Glucose Oxidase 4.34 +/− 0.01 +/− 0.09
the optimized buffer system clearly qualified for the specified purpose, meaning the separation
and characterization of proteins with pH gradient IEC.
4.3 Elution-pH determination of model proteins
To characterize the elution behavior of proteins in pH gradient IEC, the validated method was
used for an extensive characterization of 22 model proteins, with anion and cation exchange
chromatography, comparing the proteins’ elution behavior in the two chromatographic modes
and literature values of experimentally determined pI values of the proteins.
In previous studies by Ahamed et al. [3], different model proteins were analyzed in terms of
their elution behavior in pH gradient AEC, correlating the results with the pI values as well
as the proteins titration curves. Their results showed that acidic (pI < 6) and basic proteins
(pI > 8) elute roughly at their pI value while neutral proteins (pI ∼ 7) eluted at higher pH
values in pH gradient AEC. Ahamed et al. [3] explained this phenomenon with the flat nature
of the titration curve of neutral proteins. To our knowledge no study has been made, comparing
the elution-pH value in pH gradient AEC and CEC to discover possible differences between the
two chromatographic modes. Additionally the ionic strength of the buffer system, proposed by
Ahamed et al. [3] was relatively high. The buffer’s (pH 10.5 - 4.0 with 5 mM NaCl) calculated
ionic strength was 10 - 198 mM charge equivalents. This means that the ionic stength of our
optimized buffer systems is reduced roughly by one half, while providing a constant buffer
capacity and also a linear, controllable pH gradient. This results in a reduced influence on the
proteins retention behavior by ionic strength, meaning that these effects are minimized for the
characterization of proteins.
The determined elution pH values as well as literature values of experimentally determined pIs
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are shown in Tab. 4. For better interpretation of the results, they were sorted in two groups,
proteins with and without isoforms.
4.3.1 Isoform-free proteins
The identity of the detected chromatographic peak is clearly defined in both chromatographic
modes as isoform free proteins are analyzed. This allows the direct comparison of the two elution-
pH values and the isoelectric point. Interpretation of the results was done with regard to the
differences between the three values, to gain insight into mechanistical differences between the
three methods. The differences are shown in numbers for a better overview in Tab. 5.
Table 4: Elution-pH of model proteins
Protein Organism Ref. pI AECElution-pH
CEC
Elution-pH
Cytochrome C Bos taurus [41] 10.01 9.95 10.25
Cytochrome C Equus caballus [41] 10.03 9.93 10.23
Amyloglucosidase Aspergillus niger S.I. 3.60 3.93 < 4.00
Glucose oxidase Aspergillus niger S.I. 4.2 4.68 4.34
Lysozyme Homo sapiens [42] 10.0 ≈ 10.5 10.19
α-Lactalbumin Bos taurus S.I. 4.53 5.29 5.34
α-Chymotrypsinogen A Bos taurus [42] 8.97 8.88 10.07
Glucose isomerase Streptomycesrubignosus calc. 5.00 4.34 n.a.
Lysozyme Gallus gallus S.I. 11.35 > 10.5 10.72
Hemoglobin A0 Homo sapiens [42] 6.95 7.70 n.a.
RNAse A Bos taurus [43] 9.7 9.38 9.16
RNAse B Bos taurus [43] 9.7 9.38 8.83
beta-Lactoglobulin Bos taurus [42] 5.26, 5.34 4.25 5.97
Carbonic anhydrase Bos taurus [42]∗∗ 5.89∗ 8.07, 8.23, 8.64∗ 6.48, 7.41, 10.66∗
Myoglobin Equus caballus S.I. 6.8, 7.2 8.65, 8.96 n.a.
Thaumatin Thaumatococcus [44] 11.7 − 12 9.82∗, 10.02∗ 9.17∗, 9.49∗
Serum albumin Homo sapiens [45] 4.8, 5.6 5.25, 5.35 6.06
Serum albumin Bos taurus [42] 4.98, 5.07, 5.18 5.18, 5.28, 5.32 5.79





holo-Transferrin Bos taurus [46] 5.2, 5.4, 5.6, 5.7 5.64, 5.84, 5.98 6.54, 6.95
Ovalbumin Gallus gallus [47] 4.8, 4.9, 5.0 5.14
∗, 5.23∗,
5.33∗, 5.49 4.89
Trypsin inhibitor Gallus gallus [48] 3.83, 4.01, 4.17,4.28, 4.41
4.20, 5.17, 5.35∗,
5.70, 5.89 4.72
Catalase Bos taurus S.I. 5.40 5.96, 6.09∗ 5.44, 5.99∗, 6.19
• S.I.: Supplier information, Sigma-Aldrich (St. Louis, MO, USA)
• Calc.: Calculated pI (Compute pI/Mw, http : //web.expasy.org/computepi/)
• n.a.: Not available, protein denatured in application buffer
• * : Major isoform
• ** : Literature pI values incomplete
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Figure 5: pH gradient CEC of Cytochrome C
CEC elution-pH determination of the isoform-free protein Cytochrome. 250 µl of 1 mg/ml protein solution
were injected on a MonoS column and analysed by a 24.9 ml pH gradient from pH 4.0 - 11.5, while monitoring
the pH at the column outlet and the UV 280 nm signal. Elution-pH was determined by reading out the pH
value at the determined peak maximum. Chromatograms were analysed with the Unicorn 5.2 software.
The determination of a protein’s elution-pH value is exemplarily illustrated in Fig. 5. The illus-
tration shows the analysis of the isoform-free protein Cytochrome C by pH gradient CEC. To
obtain the elution-pH value of the protein the pH at the peak maximum was determined.
The hemeproteins, cytochrome C from bovine or horse heart eluted merely at the same pH
values, close to their pI values. Comparing the two IEC modes, the elution-pH values in pH
gradient CEC are slightly shifted to higher pH values.
The enzyme amyloglucosidase is very acidic, therefore the protein was not retained in pH
gradient CEC at pH 4.0 and eluted in the flow-through. The AEC elution-pH value is in the
range of the proteins pI.
The acidic protein glucose oxidase eluted close to its pI values, which is lower than both
Table 5: Comparison of protein elution-pH values and their pI values
Protein ∆pH pI-AEC ∆pH pI-CEC ∆pH AEC-CEC
Cytochrome C (bovine) + 0.06 − 0.24 − 0.30
Cytochrome C (equine) + 0.01 − 0.20 − 0.30
Amyloglucosidase − 0.33 - -
Glucose oxidase − 0.48 − 0.14 + 0.34
Lysozyme (human) − 0.50 − 0.19 + 0.31
α-Lactalbumin − 0.76 − 0.81 − 0.05
α-Chymotrypsinogen A − 0.09 − 1.10 − 1.19
Lysozyme (chicken) - + 0.63 -
Glucose isomerase + 0.66 - -
Hemoglobin A0 − 0.75 - -
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elution-pH values. The AEC elution-pH value is a little higher than the corresponding CEC
elution-pH value.
Human milk lysozyme eluted at very basic pH values in both chromatographic modes. The
protein’s elution-pH in CEC is close to its pI but lower than in AEC.
While having two nearly identical elution-pH values, the pI of α-lactalbumin differs strongly
from the proteins elution-pH values. Both elution-pH values are shifted about ∼ 0.8 pH units
to higher pH values.
The AEC elution-pH value of α-chymotrypsinogen A, is roughly in the range of its pI value.
Surprisingly the elution-pH in CEC is more than one unit higher than in AEC.
Lysozyme from chicken egg is a very basic protein, which was therefore not retained in pH
gradient AEC. The elution-pH value in pH gradient CEC is lower than the protein’s pI and than
the corresponding value in AEC.
The pI value of glucose isomerase is ∼ 0.8 pH units higher than the corresponding AEC
elution-pH. The CEC elution-pH could not be determined due to the known instability of the
protein below pH 5.0 (Supplier information).
The hemeprotein hemoglobin A0 is the major isoform of human hemoglobins. The protein’s
AEC elution-pH differs strongly from its pI value, both of them are in the neutral pH range .
The proteins CEC elution-pH could not be determined due to denaturation of the protein in the
application buffer at pH 4.0.
Summarizing the results leads to the following conclusions. The difference of the pI value and
the elution-pH value varies from protein to protein, e.g. the elution-pH values of cytochrome c
are very close to the proteins pI, while the elution-pH values of α-lactalbumin vary very strong
from the proteins pI. A plausible explanation for this lies in the fundamental difference between
isoelectric focusing and pH gradient IEC, the interaction with the stationary phase. Due to the
threedimensionaltiy of the protein only a patch of the protein might be directly involved into the
binding of the stationary phase. Depending on the strength of the attractive interaction between
the resin and the interacting patch of the protein, this might result in a difference between the
pI and the elution-pH value. The more anisotropic the proteins charge distribution is, the bigger
the difference between the values would get. By means of this explanation it is very likely that
the surface charge distribution of cytochrome c is more isotropic as the one of α-lactalbumin.
The same explanation is plausible for the elucidation of the differences between the elution-pH
values of anion- and cation exchange chromatography. Due to the oppositely charged adsorbers,
different patches of the protein surface might interact with the different adsorber type. The re-
sulting difference in the attractive interaction with the stationary phase concludes to a variation
of the two elution-pH value.
One major drawback of using long range pH gradients is the denaturation of the protein at the
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Figure 6: pH gradient AEC of Conalbumin
AEC elution-pH determination of the isoforms of Conalbumin. 250 µl of 1 mg/ml protein solution were
injected on a MonoQ column and analysed by a 24.9 ml pH gradient from pH 10.5 - 3.0, while monitoring
the pH at the column outlet and the UV 280 nm signal. Elution-pH values were determined by reading out
the pH values at the determined peak maxima. Chromatograms were analysed with the Unicorn 5.2 software.
extreme pH value of the application buffer. This problem might be easily fixed in most cases
by using protein specific pH gradients with a narrower pH range and hence a less disruptive
application buffer.
4.3.2 Proteins with isoforms
Many proteins have isoforms, resulting in charge variants of the single protein. Possible reasons
are differences in the amino acid sequence, differences in the oxidative state, post-translational
modifications, introducing a charge or masking charged amino acids and many more. Interpre-
tation of the obtained results was done with regard to the separation behavior of the isoforms
in the different methods.
The characterization of a protein with isoforms is exemplarily shown in Fig. 6. The illustration
shows the analysis of the protein Conalbumin by pH gradient AEC. To obtain the elution-pH
values of the single isoforms the pH values at the detected peak maxima were determined.
β-Lactoglobuline shows two known isoforms (A and B) in isoelectric focusing [42]. The proteins
differ in their primary structure by two amino acids (A: Asp64 ; B: Gly64). The isoforms were
not resolved by either of the two modes of long range pH gradient IEC. The resolution of the
long range pH gradient seems to be too low, most probably using a pH gradient with a shorter
pH range would resolve the two isoforms.
It is well known that carbonic anhydrase has many different isoforms. Up to 16 known isoforms
exist in mammals [49] isoforms differing in their primary structure. The results of the pH gradient
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IEC of carbonic anhydrase from bovine erythrocytes show three well separated major isoforms.
Due to the inhomogeneity of the protein it is not a simple task to assign the peaks to isoforms.
Also there is a big difference of the elution-pH between the two IEC modes, which makes it
difficult to correlate the isoforms in between the chromatographic separations. Most probably the
three major isoforms are related to carbonic anhydrase I, II, III, due to their higher abundancy
in erythrocytes [50], whereby isoform II has the highest abundancy. Isoform II would therefore
relate to the major isoform with the highest elution-pH value in both chromatographic modes.
Myoglobin showed one major and one minor isoform in pH gradient AEC. The two isoforms are
natural variants, varying in their primary structure. Comparing the proteins AEC elution-pH
with its pI shows the same result like reported previously. The elution-pH of the neutral protein
is significantly higher than its pI [3]. Ahamed et al. explain the difference with the flat shape of
the titration curve of neutral proteins, leading to a small change of charges as the pH is changed
strongly. This means the attractive interaction of the protein with the resin at pH ∼ 9 is already
too low to retain the protein. The determination of the elution-pH on the cation exchange resin
was not possible due to the denaturation of the hemeprotein at pH 4, which was also reported
by others [51].
Thaumatins are extremely basic proteins with two known isoforms, thaumatin I and thau-
matin II [52]. The two isoforms differ in their primary structure. By pH gradient IEC we were
able to separate the two major isoforms. The measured elution-pH values differed greatly from
the proteins pI, but literature values on the proteins pI are inconsistent. In another reference
a pI range from 10.2 - 10.5 [53] is reported. This indicates that the well accepted pI value of
11.7-12.0 is likely to be wrong, which was already proposed by others [54]. Thus, the elution-pH
values lie in the range of the proteins pIs.
Human serum albumin is known to form two isoforms due to different amounts of bound
lipids, related to a conformational change [45]. The two isoforms are separated by isoelectric
focusing and also by pH gradient AEC, but not by pH gradient CEC. A possible explanation is
the bound fatty acids. The negatively charged molecules have a much stronger influence on the
protein’s interaction with the anion exchange resin, than with the cation exchange resin.
Bovine serum albumin has three known major isoforms due to different oxidative states of the
intermolecular disulfide bonds resulting in the formation of multimeres [55]. Isoelectric focusing
is able to separate three of them, which were also closely separated in pH gradient AEC, there
was only one peak resolved in pH gradient CEC.
The chicken egg protein conalbumin, also known as ovotransferrin, has three major isoforms.
Those are a result of the amount of bound iron ions, as the protein’s pI drops with the amount of
bound iron [56]. The elution-pH values decrease in the following order, iron-free, mono-ferric and
the di-ferric version. pH gradient AEC of conalbumin shows the expected three major isoforms
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with almost exactly the same pH values than the pIs. pH gradient CEC was not able to separate
the isoforms, also the determined elution-pH is significantly higher. The reason for this might
be the fact, that at acidic pH values the iron ions are released from the protein [57]. Therefore
the ferric-isoforms are removed in pH gradient CEC and only the iron-free protein is detected,
which elutes at a higher pH value in pH gradient CEC. Comparing the AEC elution-pH values
with the elution-pH values, determined by Ahamed et al. [3] (pH 6.7, 7.0, 7.5) one will notice,
that these values are slightly higher than the values presented here. The reason for this is most
probably the lowered ionic strength of the used, optimized buffer, which leads to a reduced effect
on the elution behavior of the proteins and consequently lower AEC elution-pH values.
Holo-transferrin, also known as siderophilin has four major isoforms, resulting from post-
translational modification with sialic acid from mono- up to hexasialotransferrin. Di- to pen-
tasialoferrine especially tetrasialotransferrin are the most abundant [46, 58]. The references for
the pI values [46] were determined from human holo-transferrin and are used here for compari-
son due to the unavailability of the same data from the bovine protein. Three major isoforms
could be separated in pH gradient AEC, while only two were separated in pH gradient CEC.
This difference in the selectivity of both chromatographic modes is likely to be a result of the
post-translational modification with the negatively charged sialic acid. This modification has a
stronger influence on the interaction with the anion exchange, than with the cation exchange
resin. Another effect that might also be involved in the lower selectivity of pH gradient CEC is
the partial denaturation of the protein at low pH values as it is known that the bound iron ions
might be released at low pH values [59].
The hen-egg protein, ovalbumin has three known isoforms differing in their electrostatic pro-
perties a di-, a mono- and a non-phosphorylated version [47]. Three major isoforms are also
detected in pH gradient AEC. A further, minor isoform is detected at a slightly higher elution-
pH, probably this chromatographic peak is a result of the glycoforms of ovalbumin [60]. pH
gradient CEC was not able to separate the different phosphoforms. This means the interaction
with the cation exchange resin is barely affected by the negative charges introduced due to the
phosphorylation.
Trypsin inhibitor, also known as ovomucoid, is a heavily glycosylated protein. The five different
isoelectric isoforms are related to different glycoforms of the protein [47]. Only one elution-
pH could be determined by cation exchange chromatography, while five were determined by
pH gradient AEC. This indicates that the glycosylation does not have much influence on the
proteins interaction with a negatively charged resin. Ovomucoid is glycosylated at Asn residues
by various, negatively charged glycosylations with sialic acid or sulfated carbohydrates [61].
The different glycosylation degrees lead to a varying strength of attractive interaction of the
different glycoforms with the anion, but not with the cation exchange resin. This concludes to
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the differing selectivity between the two chromatographic modes.
Ribonuclease A and B are two isoforms differing in the glycosylation pattern, whereby the B
form is glycosylated at Asn34. Both isoforms have an identical pI and identical AEC elution-pH
values, but interestingly they differ in the CEC elution-pH. The reason might be the positively
charged amino acid, which is masked by the glycosylation and therefore not accessible by the ca-
tion exchange resin, thus the glycoform RNAse B elutes at a lower pH than the non-glycosylated
RNAse A. This results are in accordance with previously reported results, stating that the two
isoforms could be separated by CEC but not by AEC [62].
Catalase from bovine liver is uniform in isoelectric focusing, but in both pH gradient IEC modes,
two to three isoforms were detected. The cause for this is likely to be the partial dissociation
of the tetrameric protein at low [63] or high pH values [64] resulting in induced isoforms. To
determine the detailed composition of the resulting protein fragments, further analysis would be
needed.
Summarizing the results from the characterization of the different proteins via pH gradient ion
exchange chromatography leads to the following conclusion. It became obvious that different
modifications resulting in isoforms have a different impact on the separation efficiency of the
single methods. This issue manifests in the differing selectivity of cation and anion exchange
chromatography, e.g. the different phosphoforms of ovalbumin could be separated in pH gradient
AEC but not CEC. This means that depending on the nature of the modification pH gradient
AEC, CEC or isoelectric focusing might be the method of choice. Regarding the results it
became clear that pH gradient IEC proved to be a potent tool to separate isoforms based on
their different electrostatic properties.
5 Conclusions
In this work, we successfully demonstrated, that the in silico optimization of buffer compositions
for pH gradient IEC is a fast and simple way to generate buffer compositions for well controllable
pH gradients with low ionic strength. With this method we could successfully generate buffer
compositions for long range pH gradients, spanning up to 7.5 pH units. The applicability of the
buffer compositions was successfully validated by applying them on their corresponding resins.
The resulting pH gradients showed a high linearity and reproducibility. Additionally we collected
a list of possible buffer substances, enabling us to generate optimized buffer compositions for
nearly every pH range.
In the second part we successfully validated, the buffer compositions applicability for the charac-
terization of proteins via pH gradient IEC. As a consequence, we applied pH gradient AEC and
CEC for the characterization of 22 proteins, comparing the results with literature values of the
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proteins experimental pIs. The results clearly showed that there are major differences between
the three methods, due to the proteins interaction with a charged adsorber surface. These dif-
ferences often resulted in different selectivities of the three methods, motivating a selective use
of the methods for specific separation problems. Additionally, pH gradient IEC clearly showed
that it can be used as a real alternative for the characterization of protein charge variants.
Still there are many questions on the elution behaviour of proteins in pH gradient IEC left open
for future studies. One interesting point would be to study the differences between salt and pH
gradient IEC or a combination of both e.g. in terms of chromatographic resolution or robustness.
The comparison of protein separation behaviour in pH gradient IEC using different columns,
with different lengths and resins is also not treated by this article. The described methodology
for the development of buffer systems for pH gradient IEC makes it possible to easily generate
applicable buffer systems to work on those or further scientific questions.
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Abstract
The accelerating growth of the market for proteins and the growing interest in new, more complex
molecules are bringing new challenges to the downstream process development of these proteins.
This results in a demand for faster, more cost efficient, and highly understood downstream pro-
cesses. Screening procedures based on high-throughput methods are widely applied nowadays to
develop purification processes for proteins. However, screening highly complex biotechnological
feedstocks, such as complete cell lysates containing target proteins often expressed with a low
titre, is still very challenging. In this work we demonstrate a multidimensional, analytical scree-
ning approach based on pH gradient ion exchange chromatography (IEC), gel electrophoresis
and protein identification via mass spectrometry to rationally characterize a biotechnological
feedstock for the purpose of purification process development. With this very simple characte-
rization strategy a two-step purification based on consecutive IEC operations was rapidly laid
out for the purification of a diagnostic protein from a cell lysate reaching a purity of ∼ 80% .
The target protein was recombinantly produced using an insect cell expression system.




In the past decade research and development in biopharmaceutical process engineering was
strongly focused on the optimization of routine production platforms for monoclonal antibodies
(mAbs). In terms of upstream process development, focus was on improving the expression
organism towards ever increasing titres. To our knowledge, the current largest mAb titre is 27
g/l of cell culture volume (XD R© process by DSM with PER.C6 R© cell line from Crucell). To
eliminate time consuming process development on the downstream processing side so called
platform processes were developed centering around the initial capture step using Protein A
affinity chromatography. A typical purification platform consists today of two to three sequential
chromatographic steps, Protein A affinity chromatography, followed by polishing based on anion
and/or cation exchange chromatography (AEC/CEC) [19]. The high titres of the antibodies,
the low concentration of contaminants due to the extracellular expression of the molecule, as
well as the platform process with an affinity-based purification step, has made the production
of mAbs a rather simple, routinely performed task.
However, this achievement overshadows challenges exhibiting more complex tasks and diverse
feedstocks for the production of enzymes, protein hormones, cytokines, protein vaccines and
diagnostic proteins [11]. Using protein tags for simplified purification of those targets is very
often not an option due to potential risks for the therapeutic’s safety [65, 66]. A more general
use of expression organisms, potential intracellular products as well as more complex and diverse
products will result in lower product titres, and higher contaminant concentrations. Furthermore,
a general platform process for the purification of all different proteins is unlikely to be realized
in the near future.
In the light of the described situation, various approaches for purification process development,
such as heuristic (knowledge-based), experimental (high-throughput screening (HTS)), model-
based approaches and combinations of these, are extensively discussed in literature [17]. One
trend in downstream processing of biopharmaceuticals that could clearly be observed in the last
few years is the progress towards more rational synthesis and design methodologies [18, 22, 67–
69]. This means that the development of screening approaches that provide a rational methodo-
logy to acquire the relevant information needed to rapidly set up modular purification processes
for different targets. In a recent publication, Nfor et al. [22] proposed the use of different chroma-
tographic screenings and LC-MS based protein identification to acquire the purification relevant
physicochemical parameters of the target protein as well as the identified contaminants from a
cell culture supernatant containing a monoclonal antibody. The acquired physicochemical pa-
rameters can be classified into so called "heuristic parameters" and "mechanistic parameters".
Heuristic parameters can be used to empirically synthesize purification steps knowledge-based,
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while mechanistic parameters allow in silico prediction of the mixture’s chromatographic beha-
viour. In the previous work by Nfor et al. [22] two different methods are used to acquire the
said parameters for IEC: 1. pH gradient IEC to determine the mAb’s elution-pH to rationally
choose the pH for salt gradient IEC [3]; 2. IEC, using multiple, linear salt gradients to estima-
te the parameters for the simulation of IEC operations [70, 71]. However, using a comparable
characterization approach for the previously described feedstock would pose several, mainly ana-
lytical challenges due to the significantly increased complexity of the mixture and the strongly
decreased target protein concentration.
In this work we show the use of an adapted screening procedure based on optimized pH gradient
IEC [72] and LC-MS based protein identification to characterize a highly complex, complete cell
lysate containing a diagnostic protein with a very low expression level. A detailed description of
the screening procedure is given in the next section. The obtained data was subsequently used
to lay out a simple two step purification of the target protein based on IEC to evaluate the
applicability of the developed method.
The diagnostic protein is a 45 kDa fragment of the human protein Nucleolin (Ncl, GI num-
ber 55956788), containing all the relevant epitopes for the diagnosis of the autoimmune disea-
se systemic lupus erythematosus (SLE). The target protein is recombinantly expressed in a
SF9/Baculovirus expression system.
1.1 The screening procedure
Characterizing highly complex biotechnological feedstocks with low product titres poses several
challenges, mainly caused by the low target protein concentration and the high number of con-
tained proteins. To address these challenges, a general strategy consisting of three experimental
steps is suggested.
First, the elution-pH values of the target protein in AEC / CEC are determined by fractionating
the cell lysate using long range pH gradient AEC (pH 10.5-3.5) / CEC (pH 4.0-11.0). A target
specific analytical technique is subsequently applied to determine the fractions containing the
target protein. Possible analytical techniques are immunoassays or LC-MS based methods.
The determined elution-pH values are used to select the pH range (elution-pH +/- 1 pH unit)
for short range pH gradient AEC / CEC. By submitting the cell lysate to short range pH
gradient IEC, proteins with electrostatic properties comparable to those of the target protein,
are specifically fractionated. Significantly concentrated proteins contained in the fractions of the
short range pH gradient fractionation represent the relevant impurities for the purification of
the target protein, which will be difficult to remove by IEC. To define those impurities, the
fractions are further analysed by SDS PAGE after a concentrating step. The concentrating step
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1. Long-range pH gradient IEC
-
-
pH gradient AEC / CEC
analysis of the fractions via dot blot





short range pH gradient AEC / CEC
lyophilization of the fractions
SDS-PAGE + Silver Blue Coomassie staining




tryptic digestion of relevant contaminants
LC-MS based protein identification




Figure 1: Screening procedure for the SF9/Baculovirus cell lysate containing Ncl
(e.g. lyophilization) is mostly mandatory as only small amounts of the biotechnological feedstock
are analysed to keep the procedure in analytical scale.
Finally, the selected, relevant contaminants are identified via tryptic digestion and LC-MS.
The obtained informations are, the protein IDs, the elution-pH values in AEC / CEC, the
electrophoretic molecular weight, the molecular weight derived from the used protein database as
well as the calculated pI of each relevant protein. These informations provide a basis for rationally
designing early purification processes based on IEC. The whole process is illustrated in Fig. 1 for
the presented case. The screening procedure is applied on the insect cell lysate containing the
recombinantly expressed protein Nucleolin. On the basis of the obtained information an early
purification process of Nucleolin by IEC is laid out.
2 Materials and methods
2.1 Chemicals
The chemicals, acetonitrile, Tris, NaCl, DTT, SDS, phosphoric acid, ammoniumbicarbonate,
DMSO, 1-methylpiperazine and the enzyme benzonase, were purchased from Sigma-Aldrich (St.
Louis, MO, USA). The substances, ammoniumsulfate, EDTA, urea, methylamine, hydroxylami-
ne, 1,2-ethanediamine, 1,4-dimethylpiperazine, hydrochloric acid, sodium hydroxide, formic acid
and acetic acid were purchased from Merck (Darmstadt, Germany). The buffer substances for
pH gradient CEC (section 3.2), Triton X-100 and Tween-20 were purchased from Applichem
(St. Louis, MO, USA). Coomassie G250 was purchased from Bio-Rad (Hercules, CA, USA).
Bis-tris was purchased from Molekula (Molekula, Dorset, UK). All used buffer substances were
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of analytical grade purity.
2.2 Buffers
SF9 lysis buffer: The buffer for the SF9 cell lysis consisted of 20 mM Tris-Cl at pH 8.0,
150 mM NaCl, 0.5% (v/v) Triton X-100, 2 mM EDTA and 1x SigmaFast protease inhibitor
(Sigma-Aldrich St. Louis, MO, USA).
Solubilization buffer: The solubilization buffer for the freeze-dried samples consisted of 6 M
urea, 100 mM Tris, 5 mM EDTA and 0.5% (w/v) SDS, the buffer was adjusted to pH 8.0.
Long range pH gradient AEC: The composition of the buffer for pH gradient AEC pH 10.5








+ 10 mM sodium chloride
Long range pH gradient CEC: The composition of the buffer for pH gradient CEC pH 4.0










+ 200 mM sodium chloride
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Short range pH gradient AEC: The composition of the buffer for pH gradient AEC pH 5.5




+ 10 mM sodium chloride
Short range pH gradient CEC: The composition of the buffer for pH gradient CEC pH 9.5




+ 200 mM sodium chloride
The buffer systems for pH gradient IEC were systematically developed as it is reported in a
previous publication [72]. To set up the buffers for the pH gradient IEC, all substances were
weighed in, dissolved in ultrapure water and split in two equal volumes. One part was titrated
to the low pH extreme, the other to the high pH extreme, with the appropriate strong titrant.
Buffers for dot-blot development: For the development of the dot-blots, TBS (20 mM Tris,
pH 7.5, 150 mM NaCl) and TBS-T (20 mM Tris, pH 7.5, 500 mM NaCl, 0.5%(w/v) Tween-20)
were used.
All buffer solutions were prepared with ultrapure water from a MilliQ water purification system
from Millipore (Billerica, MA, USA). The pH adjustment was carefully performed with a freshly,
five-point calibrated pH meter (HI-3220, Hanna Instruments, Woonsocket, RI, USA). The pH
calibration buffers, pH 3, 5, 7, 9, 11, were high precision standards from Hanna Instruments.
After adjusting the pH, the buffers were brought to their final volume. Buffers used for chroma-
tographic separations were degassed and filtered using vacuum filtration with a 0.2 µm cellulose
acetate filters from Sartorius Stedim (Goettingen, Germany).
2.3 Cell lysis
Cultivation and infection of the SF9 insect cells for the recombinant production of the nucleolin
fragment was done by the industrial partner, Diarect AG (Freiburg, Germany). For the pre-
paration of the cell lysate, cell pellets of 50 ml cultivation broth were dissolved in lysis buffer
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with a ratio of 1 : 5 (w/w), by shaking the suspension for 10 min on an overhead shaker. After
dissolving the pellet, the cells were lysed by sonication: 6x 15 s sonication at 40% amplitude,
with 30 s cooling steps in between. Sonication was carried out on ice with a Branson Sonicator
450D equipped with a 1/8 inch microtip horn (Branson Ultrasonics, Danbury, CT, USA). After
lysis, 10 mM MgCl2 and 1 µl of benzonase (, 250 units) were added to digest the DNA in
the lysate. The cell lysate was then incubated for 30 min on an overhead shaker at room tem-
perature. Particulates were removed by centrifugation for 30 min at 40.000 g. The prepared cell
lysates were then aliquoted and stored at -32◦C. The cell lysates contained ∼10 g/l of protein
and ∼10–100 mg/l of the target protein.
2.4 Sample preparation for LC
The frozen cell lysates were thawed in a sonication bath (Branson Ultrasonics, Danbury, CT,
USA) to prevent strong formation of precipitates. Afterwards, particulates were removed by
centrifugation. To prepare the cell lysates for subsequent chromatographic separations, a buffer
exchange via PD-10 columns (GE Healthcare, Uppsala) into the loading buffer of the following
chromatographic step, was performed. The lysates were then filtered with 0.2 µm cellulose
acetate filters (Sartorius Goettingen Germany).
2.5 Long range pH gradient fractionation / elution-pH determination
The long range pH gradient IEC was performed to fractionate the crude lysate for the deter-
mination of the target protein’s elution-pH. The chromatographic runs were done on an Äkta
Purifier (GE Healthcare, Uppsala, Sweden) and monitored with online UV and pH measure-
ment. The used chromatographic columns were a MonoQ 4.6/100 and a MonoS 4.6/100 column
(GE Healthcare, Uppsala, Sweden). Long pH gradient AEC was run from pH 10.5 – 3.5 and
pH gradient CEC was run from pH 4.0 – 11.0. The chromatographic sequence consisted of the
following steps: 1. Equilibration for 5 CV; 2. Injection of 1 ml cell lysate; 3. Wash-step for 10
CV in AEC and 20 CV in CEC; 4. Gradient 0 – 100% in 15 CV; 5. Post-gradient at 100% for
5 CV 6. Cleaning-step with 1N NaCl for 5 CV. The flow rate was kept constant at 1.5 ml/min.
For CEC the volume of the wash-step was increased to 20 CV to wash out all unspecifically
bound contaminants until a stable UV 280 nm baseline was reached. A fraction collection device
(GE Healthcare, Uppsala, Sweden) was used to collect 1 ml fractions throughout the gradient.
The flow through step, the post-gradient step and the wash step were collected in 50 ml tubes.
The collected fractions and 1 ml of each 50 ml tube were stored at -32◦C in a 96-deepwell MTP
(Thermo Scientific, Waltham, USA) for further analysis by dot-blot.
To identify the nucleolin-containing fraction a dot-blot was performed. 1 µl of each fraction
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was spotted on a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). After washing the
membrane twice with TBS (5 min) the membrane was blocked for 1 h with 3% (w/v) BSA
in TBS. Subsequently the membrane was washed twice with TBS-T and once with TBS. The
primary antibody (detecting the 6-His-tag of Nucleolin), a mouse-anti-pentaHIS IgG (Qiagen
GmbH, Hilden, Germany), was diluted 1:1000 in blocking solution and then applied for 1 h.
The second antibody, an anti-mouse-IgG alkaline phosphatase conjugate (Thermo Scientific,
Waltham, USA) was applied for 1 h at 1:10000 dilution ratio in blocking solution after a washing
step. To develop the dot-blot it was washed first and then stained for 10 min with an alkaline
phosphatase color development kit (Bio-Rad, Hercules, USA). All steps were carried out on a
rocking shaker.
2.6 Short range pH gradient fractionation
After determining the elution-pH of the target protein, a pH gradient IEC method with a
narrower pH range around the determined elution pH (+/−1 pH unit of the target protein’s
elution-pH) was designed. The chosen pH ranges were 5.5 – 3.5 for AEC and 9.5 – 11.5 for CEC.
The buffer compositions are described in section 3.1. The chromatographic runs were performed
according to the description in section 2.5, with two minor changes: the volume of the injected
lysate was raised to 2 ml per run and the flow-through step to 20 CV. The collected fractions
and 1 ml of each 50 ml tube were frozen at -82◦C for minimum 2 h. The pre-frozen samples
were subsequently submitted to a freeze dryer (Labconco, Fort Scott, USA) and concentrated
to complete dryness. The samples were then stored at -32◦C until further analysis.
2.7 Identification of the target protein and the relevant contaminants
The chromatographic fractions of the short range pH gradient were analysed to define and iden-
tify the relevant contaminants and the target protein. The fractions were dissolved under heavy
shaking in 100 µl solubilization buffer (see 3.2) for 30 min on a thermo shaker (Bio-Rad, Hercu-
les, CA, USA) at 37 ◦C. This resulted in a 10x concentration compared to the initial fractions.
The resolubilized samples were then prepared for the SDS PAGE according to the supplier infor-
mation for 4-12% Bis-Tris NuPAGE gels under non-reducing conditions (Invitrogen, Carlsbad,
CA, USA). A protein standard (Mark12, Invitrogen, Carlsbad, CA, USA) was used to estimate
the molecular weight of the proteins. The gels were stained for 24 h with the highly sensitive
“Blue silver staining”, a colloidal coomassie staining method [73]. The gels were scanned in a
Gel Doc XII station (Bio-Rad, Hercules, USA) after destaining with ultrapure water. The gels
were analyzed densitometrically via ImageJ (NIH, Bethesda, USA). All proteins with an inten-
sity ≥ 20% of the intensity of the most prominent protein (Nucleolin) were defined as relevant
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contaminants, due to their concentration and their comparable electrostatic behaviour. The cor-
responding bands were excised and identified via tryptic digestion and LC-MS, as described in
the sections 2.8 & 2.9.
2.8 LC-MS sample preparation
The excised protein bands were destained by shrinking them for 10 min at room temperature
in 100 µl 25 mM ammoniumbicarbonate, 50% (v/v) acetonitrile. The solution was removed
and the gels were reswollen in 25 mM ammoniumbicarbonate. This procedure was repeated
until the gel was completely destained. The destained gel slices were shrunk for 10 min in
acetonitrile. Afterwards, they were immersed in 25 mM ammoniumbicarbonate with 10 mM
dithiothreitol (DTT) for 30 min to reduce the disulphide bonds of the proteins. To inhibit the
reformation of the disulphide bonds by alkylation, the gel slices were shrunk again and then
incubated in the absence of light with 25 mM ammoniumbicarbonate buffer containing 20 mM
iodoacetamide for 45 min. The gel slices were shrunk in ice cold acetonitrile (30 min, on ice)
and reswollen (30 min, on ice) in 25 µl trypsin solution, which consisted of 20 µg/ml trypsin
in 40 mM ammoniumbicarbonate with 9% acetonitrile. After reswelling the gel pieces (30 min)
with trypsin solution, another 50 µl 25 mM ammoniumbicarbonate buffer was pipetted on the
gel. The samples were then digested for 24 h at 37C on a thermoshaker (Eppendorf, Hamburg,
Germany). The liquid was separated from the gel pieces after digestion and stored at -32◦C
until LC-MS analysis. All digestion steps were performed very carefully in a clean environment
to avoid possible contaminations.
2.9 Identification of proteins by LC-MS
After digestion, formic acid and DMSO were added (both 5% v/v) to increase peptide recovery.
Protein digests were analysed by reversed phase nano-LC coupled to a LTQ Orbitrap Velos
(Thermo Fisher Scientific, Bremen, Germany). An Agilent 1200 series HPLC system was equip-
ped with an in-house packed trapping column (100 µm ID and 20 mm length) and analytical
column (50 µm ID and 250 mm length) filled with Reprosil Pur 120 C18-AQ (Dr. Maisch,
Ammerbuch-Entringen, Germany) essentially as described by Meiring et al. [74]. Trapping was
performed at 5 µl/min for 10 minutes in solvent A (0.1 M acetic acid), and elution was achie-
ved with a gradient from 0 to 40% solvent B (0.1 M acetic acid in 8:2 v/v acetonitrile:water)
for 40 minutes. The LTQ Orbitrap Velos was operated in data dependent mode automatically
switching between MS and MS/MS. Survey full scan MS spectra were acquired from m/z 400
to 1500 in the Orbitrap with a resolution of 30,000 at m/z 400 after accumulation to a target
value of 1e6 in the linear ion trap. The ten most intense, multiply charged ions at a threshold of
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above 1000 were fragmented in the linear ion trap using collision-induced dissociation (CID) at
a target value of 1e4. All raw data files were processed into peaklists using Proteome Discoverer
1.1. Mascot 2.2 was used to search the spectra against the NCBInr database using taxonomy
restrain from human, moth and viral proteins. To improve the certainty of the results, the Mas-
cot data files were additionally re-analysed in Scaffold 3.6 (Proteome Software, Portland, OR,
USA) by using the X!Tandem algorithm with the same database. pH gradient IEC fractionation,
SDS-PAGE and LC-MS were performed two to three times for protein samples with uncertain
identification to decrease the possibility of falsely identified proteins.
2.10 Two-step purification of Nucleolin
The collected data on the elution behaviour of the target protein and the contaminants was
finally used to generate a crude purification process consisting of a CEC capture and an AEC
purification step.
CEC capture step: Proteins were captured at pH 8.75 (20 mM TAPS), 200 mM NaCl on a
SP Sepharose FF column (GE Healthcare, Uppsala, Sweden). The used column was a custom
packed Kronlab class column (YMC, Wilmington, NC, USA) with an inner diameter of 20 mm
and a bed volume of 7.5 ml. Elution was carried out with a salt step from 200 – 500 mM NaCl.
The chromatographic operation was performed on an Äkta purifier, while monitoring the UV
254 nm and 280 nm signals as well as the conductivity. The chromatographic sequence was: 1.
Equilibration step for 2 CV; 2. Injection of 10 ml lysate; 3. Wash-step for 4.5 CV; 4. Step-elution
0 – 100% hold for 2.75 CV; 5. Cleaning-step with 1N NaCl for 2.5 CV. All steps were performed
at 1.25 ml/min except the injection step which was performed at 0.5 ml/min. The elution fraction
(7.5 ml) and the flow-through fraction were collected. The collected elution fraction was first 1:2
diluted using CEC running buffer at pH 8.75 without salt and further concentrated to a volume
of 2 ml using centrifugal concentrators, VivaSpin 20 (Sartorius) with a molecular weight cutoff
of 3 kDa according to the manufacturers instructions.
AEC purification step: A salt gradient elution at pH 5.2 (20 mM piperazine) from 0 – 1000
mM NaCl was used to purify the sample further after the capture step. The used chromato-
graphic column was a 1 ml (5 mm ID x 50 mm L) Q Sepharose FF (GE Healthcare, Uppsala,
Sweden) column from Atoll (Weingarten, Germany). The chromatographic operation was also
performed on an Äkta purfier, while monitoring the same signals as for the CEC capture step.
The chromatographic sequence was: 1. Equilibration step for 5 CV; 2. Sample load (conc. CEC
elution fraction); 3. Wash-step for 10 CV; 4. Elution with a salt gradient of 0 – 5% in 0 CV,
5 – 50% in 25 CV and 50 – 100% in 0 CV, hold for another 5 CV. The proteins eluted by the
salt gradient were collected in 1 ml fractions, while the flow-through and the cleaning step were
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collected in 50 ml tubes.
Dot-Blot analysis: All collected samples had to be brought to identical volumes for better
semi-quantitative interpretation of the results. The CEC flow-through fraction was concentrated
to a volume of 10 ml using VivaSpin 20 centrifugal concentrators (Sartorius) with a molecular
weight cutoff of 3 kDa. Samples with a volume of 5 µl were taken of the concentrated CEC
elution fraction and diluted 1:5, while 5 µl samples of each AEC fraction were diluted 1:10 with
ultrapure water. After bringing all samples to a comparable concentration in relation to the
injected cell lysate (10 ml) 1 µl of each was dotted on a nitrocellulose membrane (BioRad) and
developed as previously described in section 2.5.
SDS PAGE analysis: The samples were analysed by SDS PAGE and Coomassie staining to
control the purification qualitatively. The concentrations of all collected AEC fractions were in-
creased ten times by freeze-drying and resolubilization prior to SDS PAGE analysis as described
in section 3.6. Preconcentration of samples was carried out to improve result interpretation by
the following SDS PAGE analysis. Samples of the cell lysate, the CEC elution fraction and the
concentrated CEC elution fraction were untreated for analysis by SDS PAGE. The SDS PAGE
& the Coomassie staining were prepared as described previously (section 2.7). The gels were
densitometrically analyzed using ImageJ.
3 Results and discussions
3.1 Long range pH gradient fractionation / elution-pH determination
To determine the elution-pH of Nucleolin from the lysate, pH gradient AEC / CEC screenings
were performed as described in section 2.5. Dot-blot analysis was used for the identification of
the Nucleolin containing fractions. The results are shown in Fig. 2. The AEC elution range of
Nucleolin was pH 4.9 – 4.3, while the CEC elution was in the range of pH 9.7 – 10.6 at a sodium
chloride concentration of 200 mM. The protein was only eluted from the CEC column by the
1M NaCl wash step when pH gradient CEC was performed without the addition of NaCl. This
reveals a surprisingly big difference between the protein’s elution behaviour on the different IEC
columns. According to a previous publication, shifts between AEC and CEC elution-pH values
are likely to be caused by an anisotropic charge distribution on the protein surface [72]. This
might be reasoned by the fact, that the surface charge distribution of the protein dictates the
binding orientation of the protein to the charged surface [75–79]. It is known that the diagnostic
nucleolin fragment consists of the four RNA-binding domains RRM1-4. When taking the above
findings into account, it is highly probable that the very locally, positively charged RNA-binding
sites have an extreme effect on the protein’s surface charge distribution and therefore its elution
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Figure 2: pH gradient AEC/CEC screening for elution-pH determination of nucleolin from the cell lysate:
A: pH gradient AEC pH 10.5 – 3.5, 10 mM NaCl and dot-blot analysis to determine fractions containing
the target protein. The elution range is shaded in the chromatogram; B: pH gradient CEC pH 4.0 – 11.0,
200 mM NaCl and dot-blot analysis to determine fractions containing the target protein. The elution range
is shaded in the chromatogram;
behaviour in IEC. This fact is likely to be the explanation for the exceptionally strong binding
of the protein to the negatively charged CEC resin by the positively charged RNA-binding sites
as well as the large variation between the elution-pH values in AEC and CEC. The extreme
difference found for Nucleolin with respect to calculated pI (calc. pI: 8.56) and actual elution
behaviour clearly demonstrates that using the elution-pH for IEC process development has
a significant advantage over using the protein’s pI. Utilizing the pI of the protein for IEC
process development in the presented case would have led to a serious misjudgement of process
parameters. This is reasoned by the fact that the electrostatic interaction of the protein with
an oppositely charged solid phase can not be explained only by the protein’s net charge. Also
the surface charge distribution of the protein influences binding of the protein to the charged
surface which was already reported by others [75–79].
The two determined elution-pH values were further used in the presented case to choose the pH
range for the short pH gradient IEC as well as the pH and salt concentration of the subsequently
developed IEC purification steps.
3.2 Identification & characterization of the target protein and the relevant
contaminants
The most problematic contaminants for the purification of a target protein are the proteins with
closely similar physicochemical properties, such as the electrostatic properties, in ion exchange
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Figure 3: focused pH gradient AEC/CEC: A: pH gradient AEC pH 5.5 – 3.5, 10 mM NaCl, Nucleolin
elution shaded; B: pH gradient CEC pH 9.5 – 11.5, 200 mM NaCl, Nucleolin elution shaded;
chromatography. By running a focused pH gradient IEC with a shorter pH range it was possible
to fractionate the lysate with increased chromatographic resolution. The proteins, eluting closely
to the target protein are the proteins with very similar electrostatic properties.
The applied pH ranges were 5.5 – 3.5 for pH gradient AEC and 9.5 – 11.5 for pH gradient CEC.
The pH gradient CEC was run at an ionic strength of 200 mM sodium chloride. The pH was
monitored to determine the pH of the collected fractions and therefore the elution-pH values
of the eluted proteins. The chromatograms of the focused pH gradients are shown in Fig. 3.
To define the relevant contaminants the fractions were further separated by SDS-PAGE. The
gels were stained and analysed densitometrically. The criteria for the definition of the relevant
contaminants was an intensity ≥ 20% of the protein with the strongest intensity, in this case
Nucleolin. The gels with the defined relevant contaminants of both pH gradient fractionations
are shown in Fig. 4.
To identify the relevant contaminants, the corresponding protein bands were excised, tryptically
digested and the resulting peptides were identified by LC-MS and database searching. The iden-
tified proteins are listed with the determined values for each chromatographic mode in Tab. 1.
The theoretical protein pIs were calculated from the proteins’ amino acid sequence using Com-
pute pI/Mw (www.expasy.org). The proteins’ sizes were also determined via gel electrophoresis
allowing the comparison with the theoretical masses which were determined using the sequence
of each identified protein.
As expected, proteins from the host organism as well as proteins from the viral expression vector
were identified. Regarding the two pH gradients, it was expected that less proteins bind in pH
gradient CEC, as the applied conditions (pH 9.5 – 11.5, 200 mM NaCl) probably prevent many
proteins from binding to the column. For this reason, more relevant contaminants were found
in the AEC fractions compared to the CEC fractions. Some identified proteins, especially the
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proteins involved in protein synthesis, like HSP70/HSC70 are already known to be overexpressed
after infection with the baculovirus [80].
Figure 4: SDS PAGE analysis of the pH gradient IEC fractions: A: pH gradient AEC pH 5.5 – 3.5, 10 mM
NaCl, ProteinIDs of the relevant contaminants a-o are shown in Tab. 1
B: pH gradient CEC pH 9.5 – 11.5, 200 mM NaCl, ProteinIDs of the relevant contaminants p-v are shown
in Tab. 1
Several proteins (HSP70, Moesin, LEF-3) were identified multiple times on different positions
in the gel, with slightly different electrophoretic, molecular size and elution-pH values. HSP70 is
likely to exist in highly homologous variants, as it does in other species [81]. Those variants are
very difficult to distinguish via LC-MS based identification, as the unique peptides have to be
detected. The identification of highly homologous variants is further complicated by the fact that
the proteomic database of a higher taxonomical class had to be used due to the unavailability
of a complete SF9-cell proteome. Therefore, the identified HSP70 proteins at position a and d
are likely to be different HSP70 variants, which could not be distinguished by the LC-MS based
identification.
The viral protein LEF-3 (Late-expression factor 3) is detected with different molecular weights.
The explanation for this is possibly the differing oxidation states of the protein. LEF-3 is known
to exist as a dimer due to intermolecular disulphide bonds as well as monomer with reduced
or non-reduced disulphide bonds [82]. This might result in variants with slightly different chro-
matographic elution behaviour and different molecular sizes, as the sample preparation is done
under non-reductive conditions. The monomer with intramolecular disulphide bonds was repor-
ted to migrate slightly faster than the reduced monomer as a diffuse band in gelelectrophoresis
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Table 1: Protein IDs
focused pH gradient AEC pH 5.5 - 3.5, 10 mM NaCl
ID Protein Database GI number MWgel MWms AEC-elpH AEC-∆pH pI
a HSP70 moth 305693941 81 kDa 72 kDa 5.00 5.10-4.95 5.32
b Nucleolin human 55956788 52 kDa 45 kDa 4.85 4.95-4.75 8.56
c, c* Moesin moth 122920502 70, 146 kDa 70 kDa 4.80 4.90-4.40 5.90
d HSP70 moth 305693941 72 kDa 72 kDa 4.85 5.10-4.40 5.32
e Thioredoxin peroxidase moth 159459926 22 kDa 22 kDa 4.85 4.95-4.75 5.93
f Protein disulfide-isomerase moth 62241290 58 kDa 55 kDa 4.70 4.80-4.55 4.60
like protein
g LEF-3 AcNPV 9627810 43 kDa 45 kDa 4.35 4.45-4.20 5.14
h TCTP moth 112982880 20 kDa 20 kDa 4.35 4.40-4.25 4.66
i LEF-3 AcNPV 9627810 120 kDa 45 kDa 4.25 4.55-4.00 5.14
j eIF-5A moth 51702278 22 kDa 18 kDa 4.10 4.10-4.05 5.16
k LEF-3 AcNPV 9627810 51 kDa 45 kDa 4.05 4.10-4.05 5.14
l HSC70 moth 27260894 72 kDa 73 kDa 3.80 4.00-3.60 5.20
m Calreticulin precursor moth 28804517 48 kDa 46 kDa 3.85 3.90-3.75 4.49
n Occlusion-derived virus AcNPV 9627837 28 kDa 26 kDa 3.75 3.80-3.60 5.94
envelope protein
o Telokin-like protein-20 AcNPV 9627825 20 kDa 20 kDa 3.75 3.80-3.60 4.46
focused pH gradient CEC pH 9.5 – 11.5, 200 mM NaCl
ID Protein Database GI number MWgel MWms CEC-elpH CEC-∆pH pI
p Hypothetical protein moth 357626559 142 kDa 132 kDa 9.78 9.67-9.87 6.29
KGM_03313
q 26S proteasome regulatory moth 357612280 115 kDa 110 kDa 9.94 9.78-10.03 5.34
subunit RPN1
r Moesin moth 122920502 67 kDa 70 kDa 9.94 9.78-11.31 5.90
s Nucleolin human 55956788 52 kDa 45 kDa 10.44 9.78-10.70 8.56
t ATP synthase moth 114052278 54 kDa 60 kDa 10.25 10.10-10.30 9.21
v Kinesin heavy chain moth 182511222 115 kDa 108 kDa 10.97 10.57-11.18 5.82
[82]. According to this we can conclude that most probably, g = LEF-3 with intramolecular
disulphide bonds, i = LEF-3 as a dimer with intermolecular disulphide bonds and k = LEF-3
with free disulphide bonds.
The protein Moesin is found with an electrophoretical size of 70 and 146 kDa. This issue might
be caused by the fact that Moesin is forming homodimers in the anion exchange chromatography
step which are also stable under denaturing conditions. Those dimers were not detected in pH
gradient CEC, probably caused by dissociation of the dimers due to the extreme pH. The stable
formation of Moesin-Moesin homodimers has been reported previously [83].
Comparing the results of both focused pH gradients it becomes obvious that there is only one
contaminant, Moesin, detected in the fractions of both chromatographic modes. Thus, the prote-
in will be especially difficult to remove via ion exchange chromatography due to its highly similar
chromatographic behaviour. Regarding the quality of the two chromatographic separations the
CEC mode might be a highly effective step to capture the target protein. The conditions at
which the target protein still binds to the cation exchange column exclude the binding of the
majority of the proteins contained in the feedstock. Therefore a CEC capture step would have
high binding capacity and could be performed with a high volume of the cell lysate. The results
show that a combination of both chromatographic modes should already lead to a very pure
product as only one relevant protein contaminant shows comparable chromatographic behaviour
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in both IEC modes.
3.3 Purification of the target protein
As a proof-of-principle, we used the results from the analytical screening to set up a simple, small
scale, two-step purification process based on salt gradient ion exchange chromatography. Salt
gradient IEC was preferred over pH gradient IEC for several reasons. An important fact is the
much wider acceptance of salt gradient IEC in industrial, preparative bioseparation engineering
compared to pH gradient IEC. Also precipitation effects might occur in pH gradient IEC as the
pH is changing throughout the gradient, resulting in strongly reduced column lifetimes.
The suggested two-step purification consisted of a CEC capture step with salt step elution and
a subsequent AEC purification step with salt gradient elution.
The CEC capture step was conducted at pH 8.75, 200 mM NaCl, bound proteins were eluted by
a salt elution step from 200 – 500 mM sodium chloride at pH 8.75 after washing out unbound
sample. No buffer exchange was necessary to bind the protein to the column (Lysate: pH 8.0, 150
mM NaCl). Due to the pH gradient screening, the chosen conditions were known to allow binding
of the target protein to the column, while binding of the majority of proteins contained in the
lysate is prevented. The latter ensures a high binding capacity for the target protein. A safety
margin of one pH unit between the pH of the mobile phase and the previously screened elution-
pH range of the target protein (pH 9.78-10.70) was included to prevent its loss due to isocratic
elution, while washing out unbound proteins by the washing step. A possible loss of the target
protein during the wash-step was indicated by its broad elution in the pH gradient CEC screening
(Fig. 4, Tab. 1). The collected elution fraction was first diluted 1:2 with salt free CEC running
buffer pH 8.75 to halve the ionic strength and then concentrated 7.5 times by ultrafiltration
to reduce sample volume for further purification by salt gradient AEC. Salt gradient AEC was
chosen to purify the target further, using a very long, shallow gradient for elution in order to
achieve separation of the critical contaminant Moesin from the target protein. The difference
between the elution-pH values of both proteins is slightly bigger in AEC than in CEC (ref.
Tab. 1, Fig. 4) increasing the possibility to achieve separation. Also the chromatographic elution
profile of both proteins was much sharper in pH gradient AEC than CEC, indicating a higher
chromatographic selectivity of the AEC resin. The conditions for salt gradient AEC were pH
5.2 and a salt gradient from 50 – 500 mM NaCl after washing out unbound proteins at pH 5.2
with 0 mM sodium chloride. Due to the sharp elution profile of Nucleolin (pH 4.95-4.75) in pH
gradient AEC a safety margin of 0.3 pH units of the mobile phase was chosen to be sufficient to
inhibit elution of Nucleolin, while washing out weakly or unbound proteins. Sample conditions
were pH 8.75 with a salt concentration of 250 mM sodium chloride.
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D
Figure 5: Two-step purification: A: CEC capture step at pH 8.75, 200 mM NaCl, step-elution 200-500 mM
NaCl, 10 ml injection of cell lysate, 43.75 ml flow-through fraction, 7.5 ml elution fraction, column cleaning at
1000 mM NaCl; B: AEC purification at pH 5.2, 0 mM NaCl, gradient-elution 0-500 mM NaCl, 2 ml injection
of CEC-pool, 11 ml flow-through fraction, 1 ml elution fractions, column cleaning at 1000 mM NaCl; C: SDS
PAGE I and II: AEC fractions 1-16 ; SDS PAGE III: FT = AEC flow-through, C = 1N NaCl AEC cleaning
step ; SDS PAGE IV: F = SF9 feedstock, Q = conditioned CEC capture, E = CEC capture; D: Dot-blot
analysis of AEC fractions 1-10, F = SF9 feedstock, W1 = CEC flow-through, Q = AEC sample, W2 = AEC
flow-through, all samples were brought to identical volumes before dot-blot analysis for better interpretation
of the semi-quantitative result.
The chromatograms of the two-step purification process and the analysis of the chromatographic
fractions by gel electrophoresis and dot-blot are shown in Fig. 5. Regarding the analysis via gel
electrophoresis (Fig. 5: F: cell lysate ; Q: conc. CEC elution fraction; E: CEC elution fraction;
) as well as the chromatogram it becomes obvious that the major fraction of contaminating
components are already removed by the highly efficient CEC capture step. The dot-blot of the
flow-through fractions clearly shows that binding conditions were chosen well as no substantial





















is seen in the electrophoresis of the eluted fraction after CEC capture (Fig. 5: lane E).
The chromatogram of the salt gradient AEC shows two chromatographic peaks during elution.
All collected AEC fractions were concentrated ten times before gel electrophoresis increasing
band intensity to improve interpretation of the results. The analysis of the fractions collected
during elution reveals that the first peak mainly contains the target protein and the second peak
contains the critical contaminant moesin. The purity of each fraction was estimated via densi-
tometrical analysis of the gels. The determined purities are shown in Tab. 2. A real quantitative
analysis of the purification step to describe the process yield was not possible as no analytical
technique with the necessary specifity to analyse the cell lysate was available. This is a frequent-
ly occuring issue when working with highly complex biotechnological mixtures. Quantitative
analytical methods with the necessary specificty, e.g. well established ELISAs, are very rarely
available.
Nevertheless, the results clearly show the potential of the chosen approach. By applying the
suggested two-step purification a purity of the target protein of min. 66% was achieved. The
suggested CEC capture step is a very advantageous capture step due to the specific chroma-
tographic elution behaviour of the target protein. Using the capture step with the suggested
conditions already resulted in a purity of 38%. After submitting the captured material to the
AEC purification step, we ended up with a purity of 66% due to the successful removal of the
critical contaminant, Moesin. Leaving out fractions with a lower purity could increase purity
further, e.g. pooling fractions 1-7 would already result in 79% purity. However there are still
some lower concentrated impurities left which were previously not defined as relevant contami-
nants. Those impurities might be removed by further polishing steps and / or optimization of




We successfully demonstrated that analytical scale characterization of a cell lysate was sufficient
to generate highly useful information for protein purification process development. The used
approach implemented two long and two short range pH gradient IEC operations. By using long
range pH gradients and dot-blot analytics it was possible to determine its elution-pH values in
IEC. Based on this information, the range of the short pH gradient was defined. Applying short
pH gradient IEC together with the SDS PAGE analysis, made it possible to define the relevant
contaminations, significantly concentrated proteins with comparable electrostatic properties.
These were subsequently identified via tryptic digestion and LC-MS. The gained information on
the relevant contaminants, the target protein and their elution behaviour was successfully used
to establish a simple two-step purification for the target protein, resulting in a purity of the
target of ∼ 80%. As the target protein is used for diagnostic purposes in a current case study,
the achieved purity might be sufficient. The presented proof of concept showed impressively how
well the chromatographic conditions could be chosen based on the information gained from the
pH gradient screening. The strongly shifted elution-pH values of the target protein in AEC and
CEC show once more that the pI value can be strongly differing from the protein’s elution-
pH values. This fact clearly indicates the usefulness of pH gradient IEC as a tool for protein
downstream process development.
There are additional benefits to be gained from such a screening approach. As the whole cha-
racterization was done in analytical scale, it only needs a low amount of sample. This enables
the usage of the screening for the determination of essential downstream process parameters al-
ready at a very early stage of process development. Another advantage of using such a screening
approach is the acquired knowledge on the detailed composition of the biological feedstock. This
leads to simplified validation and monitoring of the subsequently designed downstream process,
in terms of feed, intermediate & product quality. Also having the information in hand which
proteins are the relevant contaminants for the purification of one target protein makes it possible
to influence their expression by recombinant engineering or by simply adapting fermentation /
harvest conditions.
A future challenge will be to find methodologies to acquire parameters usable for chromato-
graphic modelling and to implement other separation techniques, like other chromatographic
interaction modes. As proteomic technologies have become more and more affordable and tech-
nically advanced in the last few years, it might be a future perspective that standard expression
systems get completely characterized allowing in silico development of complete downstream
processes.
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Abstract
The accelerating growth of the market for biopharmaceutical proteins, the market entry of biosi-
milars and the growing interest in new, more complex molecules constantly pose new challenges
for bioseparation process development. In the presented work we demonstrate the application of
a multidimensional, analytical separation approach to obtain the relevant physicochemical para-
meters of single proteins in a complex mixture for in silico chromatographic process development.
A complete cell lysate containing a low titre target protein was first fractionated by multiple
linear salt gradient anion exchange chromatography (AEC) with varying gradient length. The
collected fractions were subsequently analysed by high-throughput capillary gel electrophoresis
(HT-CGE) after being desalted and concentrated. From the obtained data of the 2D-separation
the retention-volumes and the concentration of the contained single proteins were determined.
The retention-volumes of the single proteins were used to calculate the related steric-mass action
model parameters. In a final evaluation experiment the received parameters were successfully
applied to predict the retention behaviour of the single proteins in salt gradient AEC.




The number of protein coding human genes ranges from 20.000 to 40.000 [7–9]. As this is only the
number of protein coding genes, the number of proteins is supposed to be much higher, due to
alternative splicing, post-translational modifications and complex formation. Many of those are
associated with specific diseases due to e.g. mutations, faulty expression levels and many more.
Therefore, a large number of proteins has a potential of being used as a protein therapeutic
or as a potential disease biomarker. Also the market for biopharmaceuticals was constantly
growing in the last few years and is expected to grow to 167 billion US Dollars by 2015 [10]. The
most strongly represented class of protein therapeutics are the monoclonal antibodies (mAbs).
Expression of mAbs is mostly carried out in mammalian cell cultures, secreting the proteins
into the cell culture supernatant. High titre expression processes currently reach around 10
mg/l [84]. Downstream processing of mAbs is performed using a platform process, consisting
of a protein A affinity step and subsequent purification by ion exchange chromatography [17].
The production of other protein therapeutics like enzymes, protein hormones, cytokines, protein
vaccines, autoantigens and many more is often more challenging than for mAbs. Reasons for
that are: 1. Intracellular expression of the proteins; 2. Lower expression rates; 3. The lack of
a purification platform process; 4. The lack of an affinity purification step. Nevertheless the
demands for product quality and purity are still the same, resulting in a growing demand for
new, more cost- and time-efficient ways of rational process development.
Because of the high requirements the most important separation techniques for proteins is still
chromatography as it provides high selectivity. Furthermore, it can be performed under rela-
tively mild conditions [17]. Classical chromatographic process development based on heuristic,
knowledge-based approaches, is mostly resulting in non-optimal purification processes. A si-
gnificant progress in chromatographic process development was made by the introduction of
HTS-approaches for the screening of chromatographic conditions [85–88]. Also progresses in un-
derstanding the mechanistics of chromatographic separations and advances in computing tech-
nologies are currently changing classical chromatographic process development [89–93]. Process
development based on the usage of mechanistic models for process simulation has significant
advantages, like low developmental time, costs and increased process understanding due to the
possibility to carry out a large amount of experiments in silico. However, to use mechanistic mo-
dels for the prediction of chromatographic processes, the relevant physicochemical parameters of
the proteins have to be experimentally determined. Determining those parameters can be very
challenging for highly complex mixtures, e.g. complete cell lysates containing a target protein.
The most well regarded mechanistic model for the simulation of ion exchange chromatography
(IEC) is the steric-mass action (SMA) model developed by Brooks and Cramer [1]. Determina-
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tion of the SMA parameters in mixtures is mostly done by tracking single proteins in multiple
linear salt gradient IEC with different gradient lengths [4], which is still very challenging for
highly complex mixtures.
A recent publication by Nfor et al. [22] showed a multidimensional fractionation approach, app-
lying IEC, SDS-PAGE and LC-MS based protein identification, to determine the SMA parame-
ters for a mAb and the contaminating proteins in a cell culture supernatant. After analysing the
chromatographic fractions of the linear salt gradient IEC with different gradient lengths by SDS-
PAGE they were able to define pseudo-components, groups of proteins showing similar retention
/ elution behaviour [94], for the in silico reconstruction of the chromatograms. By tracking the
retention-volumes of these pseudo components the parameters needed for the mechanistic model
were determined. Even though the method illustrates a big progress in chromatographic pro-
cess development it is still very time consuming and the physicochemical parameters are only
determined for pseudo-components and not the single proteins.
In this publication we show an alternative multidimensional fractionation approach, avoiding
protein identification by LC-MS, with significantly increased speed and the possibility to de-
termine SMA parameters, the concentrations and the molecular weights of contained, single
proteins.
The experimental technique is based on the fractionation of multiple linear salt gradient IEC with
four different gradient lengths, a rapid desalting step, sample concentrating and fraction analysis
by high-throughput capillary electrophoresis. To demonstrate the potential of the experimental
setup, a cell lysate containing a low titre target protein is exemplarily analysed to determine the
physicochemical parameters as well as the concentrations of the contained, single proteins. The
quality of the obtained parameters is finally validated by comparing predicted chromatographic
behaviour of the single proteins with experimentally derived chromatograms.
1.1 Theory
1.1.1 The SMA model
The steric-mass action (SMA) model introduced by Brooks and Cramer [1] is a highly regarded
model, describing the sorption processes in IEC. The model incorporates three protein specific
parameters, in case of a rapid equilibrium. The equilibrium constant kSMA, the protein’s cha-
racteristic charge ν and its steric factor σ. In the case of a rapid equilibrium the equation of the






( csΛ− (νp + σi)qp
)νp (1)
cs is the salt concentration in the liquid phase, cp the protein concentration in the liquid phase,
qp the adsorbed protein concentration and Λ the columns ionic capacity.
1.1.2 Parameter determination from protein mixtures
The parameters ν and kSMA are mostly determined for mixtures containing multiple proteins
by running linear salt gradient IEC experiments with differing gradient lengths. The obtained
retention-volumes of the proteins are then related to the parameters, using the following equation
by Shukla et al. [4], which was derived of a retention model developed by Parente and Wetlaufer
1984 [95]:
VR =((cν+1i,s +
VdkSMAεcΛν(ν + 1)(ce,s − ci,s)
VG




ci,s and ce,s are the gradient salt concentrations at the beginning and the end of the salt gra-
dient, VG is the gradient volume, Vd the column’s dead volume, VR the retention-volume and
εc the total column porosity. Usually 3-4 gradient experiments with different gradient lengths
are performed to estimate kSMA and ν using equation (2). The non-linear parameter σ is re-
gularly determined by performing frontal chromatographic experiments with pure components,
therefore it can not be obtained properly from mixtures. Furthermore, the steric factor is only
influencing chromatographic separation if chromatography is performed out of the linear range
of the columns binding capacity, which is not the case in the presented work. For these reasons,
the steric factor was neglected in this work.
1.1.3 The transport-dispersive model
The employed transport-dispersive model can be used to describe mass-transfer and adsorption
processes if a rapid equilibrium is assumed, e.g. for the previously described SMA model in IEC.
The time- and position-dependent change of concentration for component i, ∂ci/∂t, on column















keff ,p[cp − cb,p] (3)
The first term in the equation describes the convective transport, the second term the dispersive
transport and the third term the mass transfer of the protein to the particle surface. The
contained parameters are: keff ,p the lumped film diffusion coefficient, rb the particle radius, uint
the interstitial velocity and Dax the axial dispersion.












with qp the conc. of the particle-bound protein p and εb the particle porosity. Thus, the expression
∂qp/∂t is defined by equation (1) as a rapid equilibrium is assumed.
Holding in hand all the necessary parameters the model can be solved numerically to predict
the chromatographic elution behaviour of proteins in silico.
2 Experimental procedure
To give a better overview of the performed experiments the procedure is briefly described in the
following:
I. Multiple, linear salt gradient IEC: The cell lysate is injected on an IEC column
and fractionated by salt gradient IEC. By performing the gradient elution with different
gradient lengths the retention-volumes of the proteins can be related to their characteristic
charge ν and the equilibrium constant kSMA. A protein was added as an internal standard
to all collected fractions, for later protein quantification.
II. Desalting: Each collected fraction is desalted by RP-trapping to remove all salt ions,
which would interfere with the later following HT-CGE. Bound proteins are eluted in
organic solvent.
III. Sample concentrating: The organic solvent is evaporated of all fractions and the proteins
are concentrated to complete dryness. Protein concentration is increased 125x, which was
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necessary for the presented case due to the low protein concentrations contained in the
sample.
IV. HT-CGE: The dried samples are resolved in the sample buffer used for the HT-CGE.
All fractions are subsequently analysed. Protein concentration and molecular weight are
adjusted by using the internal standard.
V. Parameter estimation: The single protein concentrations are extracted from the HT-
CGE results and assigned to their retention-volume. Data is then fitted by gaussian peak
fitting to determine the retention-volumes of the proteins, which are finally used to deter-
mine the SMA parameters by applying equation (2).
3 Materials and methods
3.1 Chemicals
The chemicals, DTT, dextran 2000 kDa, trifluoracetic acid, lysozyme, benzonase and Sigma Fast
Protease Inhibitor tablets were purchased from Sigma-Aldrich (St. Louis, MO, USA). The sub-
stances, EDTA, piperazine, isopropanol, acetonitrile, tris, sodiumchloride, magnesiumchloride,
sodium hydroxide and hydrochloric acid were purchased from Merck (Darmstadt, Germany).
Triton X-100 was purchased from Applichem (Darmstadt, Germany). All used substances were
purchased with analytical grade purity.
3.2 Buffers
The buffer for the SF9 cell lysis consisted of 20 mM Tris-Cl at pH 8.0, 150 mM NaCl, 0.5%
(v/v) Triton X-100, 2 mM EDTA and 1x SigmaFast protease inhibitor. A 20 mM piperazine
buffers at pH 5.2 with concentrations of 0 and 1000 mM NaCl were used for salt gradient
AEC (A: 0 mM NaCl; B: 1000 mM NaCl). The solvents for RP-trapping of proteins consisted
of H2O/Acetonitrile/Isopropanol with a ratio of 95/5/0 for the binding of the proteins and
a ratio of 5/75/20 for the elution. Trifluoracetic acid was added to both solvents with a final
concentration of 0.1% (v/v). All buffer solutions were prepared with ultrapure water drawn from
a water purification system (Sartorius Goettingen, Germany). The pH adjustment was carefully
performed with a freshly, calibrated pH meter (HI-3220, Hanna Instruments, Woonsocket, RI,
USA). The used pH calibration buffers were high precision standards from Hanna Instruments.
After adjusting the pH using the appropriate titrant, the buffers were brought to their final
volume. Buffers used for chromatographic separations were degassed and filtered using vacuum




Cultivation and infection of the SF9 insect cells for the recombinant production of the target
protein was done by the industrial partner, Diarect AG (Freiburg, Germany). For the preparation
of the cell lysate, cell pellets of 50 ml cultivation broth were dissolved in lysis buffer with a ratio
of 1 : 5 (w/w), by shaking the suspension for 10 min on an overhead shaker. After dissolving the
pellet, the cells were lysed by sonication: 6x 15 s sonication at 40% amplitude, with 30 s cooling
steps in between. Sonication was carried out on ice with a Branson Sonicator 450D equipped
with a 1/8 inch microtip horn (Branson Ultrasonics, Danbury, CT, USA). After lysis, 10 mM
MgCl2 and 1 µl of benzonase (, 250 units) were added to digest the DNA in the lysate.
The cell lysate was then incubated for 30 min on an overhead shaker at room temperature.
After that, particulates were removed by centrifugation for 30 min at 40.000 g. The prepared
cell lysates were then aliquoted and stored frozen at -32◦C.
3.4 Sample preparation for LC
The frozen cell lysates were completely thawed in a sonication bath (Branson Ultrasonics, Dan-
bury, CT, USA) to prevent strong formation of precipitates. Afterwards, particulates were remo-
ved by centrifugation. To prepare the cell lysates for subsequent chromatographic separations, a
buffer exchange via PD-10 columns (GE Healthcare, Uppsala) into the application buffer of the
following chromatographic step, was performed. The lysates were filtered before injection with
0.2 µm cellulose acetate filters.
3.5 Salt gradient AEC
Multiple linear salt gradient AEC with different gradient lengths was performed to acquire the
proteins’ SMA parameters. The chromatographic runs were carried out on an Äkta Purifier (GE
Healthcare, Uppsala, Sweden) with online monitoring of UV and conductivity. The used chro-
matographic column was a MonoQ 4.6/100 anion exchange column (GE Healthcare, Uppsala,
Sweden) with a column volume of 1.662 ml. The chromatographic sequence consisted of the
following steps: 1. Equilibration for 5 CV with 0% B; 2. Injection of 2 ml prepared sample; 3.
Flow-through step for 20 CV; 4. Gradient 0-50% B in 5, 10, 20, 80 CV; 5. Wash step at 100%
B for 5 CV. The flow rate was kept constant at 1.5 ml/min. To keep the number of fractions
equal for the four different gradient lengths, fractionation volumes 100, 200, 400 and 1600 µl
were chosen to fractionate the salt gradient. All fractions were collected in 96-deep-well MTPs.




RP-trapping of the AEC fractions was performed to remove salt ions from the solution which
would interfere with the subsequent analysis by HT-CGE. Before submitting the samples to the
RP-trapping procedure an internal standard, Lysozyme, was added. Lysozyme was dissolved in
water at an appropriate concentration and added to each fraction with a final concentration of
2 ng/µl for the fractions of the 5, 10, 20 CV gradient and 0.66 ng/µl for the fractions of the 80
CV gradient. The amount was chosen to reach 500 ng in the injection volume (250 µl for 5, 10,
20 CV and 750 µl for 80 CV). After adding the appropriately concentrated lysozyme solution,
the final volumes of the fractions were 650 µl for the 5, 10 and 20 CV gradient and 1950 µl
for the 80 CV gradient. RP-trapping was performed on an Ultimate 3000 X2 RSLC (Thermo
Scientific, Waltham, MA, USA) using a RSpak RP-18G column (Showa Denko America Inc.,
New York, NY, USA). The trapping procedure was carried out with a flow rate of 1.0 ml/min.
The procedure was conducted in the following way: 1. Equilibration for 0.95 min at 0% B; 2.
Injection of 250 µl of the sample; 3. Flow-through for 1.10 min at 0% B; 4. Step-elution for 2.15
min at 100% B. To collect the eluted proteins, 300 µl of the elution step were fractionated in
a V-shape 96-well MTP or V-shape 96-deep-well MTP for the trapping of the 80 CV gradient
fractions. The same trapping procedure was performed for the fractions of the 80 CV gradient but
repeated three times per fraction, as an injection of 750 µl, to inject the same amount of protein,
is necessary. Both MTP, the AEC sample plate and the collection plate were properly sealed
with silicon plate mats to avoid evaporation and contamination. To overcome the dead-volumes
of the injection system an amount of 290 µl was drawn of each sample. To clean the sampler
needle after injection, flow-through was performed with the collection valve switched to collect,
shortly switching it to drain before fractionation to move the needle to the collection position
on the MTP. The sample loop was washed after fractionation with 1000 µl of 5% Acetonitrile in
water. The autosampler was set to 8◦C to inhibit protein degradation. To maximally concentrate
the samples in the MTP afterwards, the organic solvent was evaporated in a rotation vacuum
concentrator (Martin Christ GmbH, Osterode, Germany) until complete dryness. By using V-
shape MTP plates small spots of dried proteins were achieved at the bottom of each well.
3.7 High-throughput capillary gelelectrophoresis
High throughput capillary gel electrophoresis (HT-CGE) was used as the 2nd analytical di-
mension to trace the single proteins elution behaviour in the salt gradient AEC fractions. The
HT-CGE was performed on a LabChip GX-II device, using HT Protein Express LabChip Kits
(PerkinElmer, Waltham, MA, USA). As the dried protein samples had to be dissolved first, the
manufacturers standard protocol was adapted. 7 µl denaturing solution with 35 mM DTT as
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reducing agent and 5 µl ultrapure water were added to each sample. To dissolve the dried pellet,
the MTP was properly sealed and incubated on a MTP thermomixer with lid heating (Ditabis
AG, Pforzheim, Germany) at 37◦C for 30 min at 300 rpm. To fully denature the dissolved pro-
teins the thermomixer was then heated to 95◦C for 5 min. The dissolved and denatured protein
samples were than cooled to room temperature, shortly centrifuged to remove condensed liquid
from the sealing and mixed with 32 µl of ultrapure water. In the meantime the Protein Express
chip was prepared as described in the manufacturer’s protocol (PerkinElmer). Protein samples
were analysed by using the HT Protein Express 200 assay. The LabChip GX 3.1 software (Perki-
nElmer) was used for sample analysis and data interpretation. The resulting electropherograms
were aligned to the internal standard Lysozyme (14.3 kDa). Quantification of the proteins in
each sample was done by using the internal standard (250 ng/µl) with peak-baseline integration.
3.8 Determination of column parameters
The column parameters of the used 4.6/100 MonoQ column were experimentally determined
on an Äkta purifier. To determine the interstitial porosity 25 µl of a 10 mg/ml Dextran 2000
Da solution were injected. The determination of the total porosity was carried out by injecting
25 µl of 1 M NaCl. The porosities were determined with a three time repeat measurement at
a flow rate of 1.5 ml/min, while monitoring UV 225 nm and the conductivity. The particle
porosity was calculated from the two experimentally determined porosities. The ionic capacity
of the anion exchange column was determined via titration. The column was equilibrated with
0.01 mM sodium hydroxide and titrated with 0.01 mM hydrochloric acid. The breakthrough
of hydrochloric acid, replacing bound hydroxide ions from the column was monitored by online
conductivity measurement. The columns ionic capacity was determined from the amount of used
hydrochloric acid and the columns total porosity. The axial dispersion was estimated by using
the 1st and 2nd moment of the chromatographic peak of the non-penetrating tracer molecule,
Dextran 2000.
3.9 Determination of protein concentrations, retention-volumes and molecu-
lar weights
Most abundant proteins, selected by interpretation of the HT-CGE results, were chosen to
be monitored in the fractions of the 5, 10, 20 and 80 CV long gradients. The concentrations
of those proteins were manually extracted from the electropherogram of each fraction. The
determined single protein concentrations were then assigned to their retention-volume by the
fraction number. Afterwards, peak fitting was performed to determine the retention-volume
for each single protein. Peak fitting was performed using OriginLab (OriginLab Corporation,
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Northampton, MA, USA) applying the standard settings for gaussian peak fitting. The retention-
volumes of the fitted peaks were corrected by the dead volumes and further used for SMA
parameter estimation. The concentrations of the single proteins in different fractions were added
up to determine the complete concentration of each single proteins. The molecular weight was
determined for each protein from the electropherograms.
3.10 Determination of the SMA parameters
The parameters ν and kSMA were determined from the retention volumes by using the previous-
ly described formalism (section 1.1). Therefore, retention-volumes of the single proteins were
assigned to their gradient length. The data points were subsequently fitted using the descri-
bed equation (eq. 2). Fitting procedure was carried out in MATLAB (MathWorks, Natick, MA,
USA) by using the "fminsearch" algorithm. The parameters ν and kSMA were obtained from the
fitting procedure.
4 Results and discussion
The described approach to fractionate a biotechnological feedstock and analyse the fractions
further by HT-CGE was carried out to acquire the SMA parameters of the single proteins
for in silico process prediction and optimization. The used biotechnological feedstock was a
SF9/Baculovirus insect cell lysate containing the target protein (protein No. 6, Fig. 1). The
protein is a 45 kDa fragment of the human protein Nucleolin (Ncl, GI number 55956788),
containing all the relevant epitopes for the diagnosis of the autoimmune disease systemic lupus
erythematosus.
The cell lysate was first fractionated by multiple linear salt gradients in AEC, with gradient
lengths of 5, 10, 20 and 80 CV. All four gradients (pH 5.2, 0 – 500 mM) were fractionated in
83 chromatographic fractions. After fractionation the internal standard, lysozyme was added to
increase accuracy of the later following protein concentration and size determination by HT-
CGE. All 83 chromatographic fractions were subsequently desalted by RP-LC, and maximally
concentrated by evaporation as described in section 3.6. Dried, desalted fractions were then
dissolved in sample buffer and analysed by HT-CGE.
By analysing each chromatographic fraction with the HT-CGE, single proteins contained in
the fractions could be resolved. From these results concentrations and molecular weights were
determined for each protein present at a significant concentration level. Protein concentrations
and the molecular weight were normalized / aligned by using the internal standard. The whole
procedure is illustrated in Fig. 1 showing the results in detail for the 5 CV salt gradient IEC.
The gel pictures show the electropherograms of each fraction listed in the elution / fractionation
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Table 1: Proteins & values
Size Concentration Retention-volumes [ml] Calc. values
ID [kDa] Ø[ng] mean dev. [%] 5CV 10CV 20CV 80CV ν kSMA
1 120 48 50.9 3.05 5.43 9.45 32.70 7.74 2.19e-08
2 89 554 40.1 1.87 3.29 5.65 15.05 3.15 2.12e-04
3 80 1088 44.1 2.30 3.94 7.31 18.20 2.77 1.44e-03
4 68 997 26.6 2.38 3.93 7.08 20.70 4.12 3.57e-05
5 63 2899 20.9 3.09 5.55 9.41 30.40 5.41 6.16e-06
6 51 9498 43.0 3.11 5.41 8.64 28.17 5.01 1.18e-05
7 53 308 33.9 1.77 2.90 4.16 7.09 1.12 6.50e-02
8 36 240 33.6 1.96 3.13 5.18 16.63 5.09 5.36e-07
9 26 196 21.0 1.63 2.93 5.49 18.30 7.94 1.29e-10
10 22 478 29.3 1.73 2.94 4.04 13.00 4.10 4.90e-06
11 19 119 34.3 1.53 2.56 3.99 13.11 5.35 6.41e-06
12 24 564 15.5 2.49 4.37 7.47 25.80 7.50 6.70e-09
13 11 150 24.3 2.61 4.44 6.93 21.45 4.07 4.54e-05
14 43 1944 46.3 5.53 10.32 19.66 72.90 16.60 2.47e-12
15 25 373 58.8 4.15 7.83 14.23 49.75 9.19 2.96e-08
order. From the band intensities it can be easily recognized that the detected proteins show
typical gaussian elution behaviour, as expected. Single protein concentrations of the selected
proteins were extracted and assigned to their retention-volume related with the fraction number.
The retention-volumes of the proteins were finally obtained by standard gaussian peak fitting
procedure in OriginLab. Same analysis was performed with the fractions of the 10, 20 and
80 CV long salt gradient. The determination of the proteins’ retention-volumes is exemplarily
illustrated for the selected target protein in Fig. 2. The whole procedure was carried out in a
two times repeat measurement. The obtained, mean retention-volumes for the selected proteins
are shown in Tab. 1.
Holding in hand the retention-volumes of each selected single protein for all gradient lengths,
consequently enabled the determination of the linear SMA parameters (kSMA and ν) of the
proteins. The necessary column parameters are shown in Tab. 3. These parameters were obtained
as described in section 3.8. The linear SMA parameters of the proteins were determined by
relating the retention-volumes of the proteins with the gradient length and fitting the described
equation (2) to it. This is exemplarily illustrated in Fig. 3 for the target protein. By repeating
this procedure for all selected proteins, kSMA and ν values of each protein were determined.
The determination of the non-linear SMA parameter σ, accounting for the shielding effect was
omitted, reasoned by the previously described facts (section 1.1.2).
Single protein concentrations were determined for the selected proteins from the protein con-
centrations contained in each fraction. As all four salt gradient IEC runs and the analysis were
performed in a repeat measurement single protein concentrations were determined eight times.
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Figure 1: Multidimensional analysis
The figure illustrates the multidimensional analysis of the cell lysate. Cell lysate is first fractionated into 83
fractions by 5, 10, 20 and 80 CV long salt gradients (pH 5.2 0 – 500 mM NaCl). A desalting buffer exchange of
each fraction is then carried out by using RPC. All resulting RP-fractions are evaporated to complete dryness
and dissolved in sample buffer for HT-CGE. The 83 fractions are then analysed by HT-CGE. The upper
gel picture shows the analysis of the chromatographic fractions of the 5 CV gradient with a rising number
from left to right. The lower gel picture is focused on the protein containing fractions, selected proteins are
marked by black squares and numbered. Protein no. 6 is the target protein. The lower protein band at 14.3
kDa, apparent in all samples is the internal standard at 250 ng/µl. Reconstructed gel lanes were aligned to
the internal standard.
Mean concentration values as well as the deviation were calculated. The resulting data is shown
in Tab. 1. Determined protein concentrations were in the range of ∼ 50 – 10000 ng/µl. The
single protein concentrations show a mean deviation of ∼ 34%, while varying between 15 – 59%.
Several reasons might have caused these variations. Dissolving the proteins in HT-CGE sample
buffer after concentrating the samples to complete dryness might suffer from incomplete solu-
bilization. This effect was already reduced by using an internal standard for normalization of
the concentration. But also with adding the internal standard, varying solubilization of different
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Figure 2: Peak fitting
The determination of the retention-volumes of pro-
tein no. 6 by fitting the single concentration values
in the different gradient elutions 5, 10, 20 and 80
CV. Peak retention-volumes were determined from
the resulting gaussian peaks.

























Figure 3: Parameter estimation
The determination of the SMA parameters of pro-
tein no. 6 was carried out by fitting the assigned
retention-volumes (triangulars) by a "fminsearch"
based MATLAB procedure using eq. 2.
proteins can not be ruled out. Also, variation of protein concentrations might be reasoned by the
changed sample preparation, probably increasing variation of the analytical procedure. Another
fact that surely influences the determined protein concentrations is the overlap of proteins with
comparable molecular size. These overlaps are likely to be influenced by the gradient length of
the salt gradient IEC, as the increased chromatographic resolution of the longer IEC salt gra-
dients probably separates overlapping proteins. Furthermore single protein concentrations vary
due to regular variations caused by the device, the protein chips and the analytical procedure.
Nevertheless, single protein concentrations were determined eight times and are, due to that
issue most probably close to the real value of the protein concentration.
To evaluate the applicability of the determined SMA parameters the values were used to predict
the retention-volumes of the single proteins in salt gradient IEC with a 15 CV long salt gradient,
by applying the obtained SMA parameters. The resulting retention-volumes were subsequently
compared to experimentally determined retention-volumes. The obtained results are shown in
Tab. 2.
Comparing the predicted retention-volumes with the experimentally obtained retention-volumes
for the 15 CV long salt gradient results in a mean deviation of 5%. The deviation varies between
0.1 and 13.6% for the different proteins. This clearly shows that the SMA parameters obtained
by using this multidimensional separation / analysis procedure can be used for predicting the
retention-volumes of the single proteins. The applicability of the parameters for in silico optimi-
zation of the chromatographic separation was further evaluated by exemplarily predicting the
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chromatograms of three proteins. Prediction of the chromatographic elution is done by applying
the transport-dispersive model as described previously. The model was solved numerically, by
applying an in-house software tool written in C++. A density of 400 knots was applied over the
whole column length. The necessary film diffusion coefficient kfilm was estimated by prediction
of the proteins diffusion constant [96], which was then related with kfilm as described elsewhere
[97]. The steric factor σ was chosen to be 30 for all proteins because it was not possible to
determine σ experimentally from such a crude mixture. However, it did not effect the prediction
of the chromatographic behaviour due to the fact that concentrations of the contained single
proteins were in the linear range of the column’s capacity. The resulting chromatographic peaks
are shown in Fig. 4. Predicted chromatographic peaks match the experimentally determined
peaks very well. Only peak width shows variation from the experimentally determined results.
Variations between the experimental and the predicted elution behaviour of the single prote-
ins are most likely to be reasoned by slight deviations of the parameters from the real values.
The determined single protein concentrations in each fraction underly the previously described
variations. As the peak fitting procedure is depending on the protein concentrations determi-
ned in each fraction, variations in the obtained retention-volumes of the single proteins are
expected. The occurrence of protein charge variants, which might get partly separated in longer
salt gradients as chromatographic resolution is increased, would also affect determination of the
retention-volumes. Slightly deviating retention-volumes are consequently influencing the estima-
tion of SMA parameters and therefore the predicted retention-volumes. Also, the precision of the
retention-volume is limited by the amount of fractions collected, a higher amount of fractions
would lead to an increased precision but decreased protein concentration in the fractions as well
as increased investment in time and experimental effort.
Still a mean deviation of the predicted retention-volumes of 5% is a very good result, defi-
nitely allowing the in silico prediction of the single proteins’ retention-volumes. Also the in
silico prediction of single protein chromatograms using the obtained parameters matched the
experimentally determined chromatograms very well. The whole procedure, four multiple salt
gradients, the buffer exchange by RPC, solvent evaporation and the HT-CGE analysis were
performed at a time-scale of two days. Still the data analysis was very time consuming as no
automated data processing exists so far.
5 Conclusions
The developed multidimensional fractionation technique was successfully applied to characteri-
ze a complex biotechnological feedstock for the acquisition of relevant parameters for in silico
prediction of the chromatographic behaviour of the contained proteins. Multidimensional frac-
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Table 2: Comparison of predicted with experimen-
tally determined VR for 15 CV gradient length
Retention-volumes [ml]
ID Calc. Exp. ∆ [%]
1 7.51 7.20 4.3
2 4.47 4.93 9.4
3 5.61 5.87 4.4
4 5.65 5.08 11.3
5 7.56 7.55 0.2
6 7.13 7.29 2.1
7 3.41 3.41 0.0
8 4.25 4.24 0.5
9 4.00 4.24 0.3
10 3.57 3.78 13.2
11 3.33 3.86 13.6
12 6.00 6.35 5.5
13 5.78 5.89 1.8
14 15.08 15.24 1.0
15 11.06 11.15 0.8































































Figure 4: Comparison of predicted with experimental results
The experimentally determined chromatograms as well as the predicted chromatograms for a gradient length
of 15 CV are illustrated for the three most concentrated proteins, no. 5, 6 and 14. The data for protein no. 6
is shown in A, no. 5 in B and no. 14 in C. Experimentally determined protein concentrations in the collected
fraction are illustrated by black diamond symbols. The fitted gaussian curve is shown by a red solid line and
the predicted chromatographic peak is shown by the dashed, blue line. Peak maxima were normalized for
better illustration.
tionation was based on salt gradient IEC, fast RPC-based sample desalting and concentrating
and a the second analytical dimension (HT-CGE). By running multiple linear salt gradients
with the described experimental set-up the concentration, the molecular weight, the charac-
teristic charge ν as well as the equilibrium constant kSMA, were determined for each protein.
Validation was successfully carried out by comparing predicted, with experimentally determined
retention-volumes. The comparison of predicted chromatograms based on the obtained parame-
ters with experimentally obtained chromatograms successfully evaluated their usability for in
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silico process prediction or further process optimization. The major qualities of this approach
are, its velocity, the analytical amount of sample necessary and the possibility to track the single
protein’s retention behaviour in complex lysates allowing the determination of parameters usable
for chromatographic process modelling. These attributes enable the application of the method
e.g. as a routinely used tool to analyse biotechnological feedstocks at a fully analytical scale
to obtain the described parameters, but also to monitor the composition of the feedstock and
probably predict possible influences of changed compositions on the chromatographic process.
Nonetheless, the approach also has its weaknesses, determined protein concentrations are still
significantly varying even though the eight times repetition of the single protein concentrations
seems to compensate for that. As this is probably reasoned by the changed sample preparation
for the HT-CGE a future revision of the experimental procedure addressing that fact might
bring improvement. Another flaw is the time consuming analysis of the resulting data. Therefo-
re, the generation of automatized data analysis tools is essential for the routine application of
the technique. Concluding all that it can be clearly stated that the application of rapid multi-
dimensional fractionation techniques, like the presented one, might be a very useful future tool
for chromatographic but possibly also non-chromatographic bioseparation process development
and monitoring.
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Abstract
For the development and optimization of chromatographic purification steps for proteins, pre-
dictive modelling has long proven to be a valuable tool, although modelling is most often applied
in the academic world for several reasons. One of them is that protein parameter estimation is a
tedious work. Parameters are pH specific and their determination often requires relatively pure
protein. Nevertheless, the pH is a crucial parameter of great interest in most optimizations it
would thus be helpful if it could be included in modelling without the need of running a lot
of calibration runs at different pH. In this article an approach is presented to determine model
parameters for the steric mass action model for a wide pH range (pH 4 to 11.5) with a limited
set of calibration experiments (linear pH gradient elution at different salt concentrations). Pa-
rameter estimation was achieved by extending the applicability of the existing SMA model to
protein elution in pH gradients and by adding certain constraints on the estimated model para-
meters. These constraints ensure a systematic progression of the characteristic charge and the
equilibrium constant KSMA over a certain pH range. Model parameters were accurate enough to
predict retention times for isocratic, mono- and bi-linear salt gradient elution and for combined
pH and salt gradient elution. A Monte Carlo study was made to investigate the effects of a 5%
experimental error on all critical parameters. It confirmed that the higher resolutions that can
Journal of Chromatography A (UNDER REVIEW), submitted March 2013
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be achieved in isocratic elution mode come at the cost of a lower robustness compared to both
salt and pH gradient elution, meaning that retention times can shift significantly already for
small experimental errors.
1 Introduction
The use of chromatographic techniques for the purification of biopharmaceuticals on both lab
and industrial scale is well established and a lot of efforts were made to speed up process
development. Especially over the last years both industry and academia were trying to establish
a platform strategy, or in other words a “plug and play” approach for finding suitable process
parameters, independent of the target molecule to be purified [98, 99]. For structurally similar
molecules, that can be purified by affinity chromatography (i.e. monoclonal antibodies) platform
strategies can be a defined as a series of two to three consecutive chromatographic steps, often
being Protein A affinity followed by an anion exchange and a cation exchange step.
Nevertheless, other recombinant proteins are to be expected to enter the market in the future
and finding a platform process for these structurally and functionally diverse molecules will most
certainly fail. Alternatively, one could think of a platform approach rather than a platform pro-
cess, meaning that all new molecules would have to pass a series of characterization steps that
will then define the layout of the process. One such approach for the identification of suitable
chromatographic separation steps and their parameters could be predictive modelling. Having
a new molecule to purify, one could characterize the molecule by determining all parameters
necessary for the chosen model to perform an in silico process optimization for choosing suitable
process conditions. In order to be sufficiently efficient to replace traditional (meaning experi-
mentally driven) process development, parameter estimation needs to be limited to a minimum
number of experiments giving a maximum amount of information on the behaviour of the target
molecule in the unit operation of interest. One additional benefit of establishing a model-based
platform approach is its value in QbD, as it implies a detailed understanding of the single unit
operations and additionally allows for robustness analysis with only little additional work.
In the field of chromatography a lot of effort has been made over the last 30 years to develop
both empirical and mechanistic models to fill this gap of a missing platform process for future
molecules to come. One step stone was the development of the “Linear-Solvent Strength” (LSS)
model [100, 101] in 1979 that was initially designed to predict retention behaviour in reversed-
phase chromatography. The basic concept was then extended to ion-exchange chromatography
in 1989 by Sasagawa et al. [102], finally leading to the “Steric-Mass Action” (SMA) model by
Brooks & Cramer published in 1992 [1], which for the first time translated the mechanistical
understanding that only part of the protein surface interacts with the adsorber material into
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mathematical equations allowing for gradient shape optimizations.
The SMA model is capable of predicting retention times on ion-exchange resins after deter-
mination of a set of two protein specific parameters: the affinity constant (KSMA) and the
characteristic charge of the protein (ν). When working outside the linear range of the adsorpti-
on isotherm, a third parameter (the steric factor σ) is needed for accurate predictions. As these
parameters are independent of salt concentration, the model can be used to optimize isocratic
and gradient elution, which has been shown in numerous publications [5, 103–106]. Although
these parameters are independent of the salt concentration, they strongly depend on the pH
in the mobile phase, limiting the use of the SMA model to serve as a platform approach for
developing new processes. For that reason, a few academic groups have tried to extend the SMA
model to different mobile phase pH.
In 1998, Bosma and Wesselingh [107] were the first that extended the SMA model to account
for changes in mobile phase pH by adding a rather complex thermodynamic framework. One
of the main assumptions of their approach was though, that the characteristic charge of the
protein, which is, based on the SMA formalism, the charge of the binding site of the protein, is
independent of pH and only the affinity of binding (KSMA) changes. From more recent studies
(including the one discussed in the next paragraph) we know today, that this assumption does
not hold.
In 2007 Yang et al. successfully predicted SMA parameters for different pH (pH 4 to 8) by
applying a quantitative structure-property relationship (QSPR) approach [108]. They used a set
of 17 different proteins and determined a set of pH specific descriptors based on the 3D structure
of these proteins. Although being capable of yielding accurate characteristic charge predictions,
the QSPR approach showed relatively high deviations for predicted KSMA values. Additionally
it was experimentally challenging (45 gradient elution runs to generate data for the training
dataset), required crystal structures for all proteins and expert knowledge on how to determine
structure-related parameters.
One of the most recent publications on incorporating pH changes into modelling was published
in 2010 by Guélat et al. [109]. They established a new thermodynamic model based on the DLVO
theory, reducing the protein-adsorber interaction to a sphere-plane interaction. In contrast to the
SMA model, their approach is based on the assumption that a protein has a homogeneous charge
distribution. By calculating pH dependent protonation states of titratable amino acids, the
surface charge density of a given protein could be calculated. Similar to the previous approach,
this one requires detailed information about the protein and the adsorber surface.
In the following we will present a purely experimental approach that is capable of yielding
SMA parameters for a wide pH range with a limited number of calibration experiments. This
approach uses a linear pH gradient (pH 4.0 to 11) ran at eight different salt concentrations (10
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to 350 mM) combined with isocratic elution experiments at three different pH values (pH 5,
7 and 9). We also show that a pH gradient at constant or changing salt concentration can be
well described mathematically by a series of isocratic elution steps with systematically changing
SMA parameters.
With this approach, SMA parameters could be determined for the whole pH range allowing for
the optimization of isocratic or gradient elutions at different pH values, which is demonstrated
for three model proteins (Ribonuclease A, Cytochrome C and Lysozyme). The parameters can
then be used to determine retention times at different pH for isocratic and gradient elution.
Additionally, the model was used to study process robustness and maximum resolution of dif-
ferent modes of operating a cation exchange column: isocratic elution, salt gradient elution and
pH gradient elution combined with an additional salt gradient.
2 Material and methods
2.1 Chemicals & buffers
For pH gradient CEC the chosen substances were MES, formic and acetic acid (Merck, Darm-
stadt, Germany), HEPPSO (Molekula, Dorset, UK), and MOPSO, TAPS, CHES, CAPS (Ap-
plichem, Darmstadt, Germany). The detailed composition of the buffer system for pH gradient
CEC is shown in Tab. 1. The derivation of the buffer systems composition is described in a










previous work [72]. Sodium hydroxide, hydrochloric acid and sodium chloride were purchased
from Merck.
2.2 Determination of column parameters
The column parameters of the used 4.6/100 MonoS column (GE Healthcare, Uppsala, Sweden)
were experimentally determined on an Aekta purifier (GE Healthcare, Uppsala, Sweden).
To determine the interstitial porosity 25 µl of a 10 mg/ml Dextran 2000 Da solution was injected.
The determination of the total porosity was carried out by injecting 25 µl of 1 M NaCl. Both
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porosities were determined with a three time repeat measurement under a flow rate of 1.5
ml/min, while monitoring UV 225 nm and the conductivity. The particle porosity was calculated
from the two experimentally determined porosities.
The ionic capacity of the cation exchange column was determined via titration. The column
was equilibrated with 0.01 mM hydrochloric acid and titrated with 0.01 mM sodium hydroxide.
The breakthrough of sodium hydroxide was monitored by online conductivity measurement.
The columns ionic capacity was determined from the amount of used hydrochloric acid and the
columns total porosity.
2.3 pH gradient elution experiments
The pH gradient elution experiments were performed on an Aekta purifier, while UV 280 nm,
the conductivity and the pH were online monitored. The used column was the previously men-
tioned MonoS 4.6/100. The chromatographic run consisted of a four column volumes (1.662 ml)
equilibration step, a flow through step for one column volume, a linear gradient from 0-100%
over 15 column volumes and a post-gradient step at 100% for five column volumes. The flow
rate was 1.5 ml/min. The pH gradient reached from pH 4.0 to 11.0. pH gradients were run at
a salt concentration of 10, 50, 100, 150, 200, 250, 300 and 350 mM NaCl. The injection volume
was 100 µl. The protein solution consisted of 5 mg/ml of each protein in the application buffer.
The retention times of the single proteins were determined afterwards from the chromatograms.
2.4 Isocratic elution experiments
The isocratic elution experiments were also performed on the Aekta purifier with the same co-
lumn as in 2.3, while monitoring the UV 280 nm signal. The chromatographic run was performed
at a flow rate of 1.5 ml/min with an injection of 100 µl of 5 mg/ml single protein solution.
2.5 Calculating retention volumes in isocratic, salt and pH gradients
To determine the SMA parameters an equation published by Pedersen et al. [5] was used for the
isocratic elution of a protein:
Vr = V0 + Vcolumn ∗ (1− εi) ∗ εp ∗KSEC ∗KSMA ∗ (Λ/(zsalt ∗ csalt))zprotein (1)
Vr is the retention volume, V0 the volume of an unattained solute, εi is the interstitial porosity,
εp in the particle porosity, KSEC is a protein specific coefficient accounting for the size exclusion
effect of the column, Λ is the total ionic capacity of the resin, zsalt is the charge of the salt
ions, csalt the salt concentration and KSMA and zprotein are the SMA parameters. The third
SMA parameter (steric hindrance factor σ) is only needed when not working in the linear region
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of the isotherm and was not included in this study as its determination requires additional
experiments. We have modified eq. 1 by substituting the volume of an unattained solute by the
following term:
V0 = KSEC ∗ Vcolumn (2)
By doing that, the retention volume of a protein under non-binding conditions does no longer
equal the retention volume of a small tracer such as acetone. Eq. 2 accounts for the size exclu-
sion effect of the column as the molecular size of a protein is considerably larger than that of
acetone. With this change calculated retention volumes for weakly retained proteins becomes
more accurate.
Eq. 1 was used for all four elution modes: isocratic, salt-gradient, pH-gradient at constant salt
and pH gradient combined with a salt gradient based on the following concept:
1. Isocratic retention volumes can directly be calculated from eq. 1.
2. Salt gradient elution is a series of consecutive isocratic elutions steps of infinitesimal small
size with increasing salt concentrations but constant SMA parameters.
3. pH gradient elution at constant salt concentration is a series of consecutive isocratic elution
steps of infinitesimal small size with constant salt concentrations but with systematically
changing SMA parameters.
4. Simultaneous pH and salt gradient elution is a series of isocratic elution steps with changing
salt concentrations and systematically changing SMA parameters at the same time.
A step width of 30 to 60 µl was used throughout this work. In each step, the protein peak moves
towards the outlet of the column, the relative movement can be calculated as:
Vi = (Vs/Viso,step) ∗KSEC ∗ Vcolumn (3)
Vi is the retention volume for step i, Vs is the step volume, Viso,step is the retention volume given
by eq. 1 for this step at this particular salt concentration. A simple example helps to understand:
For a step volume of Vs = 0.1 ml, a calculated retention volume of Viso,step = 10 ml, a KSEC
of 0.9 and a column volume of 1 ml, the protein would pass through 0.009 ml of the available
volume per step. When the sum of all Vi values equals KSEC ∗ Vcolumn, the protein has passed
through the whole column. If Viso,step is constant for all steps (as for an isocratic elution), the
protein would elute after 100 steps = 10 ml. In this simple example the retention volume could
also be directly calculated from eq. 1.
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2.6 Constraints for SMA parameter estimation from pH gradients
As discussed in the previous section, retention volumes in pH gradients were calculated based on
the assumption that a pH gradient is a series of isocratic steps with changing SMA parameters
(KSMA and zprotein). The SMA parameters would not change randomly with increasing pH but
would rather follow some rational:
1. The charge of the protein or binding site (zprotein) remains constant or decreases with
increasing pH, similar to a titration curve of a protein.
2. The affinity of the protein (KSMA) remains constant or decreases.
To add these constraints two different mathematical functions were chosen that capture these
trends. For KSMA a Boltzmann function was used describing an inverse sigmoidal trend:
KSMA = (A1 +A2)/(1 + e((x1−x2)/k) +A2) (4)
For the characteristic charge a double Boltzmann function was used describing an inverse bi-
sigmoidal trend (some examples can be seen in Fig. 1):
Zprotein = y0 +A ∗ (p/(1 + e((x−x1)/k1)) + ((1− p)/(1 + e((x−x2)/k2)) (5)
Using these two functions serves two purposes: 1) both parameters automatically fulfill the
constraints mentioned above and 2) Parameter estimation is easier since only 11 parameters
need to be determined rather than a few hundred (since KSMA and zprotein is needed for every
pH of every small isocratic elution step).
Since eq. 4 does not only capture inverse bi-sigmoidal trends but other trends that would violate
the prerequisites defined above (points 1 and 2), boundary conditions were determined for all 7
parameters. To account for the inherent characteristics of proteins this was done by generating
100,000 artificial titration curves of proteins with a random number of titratable amino acids
(lysine, arginine, histidine, glutamic acid and aspartic acid) with their respective pKa. Additio-
nally pKa values were randomly altered to increase variability and to reflect 3D structure effects
on the pKa of an individual amino acid.
Titration curves showing a pI between 4 and 12 were selected others discarded. These titration
curves where then fitted by eq. 5. The boundary conditions summarized in Tab. 2 resulted from
this study.
2.7 SMA parameter estimation




Figure 1: Double Boltzmann functions according to eq. 4. Parameters are within the boundaries defined in
Tab. 2.
1. pH gradients (4.0 to 11) at eight different salt concentrations (10-350 mM)
2. four isocratic elution conditions per pH at three different pH (pH 5, 7 and 9)
Then a random set of parameters for eq. 4 and eq. 5 within the boundaries was generated as
starting set, SMA parameters were calculated at different pH values using these parameters,
retention volumes were estimated and compared to experimental data. Parameters for eq. 4 &
5 were then iteratively refined to minimize the error.
Column and protein parameters used for all simulations are summarized in Tab. 3. The set of
parameters that best captured the experimental data was then chosen for that protein.
Table 2: Boundaries for fit parameters for eq. 5
Parameter Boundaries
A -5 to -1
k1 6 to 12
k2 0.25 to 1
p 3.5 to 6
x1 0.1 to 1
x2 6 to 12
y0 0.2 to 0.95
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2.8 Isocratic and gradient elution runs and optimization of process conditions
The model was used to identify experimental conditions that show a separation of all three
proteins as these are suitable for model validation. This was done for all four different elution
modes. Experiments were run at these conditions.
Finding suitable process conditions was done by running 250.000 in silico experiments with
random values for the parameters to optimize:
1. Isocratic elution: salt concentrations of two consecutive elution steps, both step volumes
and the pH.
2. Salt gradient elution: start and end salt concentrations of two consecutive linear salt
gradients, both gradient volumes and the pH.
3. pH + salt gradient elution: start and end salt concentrations of salt gradient, start
and end pH and gradient volume.
Peak resolution was calculated for ranking as this is the critical parameter for judging the quality
of separation. For these three model proteins the resolution was defined as retention volume
difference between cytochrome C and the next closest component as cytochrome C always eluted
in the middle. The optimal system was chosen according to certain criteria (a combination of
resolution and efficiency) that are discussed later in more detail. These parameters were then
refined by random variations within close boundaries of +/- 10 % of each parameter value until
no further improvement could be detected.
2.9 Robustness analysis
Robustness analysis was done by running 20.000 simulations with a random, normal distributed
error on some parameters that are discussed later in detail.
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Figure 2: Salt concentration dependent elution pH of lysozyme (square), cytochrome C (circle) and ribo-
nuclease A (triangular).
3 Results and discussion
3.1 pH gradient elution experiments
Fig. 2 shows the elution behaviour of lysozyme, cytochrome C and ribonuclease A in linear pH
gradients (pH 4.0 to 11, salt concentrations between 10 and 350 mM). All three proteins used
in this study have a pI in the basic region: 11.3 for lysozyme, 9.9 for ribonuclease A and 9.7
for cytochrome C (calculated using the online tool MEAD [6], which was also reflected in their
elution behaviour, especially at low salt concentrations, where the elution pH should be close
the pI of the proteins as binding strength is not weakened by the presence of salt.
With increasing salt concentration, the elution pH was shifted towards lower pH as salt effects
dominated over protein charge effects. As to be expected, the three proteins showed a different
sensitivity towards changes in salt concentration. While the retention pH of ribonuclease A
and lysozyme changed more or less consistently, cytochrome c showed a more pronounced drop
between 150 and 250 mM ionic strength. Without any modelling it is obvious that ribonuclease
could be best purified at low ionic strength, cytochrome C at about 180 mM ionic strength and
lysozyme at ionic strengths above 200 mM.
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Figure 3: Isocratic elution data for lysozyme (A), cytochrome C (B) and ribonuclease A (C) measured
experimentally (dashed lines) and calculated during fitting (solid lines).
3.2 Results of SMA parameter estimation
SMA parameters were estimated, simultaneously capturing retention volumes of pH gradient
elution data at different salt concentrations and isocratic elution data at different but constant
pH. Fitting quality for the isocratic data is shown in Fig. 3. The average relative error in retention
volumes was 6 %, 5 % and 10 % for lysozyme, cytochrome C and ribonuclease A. The average
relative error for pH gradient elution was 5.5 %, 14.5 % and 2.2 % respectively.
The resulting parameters are plotted in Fig. 4 for a pH between 4 and 12. Obviously, all predicted
isoelectric points for the binding sites were above the ones for the whole proteins (∼11.6 for
lysozyme and cytochrome C, ∼11 for ribonuclease A). It has been reported earlier that some
proteins, including lysozyme, bind to cation exchange matrices above their pI, as a fraction of
their surface can still be positively charged even above the pI (lysine are arginine both have
pKa values between 10 and 12 depending on the structural environment). It should be noted
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Figure 4: Characteristic charge (A) and KSMA (B)for lysozyme, cytochrome C and ribonuclease A. Para-
meters were estimated using pH gradient and isocratic retention experiments.
that the KSMA for ribonuclease A drops to values close to zero at around pH 8, resulting in
retention volumes close to zero. Thus the characteristic charge curve beyond this pH might not
be very accurate. In fact, ribonuclease A did not show retention at pH 9 in the isocratic elution
experiments.
While cytochrome C has the highest characteristic charge of up to pH 10, lysozyme apparently
binds stronger leading to higher KSMA values, which explains why lysozyme always eluted last
under all conditions.
3.3 Model validation
In order to validate the model for different elution modes, separation runs of all three components
were performed and compared to modelling results: 1. Two isocratic elutions, 2. A linear salt
gradient elution with a monotonously increasing salt concentration of 250 mM over the whole
gradient, 3. bi-linear salt gradient elution at constant pH, 4. A pH gradient elution combined
with a salt gradient. The model was used to identify conditions that were expected to give
a reasonably good separation (resolutions around > 2) simply by calculating retention times
at different salt concentrations and pH values of all three components before the experiments
were performed. Resolutions were calculated for Cytochrome C only as it always eluted in the
middle. Thus in a system with a resolution of 2 for cytochrome C, ribonuclease A would elute
first followed by cytochrome C with at least a difference of 2 ml and then finally lysozyme again
with a difference of at least 2 ml.
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Figure 5: Elution runs at different conditions: isocratic at 225 mM (A) and at 235 mM (B) ionic strength,
monotonously increasing salt gradient (C), bi-linear salt gradient (D) and a combined pH and salt gradient.
Solid lines in blue refer to experimental data, dashed lines in gray are peaks shifted to retention volumes
predicted by the model.
3.4 Isocratic elution
Using the SMA parameters determined, suitable elution conditions giving a selectivity of 5.5 in
a total run volume of approximately 16 ml were found at a salt concentration of 225 mM salt
at pH 6.92. Calculated retention volumes were 1.92 ml, 7.38 ml and 15.9 ml for ribonuclease A,
cytochrome C and lysozyme. Figure 5 A shows the experimental results for these conditions,
experimental retention volumes revealed a prediction error of 0.18 ml (9.4 %), 0.1 ml (1.4 %)
and 0.79 ml (5.0 %). Resolution was 5.2 instead of 5.5. The peaks showing the predicted elution
profiles are the measured peaks, shifted to the predicted elution volume, peak shapes were not
calculated as mass-transfer and binding kinetics were not included in the model.
To experimentally validate one of the drawbacks of isocratic elution, namely a relatively low
robustness due to a high sensitivity for small changes in salt concentrations, a second run was
performed at the same pH but with a slightly higher salt concentration of 235 mM (instead of 225
mM). The model predicted a drop in resolution down to 4.38, mainly due to a shift in retention
volume of cytochrome C from 7.38 to 6.18. Experiments again confirmed the retention volumes
predicted with an error of < 0.4 ml, resolution dropped to 4.08. All details are summarized in
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Table 4: Summary of model predictions and experimental validation for isocratic and gradient elution. All
volumes in ml. MC indicates the results of Monte Carlo simulations.
Parameters Ribonuclease A Cytochrome C Lysozyme Resolution
Vr Vr Vr Vr Vr Vr
pH calc. exp. Error calc. exp. Error calc. exp. Error Calc. Exp.
csalt,iso
225 mM 6.92
1.92 2.10 0.18 7.38 7.28 0.10 15.90 15.11 0.79 5.46 5.18
9.4 % 1.4 % 5.0 %
MC: 1.56 to 2.58 MC: 6.48 to 8.34 MC: 11.88 to 20.94
235 mM 6.92
1.80 2.10 0.30 6.18 6.18 0 12.78 12.42 0.79 4.38 4.08
16.7 % 0 % 2.8 %
MC: 1.5 to 2.22 MC: 5.64 to 7.08 MC: 9.60 to 16.38
cinitial,1 161 mM
6.32
6.36 6.45 0.09 11.76 11.80 0.04 15.84 16.72 0.88
4.8 4.08cfinal,1 410 mM 1.4 % 0.3 % 5.6 %









9.3 %V2 2 ml 5.10 2.90 10.38 11.04 13.02 14.23
cinitial,3 116 mM
cfinal,3 651 mM
V3 28 ml MC: 2.02 to 7.01 MC: 9.66 to 11.43 MC: 12.24 to 14.01
cinitial,4 200 mM







V4 28 ml MC: 2.78 to 3.88 MC: 6.82 to 8.59 MC: 10.51 to 12.93
Tab. 4, chromatograms are shown in Fig. 5 B.
3.5 Salt gradient elution
The first gradient run was a linear salt gradient from 161 mM to 410 mM over 28 ml ran at
pH 6.32. The gradient shape was restricted to have a monotonously increasing shape with a
minimum difference of 250 mM salt between start and final concentration. The model predicted
a resolution of 4.9 ml and the closest eluting component was predicted to be lysozyme. Predicted
retention volumes had an error of 0.09 ml (1.4 %), 0.04 ml (0.3 %) and 0.88 ml (5.6 %), predictions
are shown in Fig. 5 C (detailed results are summarized in Tab. 4). Due to the relatively high
error for lysozyme, the experimental resolution was only 4.08 ml.
In the second gradient elution example (Fig. 5 D) the gradient was not restricted to any particular
shape. A steep gradient from 183 mM to 297 mM over 2 ml was used to elute ribonuclease A,
according to the model, followed by a relatively flat gradient from 163 mM to 631 mM over 28 ml,
all at pH 6.44. The resolution was calculated to be 2.64. Retention volumes of cytochrome C and
lysozyme were predicted with an error below 10 %, while the retention volume of ribonuclease
A was off by about 2.2 ml (43 %) a possible explanation is given in the next section. The
experimentally determined resolution was 3.19.
The third and last gradient was a linear salt gradient from 200 mM to 400 mM over 29.5 ml
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while simultaneously decreasing the pH from 6.93 to 5.15. Predicted retention volumes matched
the experimentally determined ones with an error of 0.93 ml (41.1 %), 0.38 ml (5.2 %) and 0.36
ml (3.2 %) as shown in Fig. 5 E. A resolution of 4.38 ml was achieved experimentally, while the
predicted value was 4.07.
3.6 Error estimation
Especially for the second gradient elution, the error in retention volumes was relatively high (2.2
ml or 43 % for ribonuclease A, the highest error of all validation runs). To access whether this
high error was due to a general problem with SMA parameter estimation, a series of Monte-
Carlo simulations was performed, assuming a normal distributed error of up to 5 % on all salt
concentrations and the pH. 20.000 simulations runs were performed for each experiment. The
results are shown in Fig. 6 for the second gradient elution. This figure shows the calculated
retention time on the x-axis and the calculated resolution on the y-axis, each dot is the result
of one modelling run, each cluster relates to one protein. Interestingly, the retention volume of
ribonuclease (cluster on the left) was most strongly affected by the artificial error and varied
between 2.02 and 7.01 ml. The reason for this is the very short first salt gradient at the beginning
that was supposed to speed-up ribonuclease A elution. If salt concentrations were slightly too
low or pH was slightly too high, ribonuclease A would not elute in this small gradient but rather
in the longer second gradient, which was actually seen in the experimental data, explaining the
relatively high error of 2.2 ml measured for ribonuclease A. Actually, all measured retention
volumes summarized in Tab. 4 were within the limits determined by Monte-Carlo simulations,
except for two cases: 1) lysozyme in the bi-linear gradient that eluted after 14.23 ml, while the
Monte Carlo simulation gave a maximum retention volume of 14.01 ml and 2) ribonuclease A
elution in the inverse pH gradient.
3.7 Maximum resolution, efficiency and robustness
Looking at the Monte Carlo simulation results summarized in Tab. 4, two robustness issues
become obvious:
1. As retention times increase in an isocratic elution, errors in both salt concentration and
pH can lead to a wide distribution of retention volumes (e.g. 11.9 to 20.9 ml for lysozyme
eluting at 225 mM (+/- error) ionic strength)).
2. For gradient elution, if the gradient shape becomes more complex, elution volumes can
also significantly shift (2 to 7 ml for ribonuclease A in the bi-linear gradient elution).
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Figure 6: Sensitivity analysis for the bi-linear gradient elution for ribonuclease A (left cluster), cytochrome
C (middle cluster) and lysozyme (right cluster). Errors of 5 % were put on pH and on all salt concentrations.
Blue & green & red dots represent all individuals, green and red represent 95 % of all individuals and red
dots represent 50 % of all individuals.
To determine what kind of gradient is a) most selective in terms of archiving the highest reso-
lution, b) most efficient and c) most robust an in silico study was done with 250.000 random
parameter combinations for isocratic, salt gradient and pH gradient elution. The results are
shown in Fig. 7. As to be expected, the highest resolution could be achieved with isocratic elu-
tion, resulting in a maximum resolution of 14. Of course, for isocratic elution peak broadening
is more pronounced compared to gradient elution, but as this is not accounted for in the mo-
del we used, this will also not be part of the discussion. pH gradients operated under isocratic
salt conditions achieved the same maximum resolution (data not shown). In contrast to this,
salt gradient mode performed worse in terms of maximum resolution, as it stayed well below
6. Surprisingly, isocratic elution also outperformed gradient elution in terms of elution efficien-
cy (meaning a maximum resolution at minimum time). For all conditions, the same resolution
could be achieved with reduced elution times. Again, the more pronounced peak broadening for
an isocratic elution could have a negative impact. Figure 7 C shows that pH gradient elution
combined with a salt gradient gave higher resolutions of up to 7 ml compared to a salt gradients
at constant pH. When running a process in an industrial environment, process robustness beco-
mes an issue. To study the effect of small fluctuations in salt concentrations and pH, conditions
were chosen for four systems, one for each elution mode (isocratic, isocratic + pH gradient, salt
gradient and salt gradient + pH gradient). Systems were chosen that gave a resolution of 5 at
minimum in a total volume as low as possible, results are shown in Fig. 8. While retention vo-
lumes for all modes including a salt gradient showed deviations of about +/- 1.3 ml independent
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Figure 7: Resolution over gradient length plots for isocratic elution (A), gradient elution with a minimum
increase of 250 mM (B) and pH gradient combined with a salt gradient with a minimum increase of 250 mM
(C).
Figure 8: Range of deviations in retention volumes for four different elution modes resulting from Monte
Carlo simulations (5 % error on salt concentrations and pH).
of retention volume (except cytochrome C in the salt gradient which showed significantly lower
deviations), all isocratic elution modes showed an increasing deviation with increasing retention
volume of up to +/- 3.75 ml for lysozyme eluting last. Furthermore, in the worst case scenario
the resolution in the isocratic runs dropped down from 5 to 3.7 for constant pH and even further
down to 1.8 for the pH gradient runs, compared to 4.4 for the salt gradient at constant pH and
4.8 for the salt gradient combined with a pH gradient.
Although magnitudes of the effects seen might be specific for this particular separation task,
the overall trends will probably hold for other separations as well: using a salt gradient with the
minimal slope necessary to achieve the needed resolution might be the best choice for a robust





In this manuscript we were able to show that all possible elutions modes in ion exchange chro-
matography can well be captured by an equation that was originally derived for isocratic elution
only. Using this equation, pH gradients in combination with a set of isocratic elutions were
successfully used to determine a set of SMA parameters for a wide range of pH values for three
different model proteins. Resulting SMA parameters could be used to calculate retention volu-
mes for a number of different elution modes, predictions compared well to experimental data and
deviations could be explained by Monte Carlo simulations. SMA parameters were also accurate
enough to allow for an in silico optimization of separation conditions and a subsequent robust-
ness analysis, showing that isocratic elution conditions (at constant pH or combined with a pH
gradient) can yield the highest resolutions but are also more sensitive to small changes in salt
concentrations and pH. Compared to that, salt gradient conditions at constant pH were more
robust but less selective. Simultaneously applying a pH gradient increased maximal resolution
without decreasing robustness.
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Abstract
Covalent attachment of PEG to proteins, known as PEGylation, is currently one of the main
approaches for improving the pharmacokinetics of biopharmaceuticals. However, the separation
and characterization especially of positional isoforms of PEGylated proteins is still a challenging
task. A common purification strategy uses ion exchange chromatography with increasing ionic
strength by shallow salt gradients. This paper presents a method which applies a linear pH
gradient chromatography to separate five of six possible isoforms of mono PEGylated lysozyme,
modified with 5 kDa and 10 kDa mPEG-aldehyde. To identify the corresponding PEGylation
sites a comparison of elution pH values and calculated isoelectric points of each isoform, was used.
The resulting correlation showed an R2 > 0.99. Fractionation, tryptic digestion and subsequent
MALDI-MS analysis of each peak, verified the predicted elution order. Based on UV areas the
N-terminal amine at lysine 1 exhibited the highest reactivity, followed by the lysine 33 residue.




Since the first PEGylation in 1977 by Abuchowski and Davis, polymer modification with po-
ly(ethylene glycol) (PEG) has become an important method to enhance the pharmacological
properties of therapeutic biopharmaceuticals [110]. The covalent attachment of PEG chains to
a target molecule is well established and successfully used for numerous FDA approved proteins
such as PEGylated interferon-α and erythropoietin (Pegasys R© and Micera R© from Hoffmann
LaRoche, respectively).
Advantages of polymer modification generally include increased circulation half-life and a re-
duced immunogenicity of the conjugate compared to the unmodified form. Additional positive
effects of PEGylation can be an increased thermal stability as well as a higher solubility which
are also important for the therapeutics final formulation [111–113]. These changes in the phar-
macological behaviour can mostly be explained with the increased hydrodynamic radius of the
conjugate and the resulting “shielding effect” of the attached PEG, which is reviewed in detail
by many publications [114–116].
For PEG attachment, various activated PEG agents and coupling strategies are commercial-
ly available. Depending on the polymer modification, the attachment takes place at different
surface residues of the target molecule. A common chemistry for PEGylation targets accessi-
ble amino residues such as lysine or the N-terminus. For this, a modification with succinimidyl
activated PEGs (PEG-NHS) or PEG-aldehyde as shown in Fig. 1, can be applied. While PEG-
NHS is capable of binding also with histidine and tyrosine residues, the latter approach allows
a main binding of PEG at the N-terminal α-amine at low pH values and was chosen by Kinstler
et. al. [117, 118] to develop polymer modified granulocyte colony stimulating factor (G-CSF,













Figure 1: PEGylation reaction with PEG-aldehyde and NaCNBH3 as reducing agent.
sible conjugation site, result in randomly attached PEGs and thus in heterogeneous mixtures.
The resulting product consists of proteins with a different number of bound PEG and positio-
nal isoforms. Due to steric hindrance of the attached polymer, changes in PEGylation degree
and binding site can have a major influence on biological activity of the different conjugates
[119, 120]. With only 7 % residual activity compared to the native protein, Pegasys R©, a mixture
of different PEG-interferon (IFN) isoforms, shows how drastic this effect can be [121]. Additional
experiments with PEG-IFN showed a range of residual activity from 6 % to 40 % depending on
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the binding site of the attached PEG [122]. The loss in activity is generally compensated by the
increased body residence time, but the high variance in activity underlines the influence of the
PEGylation site. Consequently, mixture characterization and isoform identification is of high
interest and also needed for regulatory approval. Additionally, the selective PEGylation either
of a single site or the screening of reaction conditions towards favorable PEGylation sites with
high residual activity are preferred.
The separation of conjugate mixtures regarding the PEGylation degree can be achieved ef-
fortlessly with size exclusion chromatography (SEC), due to the increase in size. Thus, fast
monitoring of crude PEG-protein mixtures combined with an improved data evaluation, such as
multivariate data analysis (MVDA) can be achieved by size based separation and can be used
in a first step to screen and optimize different PEGylation conditions [123]. A less systematic
approach for a lysozyme PEGylation optimization without an isoform analytic was shown for
example by Moosmann et. al [124].
However, the separation of isoforms with varying attachment site and the preparative purifi-
cation is challenging. Many approaches showed that ion exchange chromatography (IEC) is an
effective tool and currently the method of choice for conjugate and positional isoform separation,
by means of shallow salt gradients [125–127]. The different behaviour is based upon the shiel-
ding effect of attached polymer chains, and thus reduced interactions between chromatographic
matrix and protein. Additionally a decreasing protein surface charge with an increasing number
of bound PEG weakens the interaction with the oppositely charged resin, which was already
shown by Fee in an in silico approach [128]. Applying classical salt gradient chromatography,
different lysozyme PEGylation studies with PEG-NHS and PEG-aldehyde showed that it was
not possible to separate more than three isoforms, although six isoforms are being formed during
PEGylation. Even though some approaches showed promising results, only little attention was
paid to alternative ion exchange chromatography with pH gradients [122, 129].
Besides the isoform separation, identification of PEG attachment sites is another challenge. Ti-
me consuming methods that are widely used comprise Edman degradation for small peptides
and peptide mapping with combined MALDI-TOF analysis [130–132]. The mass spectrometric
approach was applied by Lee and Park [130] for the characterization of PEGylated lysozyme.
For lysine residue modification the authors used biotin-PEG-NHS, to separate PEG-peptide
fragments from unmodified peptides, after tryptic digestion. Employing mass spectrometrical
analysis of the peptide fragments, three positional isoforms with different reactivities were iden-
tified.
The presented work describes the separation of mono-PEGylated lysozyme isoforms with a
linear pH gradient on a cation exchange column. In contrast to salt gradient chromatography
runs, a significant increase in resolution could be achieved and five of six possible isoforms were
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separated. Based on the assumption that every PEG conjugation to amino residues neutralizes
an effective charge of the protein, a fast in silico approach was used to calculate the isoelectric
point of each isoform. The elution pH values were correlated with the calculated isoelectric points
to identify the PEGylation sites and to determine the isoform reactivities. Peptide mapping and
the common mass spectrometric approach was applied to verify the results.
2 Materials and methods
2.1 Chemicals
Sodium phosphate and sodium chloride for chromatography buffer and PEGylation buffer pre-
paration were obtained from Merck (Darmstadt, Germany). Hen egg white lysozyme and sodi-
um cyanoborohydride (NaCNBH3) were provided from Sigma-Aldrich (St. Louis, MO, USA).
Methoxy-PEG-propionaldehyde (mPEG-aldehyde) with an average molecular weight of 5 kDa
and 10 kDa were provided from NOF Cooperation (Tokyo, Japan). CABS (Cyclohexylamino-
butansulfonic acid) with a pKa value of 10.7 was provided from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA, USA) and was used as buffer substance for pH-gradient chromatography.
The calibration of the pH meter was performed with high precision calibration standards from
Hanna instruments (Woonsocket, RI, USA). The reagents for the proteolytic digestion of the
PEGylated protein, including ammoniumbicarbonate which was used as the buffering substance,
as well as dithiothreitol and iodoacetamide which were used for the reduction and alkylation of
the disulfide bonds, were obtained from Sigma-Aldrich. Proteolytic digestion was prepared with
proteomics grade trypsin from Sigma-Aldrich and RapiGest surfactant (Waters Corporation,
Milford, MA, USA). For the hydrolysis of the acid labile surfactant trifluoracetic acid (TFA)
from Sigma-Aldrich was used. For MALDI matrix preparation α-cyano-4-hydroxycinnamic acid
(CHCA) from Sigma-Aldrich and LC-MS grade acetonitrile from Merck (Darmstadt, Germany)
was used. Ultrapure water was generated with the Arium pro water purification system from
Sartorius Stedim (Goettingen, Germany). All solutions used for chromatography were filtered
using 0.2 µm cellulose acetate filters from Sartorius Stedim (Goettingen, Germany) and degassed
for 20 min in an ultrasonic bath.
2.2 Batch PEGylation reaction
Lysozyme (5 mg/mL) and mPEG-aldehyde with a molar polymer to protein ratio of 6:1 were
dissolved in a 25 mM sodium phosphate buffer pH 7.2. containing 20 mM sodium cyanoboro-
hydride as reducing agent. The reaction was carried out in a continuously shaken falcon tube
at room temperature, for about 3.5 h. Monitoring of the PEGylation reaction was conducted
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with size exclusion chromatography (SEC) using a Superdex 200 GL10/300 column on a Äkta
Ettan system (GE Healthcare, Uppsala, Sweden). For SEC 25 mM sodium phosphate pH 7.2
containing 150 mM NaCl as mobile phase was used.
2.3 Analytical protocol
2.3.1 Separation of PEGylation degree
After the PEGylation reaction an IEC was used as a first chromatographic to separate the
different PEGylation degrees and to stop the reaction. The reaction mixture was separated
with a Toyopearl GigaCap S-650M resin (Tosoh Bioscience GmbH, Stuttgart, Germany) packed
according to the manufacturers protocol into an Omnifit glas column (25 mm x 400 mm, Diba
Industries Ltd., Cambridge, UK). The resulting bed volume was 13.4 mL. The sample was
diluted with ultrapure water (1:1) to reduce ionic strength. After column equilibration with
running buffer (25 mM sodium phosphate, pH 7.2), 50 mL sample mixture was loaded onto the
column. For elution a gradient ranging from 0 to 40 % of the elution buffer (25 mM sodium
phosphate, 500 mM sodium chloride, pH 7.2) was performed over 21 column volumes. The flow
rate was maintained at 1 mL/min. To obtain mono-PEG lysozyme samples, the fractionation
volume was set to 5 ml. Until further measurement, the fractions were pooled and stored at
-32◦C.
2.3.2 Molecular weight determination
Peak fractions from IEC were analyzed by SEC with a light scattering (LS) detector. This
analysis was conducted using an Äkta Ettan system from GE Healthcare (Uppsala, Sweden)
in combination with a Dawn Heleos 8+ multi-angle LS detector and an Optilap rEX refractive
index (RI) detector, both from Wyatt Technology (Santa Barbara, USA). The LS detector was
equipped with a fused silica cell and a laser with a wavelength of 658 nm. The LS and RI
detector were calibrated with toluene and NaCl, respectively. The LS detector was normalized
using 2 mg/ml of bovine serum albumin (BSA) monomer from Sigma Aldrich, as reference.
For SEC a Superdex 200 GL10/300 (GE Healthcare, Uppsala, Sweden) with a mobile phase
of 25 mM sodium phosphate, pH 7.2, containing 150 mM NaCl was used. The flow rate was
set to 0.8 ml/min. Injection volumes between 50 and 100 µl were chosen. After UV absorbance
monitoring at 280 nm using the Äkta UV-900 monitor, each sample passed the LS and RI
detector. Correction of detector alignment and band broadening, as well as molecular weight
(Mw) calculation were done by the ASTRA software (software version 5.3.4.18)
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2.3.3 Separation of isoforms
Isoform separation was conducted on a MonoS 4.6/100 column from GE Healthcare (Uppsala,
Sweden). Sample volumes between 100 µl and 150 µl of previously purified mono-PEG lysozyme
(modified with 5 kDa and 10 kDa mPEG) were chosen. For pH-gradient elution 20 mM CABS
was used as buffer component. Running buffer A and elution buffer B were titrated with 4 M
NaOH to pH 10.5 and pH 11.5, respectively. The pH was measured with a pH meter from Hanna
Instruments (Woonsocket, RI, USA), calibrated from pH 10 to 12 with high precision calibration
standards. The elution was carried out with a linear gradient ranging from 0 % to 100 % buffer
B over 12 column volumes. The flow rate was set to 1.5 ml/min. To obtain samples for MALDI-
TOF analysis the resulting peaks from mono-PEG5.000-lysozyme isoforms were fractionated with
a constant volume of 250 µl. The fractions of multiple runs were pooled to reach sufficient
amount of single isoforms for subsequent mass spectrometrical peptide mapping. The results
of the pH gradient separation were additionally compared with a classical salt gradient based
cation exchange chromatography. For salt gradient elution the same column, injection volume as
well as gradient length was used. As buffer system 25 mM sodium phosphate pH 7.2 was used.
The elution was carried out with a salt gradient reaching from 0 mM to 500 mM NaCl.
2.3.4 Tryptic digestion of PEGylated lysozyme
After the chromatographic runs the collected fractions were transferred to VivaSpin 20 ultrafil-
ters (Sartorius Stedim, Germany) with a molecular weight cutoff of 5 kDa and were diafiltrated
into 50 mM ammoniumbicarbonate buffer with pH 8.0 including 0.1 % (v/v) RapiGest. Addi-
tionally the fractions were concentrated to the maximum degree and the protein concentration
was determined via UV 280 nm absorption measurement on a Infinite M200 plate reader (Te-
can, Maennedorf, Switzerland). The samples were then chemically reduced by the addition of
dithiotreitol up to a final concentration of 20 mM and denatured for 30 minutes at 60◦C on a
thermoshaker (Eppendorf, Hamburg, Germany). Alkylation was carried out by adding iodoa-
cetamide with a final concentration of 60 mM and mixing the samples for 45 min on a shaker
under exclusion of light. The prepared samples were then digested with a trypsin to protein ratio
of 1/2 - 1/10, depending on the sample protein concentrations. The digestion was carried out at
37◦C over night. After the digestion, TFA was added to a final concentration of 0.5 % (v/v) and
the samples were incubated for another 45 minutes and then centrifuged to remove the RapiGest
surfactant from the solution. The samples were stored at -32◦C until measurement.
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2.3.5 MALDI-MS based PEGylation site identification
To prepare samples for the final MALDI-MS measurement, they were processed with C18 Zip-
Tips (Millipore Corporation, Billerica, MA, USA). The samples were bound to preconditio-
ned C18 ZipTips by pipetting and then eluted with the matrix solution, 10 mg/ml α-cyano-4-
hydroxycinnamic acid (CHCA) in 70 % (v/v) ACN and directly spotted on a MALDI stainless
steel target. After drying the sample spots, MS analytics were analyzed in a MALDI TOF/TOF
4800 analyzer (Applied Biosystems, Framingham, MA, USA). The mass spectrometer was run
in positive, reflectron mode. Optimized device settings for the matrix were used. The measured
data was analyzed and exported using Data Explorer Software 4.0 (Applied Biosystems, Fra-
mingham, MA, USA). To identify the PEGylation site the masses of the expected peptides were
predicted with the PeptideCutter tool (Expasy - SIB Bioinformatics Resource Portal), modified
by the mass of the carbamidomethylation and compared to the results of the single measure-
ments. The PEGylated peptide fragment is heavier by the mass of the PEG molecule (5008 Da)
and could therefore be identified. Due to the polydispersity of the PEG molecule the avera-
ge mass of the measured fragment was determined by “gauss-fitting” the resulting signal and
determining the maxima of the fitted curve with MATLAB (MathWorks, Natick, MA, USA).
2.4 pI calculation
Isoelectric point calculation of native lysozyme and PEGylated lysozyme isoforms were con-
ducted with the freely accessible web tool ’protein continuum electrostatics’ (PCE). This tool
calculates pKa values of titratable groups in proteins solving the Poisson-Boltzmann equati-
on based on the MEAD (macroscopic electrostatics with atomic detail) program, developed by
Bashford [133, 134]. For pI calculation, the structural information of native lysozyme (PDB-ID:
132L) obtained from the RSCB protein data bank was used. With resulting pKa values, pI calcu-
lation was done applying the Henderson-Hasselbalch equation with Microsoft Excel (Microsoft,
Redmond, MA, USA). The pI value of each PEG-isoform was calculated with neutralized lysine
residues, involved in the conjugation.
3 Results and discussion
3.1 Lysozyme PEGylation degree
As PEGylation target the model protein lysozyme from chicken egg was used in this work.
According to the manufacturers datasheet it has a molecular weight of 14.3 kDa and an isoelectric
point of 11.3. Possible binding sites for the PEG-aldehyde reaction are six lysine residues and the
N-terminal amino group. The three dimensional model, shown in Fig. 2, illustrates a lysozyme
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molecule and depicts that all lysine residues as well as the N-terminus are located at the surface
of the molecule, which can be explained with their hydrophilic character. With the additional N-
terminal amino group, lysine 1 contains two binding sites. Consequently, PEGylation reactions
with amino coupling PEG agents can yield six mono-PEG lysozyme isoforms. However, different
PEGylation studies with PEG-NHS and PEG-aldehyde showed, that it was not possible to
detect and separate more than three isoforms [127]. The PEGylation reaction was monitored
180°







Figure 2: Two orientations of the three dimensional structure of lysozyme with labeled surface lysine
residues.
using SEC, to optimize the reaction time towards a high mono-PEG-lysozyme yield. In Fig. 3
the SEC chromatograms of PEG-lysozyme mixtures modified with 5 kDa and 10 kDa PEG-
aldehyde, after 3.5 hours reaction time are shown. The different elution volumes in each mixture
result from the increase in size by PEG attachment and indicates different PEGylation degree.
As can be seen, di-PEG5.000- and mono-PEG10.000-lysozyme conjugates have the same retention
time in SEC, resulting from the same hydrodynamic radius. This illustrates that the increase in
size is only dependent of the molecular weight and is regardless of the number of bound PEG,
which was already shown by Fee and Van Alstine [135]. As PEG-aldehyde is a non UV active
component, unreacted PEG was not detectable in the 280 nm UV trace.
For mono-PEG-lysozyme sample preparation, preparative purification of PEG-lysozyme mix-
tures with ion exchange chromatography was applied, according to Moosmann et al. [136]. In
addition to PEG-lysozyme conjugate separation, this method provides a removal of unreacted
native protein as well as a flow through of unreacted PEG. Fig. 4 depicts a resulting chromato-
gram with a 5 kDa PEG-lysozyme mixture and shows a comparable elution behaviour to SEC
(see Fig. 3). After peak fractionation, SEC with combined light scattering was conducted with
mono-PEG-lysozyme samples to verify purity and PEGylation degree. The overall molecular
mass of pooled mono-PEG5.000-lysozyme samples were calculated to 19.2 kDa with a protein
fraction of 14.1 kDa. Calculated values of mono-PEG10.000-lysozyme samples provided masses
of 24.2 kDa and 13.9 kDa, respectively. SEC chromatograms of purified mono-PEG-lysozyme
samples showed no impurities of other PEGylation degrees (data not shown).
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Figure 3: SEC chromatograms of 5 kDa and
10 kDa PEGylated lysozyme mixtures after 3.5 h
with a Superdex 200 10/300 GL column and follo-
wing elution order: di-PEG-lysozyme, mono-PEG-
lysozym and native lysozyme.


























































Figure 4: Chromatogram of preparative purifi-
cation of 5 kDa PEG-lysozyme mixture, using a
GigaCap 650S ion exchange adsorber. PEGylation
degree was validated with SEC-LS.
3.2 Isoform separation
The isoform separation was conducted with purified mono-PEGylated-lysozyme samples, mo-
dified with 5 kDa and 10 kDa PEG-aldehyde. In Fig. 5 the resulting chromatograms with salt
gradient and pH gradient elution are shown. Five peaks could be detected in the 280 nm trace in
the pH elution chromatogram, while salt gradient elution resulted in a separation of only three
peaks. The different elution volumes of each peak can be linked to altered surface charge due
to different PEGylation sites. As only pure mono-PEG lysozyme samples were injected, each
peak represents lysozyme with one bound PEG chain attached to a different amino residue.
Even though lysozyme consists of six possible conjugation sites, as mentioned before, only five
isoforms were detected. The separation of a 10 kDa PEG modified lysozyme sample showed
lower elution pH values, but the same elution pattern compared to mono-PEG5.000-lysozyme.
3.3 Isoform identification
In pH gradient chromatography the elution of proteins is based on a decreasing surface charge,
which results in a decreasing strength of interaction between the adsorbed proteins and the
oppositely charged adsorber. Thus, resulting elution pH values correlate sometimes with the
proteins isoelectric point [137]. In classical salt gradient chromatography the proteins are eluted
due to an ion exchange process. This difference leads to salt and pH gradient elution strategies,
which can result in a different separation performance.
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Figure 5: Chromatogragraphic separation of PEG-lysozyme isoforms using a pH gradient with a pH rage
from 10.5 to 11.5 (A) and a salt gradient from 0 mM to 500 mM NaCl in 25 mM phosphate buffer, pH 7.2
(B) on a Mono S 4.6/100 column. The peak labels correspond to different positional isoforms.
PCE tool from Mitera et al. [6]. Applying the described method, the pI for native lysozyme was
calculated as 11.28, with a good correlation to already published values by Ahamed et. al [137].
The altered charge of the lysine residues caused by attaching a PEG molecule was taken as a basis
for the isoform pI calculations. Assuming that every PEG conjugation to the primary amine of a
lysine residue neutralizes the positive charge, surface net charge, isoelectric point and also elution
pH are reduced compared to native lysozyme. For isoform pI calculation of PEG-lysozyme,
lysine pKa values involved in the conjugation were ignored. Titration curve calculations, using
the Henderson-Hasselbalch equation to determine the proteins pI, were applied regardless of the
attached PEG molecular weight. Comparing the elution pH values with the calculated isoelectric
points, a peak identification to corresponding binding sites as shown in Tab. 1 was conducted.
The isoform with PEG binding site lysine 33 (in the following labeled as PEG-lys33) exhibited
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Figure 6: Plotted elution pH values of mono-PEG-lysozyme isoforms(left: modified with 5 kDa, right:
modified with 10 kDa) and native lysozyme versus calculated isoelectric points.
the lowest calculated pI and was assigned to the peak with the lowest elution pH. As lysine 97
and 116 exhibited the same calculated pI, these isoforms were assumed to elute in one peak. The
isoform elution sequence obtained from pI calculation results, starting with the lowest elution
pH, was as follows: PEG-lys33, PEG-lys1, PEG-lys96, followed by PEG-lys97 and PEG-lys116
eluting in one peak and PEG-lys13 eluting last.
Fig. 6 depicts the obtained results and shows that native lysozyme eluted roughly at its iso-
electric point. PEG-isoforms eluted earlier and at lower pH values than native lysozyme, as
expected. Additionally the elution volume of both PEG species correlated with an R2 > 0.99
to the calculated pI values. However, the elution pH of 10 kDa-PEG isoforms and 5 kDa-PEG
isoforms were shifted to lower pH values, indicating a lower interaction to the adsorber matrix
with increasing PEG weight. In addition to reduced net charge, attached PEG chains might
weaken the interaction of the isoforms to the adsorber matrix, due to steric hindrance. This
effect is probably dependent on the attached molecular PEG weight. An increased protein-resin
Table 1: Elution pH values of separated mono-PEG-lysozyme isoforms and coresponding calculated isolectric
points. Calculation of isoelectric points were applied with pKa values based from PCE-tool.
Binding Calculated Elution pH
site pI 5 kDa 10 kDa
Lys 33 11.07 10.94 10.88
Lys 1 11.12 10.99 10.92
Lys 96 11.18 11.03 10.98
Lys 97 11.27 11.11 11.05Lys 116
Lys 13 11.28 11.13 11.08
native lysozyme 11.28 11.23
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distance, might thus explain the differences in the elution behaviour of mono-PEG5.000- and
mono-PEG10.000-lysozyme isoforms. A study by Abe et al. [119] investigated this effect for ion
exchange chromatography and can be used for a detailed view of PEG-protein binding mecha-
nisms. By comparing the UV areas of each isoform, the reactivity of the different binding sites
were evaluated. Thus, PEGylation with 5 kDa and 10 kDa PEG occurs preferentially at lys1,
followed by lys33 using the described reaction conditions. Only small reactivites were found for
lysine 97, 116 and 96.
3.4 MALDI-MS analysis
To verify the conducted binding site identification, peptide mapping in combination with mass
spectrometric analysis was applied. The common procedure involves a tryptic digestion of the
isoform mixture and the comparison of the resulting peptides with the peptide pattern of a
digested native protein solution. Considering trypsin is sterically blocked by attached PEG
molecules, missing peptides refer to PEG-conjugation sites.
Instead of analyzing the peptide pattern, we decided to investigate the mass of the PEG-peptide
fragments. Lysozyme peptides resulting from tryptic digestion, hydrolyzed at lys1 or lys97 consist
of only one amino acid and are consequently difficult to detect within the signals of the used
MALDI matrix. With the analysis of the heavier PEG-peptide fragments, this problem was
avoided.
Analyzing unbound PEG-aldehyde samples with the described MALDI-TOF analytics the poly-
disperse character of the polymer was obvious, which is caused by the production process. Pure
PEG samples showed a normally distributed signal which was composed of single mass peaks.
Each peak showed differences in weight of 44 Da, indicating PEG chains with a different number
of monomer units. Fitting the PEG sample peaks using a gaussian fit function in MATLAB R©,
the calculated average molecular mass was 5031 Da. The quality analysis by the PEG supplier
provided an average weight of 5008 Da for the same charge, confirming the used fitting method.
Four PEG-peptide fragments were detected in the separated and fractionated PEG-lysozyme
isoform samples. Mass differences between the mass peaks in each detected PEG-peptide signal
were 44 Da and refer consequently to PEG. The PEG-peptide fragments, detected in isoform
fractions PEG-lys33 and PEG-lys1 are shown in Fig. 7, with the corresponding calculated gaus-
sian fits and peak maxima. Weight differences between the two fragment signals can be noticed,
which are caused by different peptide masses due to varying PEG binding sites. Calculated theo-
retical PEG-peptide fragments and evaluated average masses of analyzed PEG-peptide signals
are listed in Tab. 2 and assigned to their corresponding binding sites. For calculating the theore-








Figure 7: MALDI-TOF spectra with PEG-peptide fragments of two 5 kDa PEG-lysozyme isoforms. Spectra
correspond to lysozyme with bound PEG at lysine 33 (PEG-lysozyme33) and lysine 1 (PEG-lysozyme1),
respectively
.
Table 2: PEG binding site, resulting mass of peptide-fragments and measured mass of PEG-peptide frag-
ments of mono5000-PEG-lysozyme isoforms. Theoretical mass of each PEG-peptide-fragment was calculated
with a PEG weigth of 5008 Da and corresponding peptides. The mass of a water molecule was subtracted
additionally.
Peak PEGylation Peptide PEG-peptide
number site mass [m/z] fragment mass [m/z]
expected measured
1 Lys 33 22-33 34-351325.63 1428.65 7744 7697
2 Lys 1 1 2-5147.11 478.28 5615 5619
3 Lys 96 74-96 972508 147.11 7645 n/A
4
Lys 116 115-116 117-125307.14 1045.54 6343 6352
Lys 97 97 98-112147.11 1675.80 6813 n/A
5 Lys 13 6-13 14 15-21893.42 175.12 874.42 6933 6854
one water molecule was subtracted. A good agreement of theoretical and the measured masses
of the first two peaks, labeled as PEG-lys33 and PEG-lys1 can be noticed. Considering baseline
separation was provided between these peaks the proposed peak identification was validated.
Peak 3, labeled as PEG-lys96 contained no detectable PEG mass peaks. Due to small sample
concentrations, a detection of the PEG-peptide signal was not possible. In addition, the small
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resolution to peak 2, hindered the fractionation of sufficient sample volume.
Instead of two PEG signals in peak 4, only one PEG-peptide fragment was found. With an
average weight of 6352 m/z the measured signal corresponds well to the theoretical PEG-peptide
mass of 6343 m/z of the proposed lys116 binding site.
In peak 5, labeled as PEG-lys13 a theoretical PEG-peptide weight consisting of two peptides and
attached PEG could not be found. Thus, the corresponding PEG-peptide mass was corrected
assuming a sterical hindrance of PEG blocking the tryptic digestion between lys13 and arg14
additionally. The resulting expected fragment weight of 6933 m/z agreed then with the measured
average weight of 6854 m/z. Comparing the mass peaks of the last isoform peak, it can be
noticed that the measured mass of 6854 m/z is between the expected weight of binding site
lys97 and lys13. Therefore, the proposed lys13 binding site of peak 5 could not be validated by
MS analytics.
A comparison of the findings using MS analytics with the alternative in silico binding site iden-
tification showed a good correlation and demonstrates the applicability of this fast method.
Lysozyme PEG binding site identifications were already conducted by numerous authors inclu-
ding Lee et. al and Tilton et al. [130, 138], using MS analytics. Studies by Lee et al. suggest
lysine 33, lysine 97 and lysine 116 as major PEG binding sites, using a PEG-NHS modification.
Tilton applied a PEG-aldehyde reaction and proposed a predominant N-terminal (lysine 1) mo-
dification of mono-PEG-lysozyme, with slight modifications at lysine residues 33 and 97. This
suggests a major influence of the coupling reaction to the resulting PEG conjugation site. By
comparing the results made in this study with results published by Tilton with the same PEG
reaction, a good agreement regarding the lysine reactivities can be detected. In addition both
results corresponds with the fact that main attachment of PEG-aldehyde primarily occurs at
the N-terminal amino group at low buffer pH values.
4 Conclusion and outlook
In this paper the separation of five positional isoforms of mono-PEGylated lysozyme is shown,
and thus represents an increase in resolution compared to published results. By applying a pH
gradient elution, we were able to achieve a superior resolution in contrast to classical salt gradient
runs, which underlines the high separation performance of pH gradients regarding charge variant
separation. An isoform elution order and the resulting PEG conjugation sites were identified,
using a fast in silico approach. The resulting reactivities of the identified lysine residues were
evaluated, and showed a good agreement to comparable PEG reactions [138]. To validate the
proposed binding site results, common MS analytics were applied. The usability of the in silico
binding site identification application was only shown for PEG-lysozyme. With the presented
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chromatographic method, the evaluation of lysozyme isoform reaction kinetics are possible and
are already under investigation. In addition, on-column PEGylation experiments can now be
conducted and analyzed for changes in lysozyme binding orientations.
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Conclusions
In this work novel approaches to accelerate the development of chromatographic purification
processes for low concentrated proteins contained in very complex biotechnological mixtures,
are demonstrated. Due to the low concentration, the feedstock complexity as well as the lack of
applicable affinity techniques, purification process development for these proteins is exceptionally
challenging. In 2007 Ahamed et al. [3] demonstrated that pH gradient IEC can be used as a very
useful tool for chromatographic process development.
However, establishing pH gradient based IEC methods is very challenging as no systematic
approach to generate buffer systems for linear, controllable pH gradients with a preferably
low ionic strength existed so far. A fast and simple methodology to routinely generate such
buffer systems was necessary. Therefore, an in silico methodology to optimize the composition
of buffer systems for pH gradient IEC (chapter I) was developed. Multicomponent buffers with
constant buffer capacity, minimized ionic strength and a linear titration curve over a defined
pH range (7.5 pH units) were generated, using the in silico approach. These were successfully
applied to form linear pH gradients in AEC / CEC. After validating the buffers applicability
for protein separation, pH gradient IEC was further applied to characterize model proteins
and comparing the results with those of isoelectric focusing. The comparison revealed clear
mechanistic differences between the separation methods (AEC / CEC / IEF), motivating a
selective use for different separation challenges. With the in silico tool, buffer compositions in
any pH range for many different purposes, e.g. for pH gradient IEC as a process developmental
tool, can be easily generated.
A systematical screening approach applying pH gradient IEC to determine the information
necessary for laying out purification of low titer proteins from cell lysates by IEC, is demons-
trated in chapter II. The screening process is based on multidimensional fractionation of the
biotechnological feedstock, applying pH gradient IEC, target specific analytics (Dot-Blot), SDS
PAGE as well as protein identification using LC-MS. First the elution-pH values of the target
protein are determined using long range pH gradient IEC (∆pH = 7.5) and target specific ana-
lytics. Afterwards, critical impurities, proteins with electrostatic properties comparable to those
of the target protein, are specifically fractionated using a short range pH gradient IEC (∆pH
= 2) focused on the elution range of the target protein. Fractions are further separated using
SDS-PAGE, the contained proteins are identified using LC-MS based protein identification. By
applying this screening procedure a cell lysate (SF9/Baculovirus) containing a recombinantly
expressed autoantigen was successfully characterized. The obtained information was used to lay
out a simple two-step purification based on IEC, achieving 80 % purity for the target protein.
100
The achieved purity underlines the usage of such an analytical screening for purification process
development instead of classical, knowledge-based purification process development. The shown
screening procedure based on pH gradient IEC is very time efficient, can be easily handled by
a skilled lab technician, while only a small amount of sample is necessary, allowing purification
process development at a very early developmental stage.
A 2nd approach for purification process development focusing on analytically acquiring para-
meters for in silico simulation / optimization of chromatographic separations of complex bio-
technological mixtures with low titers, is demonstrated in chapter III. In silico optimization of
chromatographic procedures has clear advantages over classical process development, the low
developmental time, costs and the increased gain of process understanding due to the possibility
to carry out a large amount of experiments in silico. A rapid, multidimensional fractionation
approach applying IEC, RPC, sample concentrating and HT-CGE was designed and successfully
applied to characterize a complex biotechnological mixture (SF9/Baculovirus cell lysate). To ob-
tain the linear SMA parameters for each single protein contained, the lysate was fractionated by
salt gradient AEC and analysed, using the described approach four times with different gradient
volumes. From the retention volumes and the determined column parameters the linear SMA
parameters of each protein were successfully determined [95]. Acquired parameters were finally
validated by comparing experimental and predicted retention volumes of each protein contained.
Also three exemplary chromatograms were predicted using the transport-dispersive model. Pre-
dicted retention volumes of all proteins, as well as predicted chromatographic elution profiles of
the three chosen proteins were highly comparable to the experimentally determined ones, under-
lining the quality of the determined parameters. The advantages of the described approach are
its velocity, the low amount of sample consumed as well as the possibility to acquire parameters,
allowing for in silico process optimization. The described multi-dimensional fractionation ap-
proach might not only be used for parameter estimation but also for monitoring the composition
of such biotechnological feedstocks. To our knowledge this is the first approach treating single
protein parameter acquisition for mechanistic modelling from very complex mixtures.
The methodologies described in chapter II-III are clearly showing that analytical screenings to
characterize biotechnological feedstocks can be applied as a very useful tool in chromatographic
process development. Furthermore, the screening procedures are designed for the application on
very complex biotechnological feedstocks containing low concentrated proteins. Both approaches
can be used at an early stage of process development as all the experiments can be performed in
analytical lab scale. This concludes to the fact that the major challenge, to speed up purificati-
on process development for low concentrated proteins contained in very complex mixtures, e.g.
biotechnologically produced autoantigens, can be directly addressed by implementing these pro-
cedures already at the stage of upstream process development. Put together with the fact that
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these analytical procedures can be performed very fast by a trained technician, a considerable
decrease of the time-to-market for such proteins can be achieved.
The work described in chapter IV is focusing on a later stage of chromatographic (IEC) pro-
cess development, meaning the decision on detailed chromatographic conditions (pH, salt conc,
gradient operations) for the purification of proteins, also treating the robustness of a process
as an important parameter. To acquire the linear SMA parameters for in silico process deve-
lopment a set of pH gradient operations at different salt concentrations (10 - 350 mM) and
isocratic elution experiments at three different pH values (pH 5, 7, 9) were performed. SMA
parameters were successfully determined from the acquired data by extending the applicability
of the existing SMA model [5] to protein elution in pH gradient IEC. The obtained parame-
ters were successfully validated by comparing predicted elution behaviour of the proteins in
various possible elution modes to experimentally determined data. Resulting deviations could
be explained by typical experimental errors (pH value, salt concentration), which was concluded
from a Monte Carlo simulation expecting a defined error range for pH and salt concentration.
In silico studies on the separation, concerning resolution, efficiency and robustness resulted in
the fact that highest chromatographic resolution can be achieved with pH gradient or isocratic
elution, while robustness is very low. Salt gradient IEC provides the lowest resolution, while
showing very high robustness. The resolution of salt gradient IEC can be increased by adding a
pH gradient to the salt gradient, while robustness of the separation is not negatively influenced
hereby. Determining SMA parameters by the described set of experiments delivers very valua-
ble datasets which allow full optimization of ion exchange chromatography including all elution
modes, furthermore robustness studies can be performed in silico for all conditions and elution
modes. To our knowledge, the approach to obtain full SMA parameter sets for a wide pH range
is the first one described in literature and will surely find further applications in academic and
industrial R&D for purification of proteins. The demonstrated approach might also be used for
purification process development of low concentrated proteins from very complex mixtures but
most possibly at a later stage in process development, as tracking the elution of many different
proteins in pH gradient and isocratic IEC experiments would be very challenging. Therefore,
determining the SMA parameters using the described procedure rather demands for a partly
purified intermediate product instead of a complex feedstock, containing a reduced amount of
different proteins.
In the last chapter a further application of pH gradient IEC in protein charge variant analysis
is described. The idea of using pH gradient IEC for the analysis of PEGylated proteins emerged
due to the discovery of increased chromatographic resolution achieved by pH gradient IEC
(chapter IV) compared to classical salt gradient IEC. For validation, mono-PEGylated lysozyme
was analytically separated using pH gradient IEC. Thereby, we were able to separate five of
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six possible PEGylation isomers. PEGylation sites were identified by correlating calculated pI
values of the different isoforms with the elution-pH values (R2 > 0.99). Elution order was finally
validated by identifying the PEGylation sites using tryptic digestion and MALDI-MS. To our
knowledge the separation of three isoforms of mono-PEGylated lysozyme using chromatography
was the maximum amount so far. Therefore, pH gradient IEC clearly demonstrated its strength
in the separation of charge variants due to its increased chromatographic resolution. This leads
to the conclusion that pH gradient IEC might also be a very useful tool for the analysis of other
protein charge variants, e.g. glycosylation variants of mAbs.
It can be concluded that the set objective to develop simple, more rational methodologies to
accelerate purification process development for protein diagnostics, contained with low titers
in complex biotechnological feedstocks was clearly achieved. The developed analytical screening
methodologies have proven their applicability as experimental approaches for regular application
to accelerate and simplify purification process development for these proteins. Even though
protein concentrations were very low, screening procedures are still kept on analytical scale
consuming only low amounts of sample. Due to the low amount of sample consumed, these
methods may be applied in lab scale at a very early process developmental stage. Additionally, a
systematic approach to generate buffer systems for pH gradient IEC was developed, enabling the
application of pH gradient IEC as standard separation method for proteins and other molecules.
pH gradient IEC proved its usability not only as a screening tool for process development, or
to obtain SMA parameters, but also as a tool for the analytical separation of protein charge
variants, e.g. positional isoforms of PEGylated proteins.
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Outlook
The purification process development for proteins expressed with low titers in very complex bio-
technological mixtures is still a challenging subject, even though the described analytical scree-
nings represent a big step towards rational and accelerated process development. All approaches
demonstrated in this work are applying ion exchange chromatography only, for purification of
these proteins, currently not taking other separation technologies into account. The next step
would be to implement other chromatographic or even non-chromatographic techniques into
the analytical screening approaches to extend the portfolio of applicable techniques to purify
these proteins. The biggest challenges associated with the implementation of these technologies
are already solved, as the analytical methodologies might be easily linked to other screening
experiments.
A bigger step further would be the development of complete databases containing purificati-
on parameters of all contained components in standard expression systems, e.g. CHO, insect
cell/Baculovirus expression systems. These databases would further be applicable to completely
develop purification processes in silico for target proteins expressed in these systems. As proteo-
me analytical technologies got more and more technically advanced and affordable in the last
few years this perspective is not a simple pipe dream any more and most probably first promi-
sing scientific results in that field will be seen in the next few years. Nevertheless, obtaining full
parameter databases for standard expression systems is still a long road to go.
Due to the introduction of a systematic method to develop buffer compositions for pH gradient
IEC, method development for protein separation using pH gradient IEC is not a challenge any
more. As it was already demonstrated that by using pH gradient IEC superior chromatographic
resolution can be achieved, pH gradient IEC will most probably find further application in the
separation of protein charge variants, e.g. glycosylation variants of antibodies. Further applica-
tions might be the usage of buffer systems for pH gradients in Mixed Mode Chromatography
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